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Abstract
Infectious bursal disease virus (IBDV) is a member of the birnavirus family and is 
the causative agent of infectious bursal disease (IBD). The virus has a 
bisegmented dsRNA genome; the larger of these 2 segments is segment A and 
has 3 open reading frames (ORFs). One of these ORFs encodes a polyprotein that 
is processed to 3 polypeptides VPX, VP3, and VP4. VP4 has been dem onstrated 
to be responsible for the the cleavage of the polyprotein in an autocatalytic co- 
translational manner.
The VP4 protein has not yet been characterised and has no homology with any 
other know n protease except a lim ited hom ology w ith  the Lon pro tease in 
bacteria. Several active sites are proposed; w ith the spacing of type I serine 
proteases, w ith spacing of type II serine pro teases and w ith  spacing of the 13-
lactam ase fam ily of pro teases. The cleavage sites have been proposed by 
molecular weight determination as being 2 dibasic residues at either end of VP4. 
Here I describe the expression of the full length polyprotein  in a coupled 
transcription/translation system and in E. coli. Deletion mutagenesis of the VP4 
revealed that VP4 is required for correct processing of the processing of VP3 and 
the processing of VPX to VP2. However, the processing of VP3 is only completely 
abolished when a deletion into VP3 passed the A-x-AAS cleavage site. Deletion 
m utagenesis of the N term inus of VP3 in the polyprotein  showed that the 
cleavage sites of VP4 as being A-x-AAS sequences. Site directed mutagenesis 
studies w ith in  VP4 revealed several im portan t residues for the correct 
processing, the most im portant of these being the S652. Of the residues m utated 
here, there does not seem to be a "classical" catalytic triad for this pro tease.
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1 Introduction
1.1 Infections Bursal D isease Virus
1.1.1 The History of IBDV
Infectious bursal disease virus (IBDV) is the aetiological agent of infectious bursal 
disease (IBD), which was first observed in a broiler flock in Gumboro, Delaware, 
USA in 1957 (Cosgrove, 1962). The disease was characterised by the enlargement 
of the bursa of Fabricius (hereafter referred to as 'bursa ') and lesions in the 
kidneys. This lead to an initial diagnosis of nephritis-nephrosis syndrom e of 
chickens (Cosgrove, 1962). The first putative causative agent to be isolated was 
Gray virus (W interfield & Hitchner, 1962), which came from a field case of 
nephrosis w ith lesions in the kidney similar to those of IBD. However, later 
studies showed that birds that were immune to Gray virus could still be infected 
w ith  the IBD agent. Gray virus w as finally identified  as an IBV isolate 
(Winterfield et al, 1962). IBDV was first isolated by Edgar and Cho (1965) and 
was initially classified as a picornavirus (Cho & Edgar, 1969). It was later 
classified as a reovirus (Lukert & Davis, 1974), on the basis of possessing a 
segmented dsRNA genome, and subsequently as a m em ber of a new family of 
viruses, the biniaviridae (Brown, 1986, Dobos et ai, 1979). The birrwviridne m'e now 
su b d iv id ed  in to  3 genera, the aq u ab irn av iru ses, av ib irn av iru ses and 
en tom obirnaviruses (M urphy et al. 1995). IBDV is the only m em ber of the 
avibirnavirus genus. Infectious pancreatic necrosis virus (IPNV), oyster virus 
(OV) and tellina virus (TV) are all members of the aquabirnavirus genus and
Drosophila X virus (DXV) is the only member of the en te mob i r n a v i r us genus 
(Murphy cfn/. 1995).
After the initial isolation in the USA, IBDV has been reported in all major 
commercial poultry producing countries. Only recently has IBDV been reported 
in New Zealand, introduced possibly as a contaminant of a poultry vaccine.
1.1.2 Significance of IBDV
IBDV was first reported , by Allan et al. (1972), to be im m unosuppressive 
following infection at an early age. By serum  neutralisation studies, it was shown 
that there w ere two serotypes of IBDV. Serotype I viruses give rise to clinical 
symptoms in chickens and also infect ducks asymptomatically. Serotype II strains 
were isolated from turkeys and do not give rise to any clinical sym ptom s in 
turkeys or chickens (McFerran et al, 1980, Todd & McNulty, 1979).
Original type I IBDV isolates resulted in up to 90% flock m orbidity and up to 
20% m ortality in susceptible 3-8 week old hybrid Leghorn replacement pullets 
but a lower m orbidity and mortality (50% and 3% respectively) was observed in 
broilers aged 3-6 weeks, however the exact status of these isolates are not known 
and other advantageous agents, such as chicken anaem ia virus, may have been 
present. Exposure of flocks of less than 2 weeks of age to IBDV generally leads to 
asymptomatic infection (Lasher & Shane, 1994). Vaccination using live vaccines 
(see section 1.2 Control of IBDV) and the transfer of m aternal antibody from 
parents to progeny have reduced the impact of type-1 IBDV infection.
In 1985 an outbreak of IBDV in the Delmarva Peninsula in the US, resulted in 
16% flock m ortality despite vaccination with the standard type-1 strains. Four
variant virus strains were isolated which differed from the "classical" type-1 
strains by causing rapid atrophy of the bursa and im m unosuppression without 
the usual inflam m atory responses. Vaccination w ith killed variant viruses 
conferred protection against these variant strains and against the "classical" type- 
I strains (Rosenberger et al., 1987). These variant strains were found to be lacking 
a monoclonal antibody (Mab) site found in all the "classical" strains (Snyder et 
al., 1988). In 1989, two further antigenic variants (GLS and DS326) were 
discovered, which lacked two of the Mab sites found in all the "classical" strains 
and did not show the standard clinical signs of mortality or lesions (Snyder et al., 
1989) bu t did cause extremely rapid bursal atrophy and im m unosuppression 
(Snyder, 1990).
Until the emergence of "very virulent" (vv) IBDV the significance of IBDV was 
mostly confined to the im m unosuppressive effect of the virus (Allan et al., 1972, 
Hirai & Shimakura, 1974). vvIBDV emerged in Europe in 1986 in Holland and 
Belgium (Chettle et al., 1989, Van Den Berg & M eulemans, 1991). The vvIBDV 
pathotypic variant gave rise to a 70% mortality rate in egg laying pullets but were 
antigenically similar to the "classical" strains (Oppling et al., 1991a, Snyder, 1990, 
Van-der-Marel et al., 1990), how ever they may not be antigenically identical. 
vvIBDV can break through m aternal antibodies that norm ally w ould protect 
chicks against the "classical" strains (Chettle & Wyeth, 1989). vvIBDV has now 
been reported in the UK, the Middle East, Northern and Southern Africa, China, 
Russia and Japan although there have been no reported outbreaks in the USA, 
Australia or New Zealand to date.
1.1.3 Transmission
IBDV is highly contagious and spreads rapidly between flocks via contact with 
contam inated feed or even a contam inated person (Benton et ni, 1967). IBDV is 
shed from infected birds 1-2 days post infection (dpi) up until the 16th dpi 
(Winterfield et a i, 1972). IBDV can also be transmitted through fomites (Benton et 
nl., 1967), from an earlier infected flock, through intranasal, intraocular and oral 
routes of infection (Hemboldt & Garner, 1964).
IBDV is very stable in the environment, persisting in poultry houses for up to 60 
days and may still be viable after through cleaning and disinfection (Lukert & 
Hitchner, 1984). Once there is an outbreak of IBDV in a poultry  house, it can be 
very difficult to disinfect and prevent a future flock from being infected.
1.2 Control o f  IB D V
IBD is w idespread in commercial chicken populations throughout the world. 
Because of the stability of the virus in the environm ent, control through 
sanitation and isolation is not practical for com m ercial poultry  production 
(Benton et nl., 1967, Cosgrove, 1962). The principle m ethod of control is through 
vaccination. As the serotype II strains are generally asymptomatic most vaccines 
are based on serotype I strains.
The main emphasis for the control of IBD is by vaccination of the dam in order to 
obtain chicks which have passive im m unity for the first four to five weeks of life 
to protect them against early subclinical infection (Kibenge et nl., 1988).
Because the level of passive im munity is variable and unpredictable, a common 
commercial practice is to vaccinate all chicks against IBDV with a live vaccine
during the first three weeks of life (Winterfield ct nl., 1980). A ttenuated vaccines 
vary in their safety and efficacy (Giambrone & Clay, 1986, Giambrone & Glosser, 
1990, Lukert & H itchner, 1984, Naqi ct nl., 1980, Thornton & Pat tison, 1975, 
Winterfield et nl., 1980, Winterfield & Thacker, 1978) and are classified as "mild", 
"intermediate" and "hot" vaccines, but fully attenuated strains do not induce 
im munity in the presence of maternal antibodies (Kibenge et nl., 1988).
Vaccination against vvIBDV can be difficult because these strains can break 
through the levels of maternal antibodies that were previously protective (Box, 
1989, Chettle et nl., 1989, Chettle & Wyeth, 1989, Van Den Berg et nl., 1991, Van 
Den Berg & M eulemans, 1991), however they are antigenically similar (Oppling 
et n i ,  1991b). The use of "hot" vaccine strains can p reven t vvIBDV to an 
acceptable level (Kouwenhoven & van den Bos, 1994), as the vaccine can be 
in troduced in the present of higher levels of m aternal antibodies, bu t these 
vaccines can induce pathology themselves.
1.3 hnniunopathologi/ o f  IBDV
Infection of chicks below 3 weeks of age results in a subclinical infection which 
gives rise to severe im m unosuppression (Allan et nl., 1972, W interfield et nl., 
1972). With classical IBDV strains, infection after 3 weeks results in a morbidity 
of 25-100% whilst the flock mortality ranges between 0-15% (Lukert & Hitchner, 
1984). Flock m ortality peaks at 3 dpi but death may still occur for up to 7 dpi 
(Parkhurst, 1964). Clinical signs are detected from the second dpi and are 
described as pecking at vent feathers, followed by a whitish diarrhoea as well as
anorexia, depression, ruffled feathers, severe prostration and occasionally death 
(Cosgrove, 1962). The cause of death is not known.
The severity of the disease depends on the age of the chicken as well as the sti^ain 
of the virus. Clinical signs are usually observed in chickens of three to eight 
weeks of age whereas younger birds do not manifest these symptoms (Hemboldt 
& Garner, 1964). It has been hypothesised that im m une complexes may play a 
role in the pathogenesis of IBD (Ivanyi & Morris, 1976, Ley et al., 1979), however 
in SPF chickens, the m ortality rate is higher than in commercial chickens. 
M ortality from IBDV has been linked to a severity in the depletion of the 
complement (Skeeles et a i,  1980) but in a later study the same authors reported 
that clotting abnormalities were associated with severity of clinical IBD without a 
change in complement levels (Skeeles et al., 1980). It has also been suggested that 
clinical IBD is dependent on the ability of the virus to infect and replicate in 
bursal cells. However, several groups have dem onstrated that infection of the 
bursa is not necessary for establishment of an IBDV infection but is required for 
clinical signs (Kaufer & Weiss, 1980, Okoye et al., 1992, Okoye & Uzoukwu, 1990).
The bursa, the target organ, has been studied during the course of classical IBDV 
infection by (Cheville, 1967). Three days post infection the bursa swells and has a 
gelatinous, yellow covering. By the fourth day the bursa doubles in weight but 
then afterwards there is bursal atrophy so that on the eighth day the bursa has 
reduced in size to a third of its normal weight. In the case of the American 
"antigenic variants" there is no increase in weight but only rapid bursal atrophy 
(Rosenberger et al., 1987).
IBDV has been shown to infect several organs within the chicken including the 
bursa, spleen, thym us, caecal tonsils and the gut-associated lym phoid tissue 
(Cheville, 1967, H em boldt & Garner, 1964, Okoye & Uzoukw u, 1984, Okoye & 
Uzoukwu, 1990, Sharma et nh, 1989, Sivanandan et al., 1986) but it is the bursa 
that is most markedly damaged with the lesions occurring at one dpi. Within the 
cortex there is a lym phoid depletion, which are replaced by heterophils as time 
progresses. By the second dpi the follicles appear as centres of necrotic debris. 
Destruction of the follicles continues over the next three days resulting in the 
accumulation of tissue debris.
After eight dpi there seems to be a follicular regeneration w ith an increase of 
small lymphocytes in the cortex of some of the follicles and by day nine most of 
the follicles have recovered and this continues until large, healthy, if irregularly 
shaped, follicles are present in the bursa.
There are several lines of evidence that point to B cells being the major cell target 
for virus replication: (i) the bursal necrosis m entioned above, (ii) the antibody 
response to vaccines, (iii) the num ber of B cells is lower in the lymphoid tissues 
and blood of infected chickens (Hirai & Calnek, 1979) and (iv) the virus replicates 
in B cells but not in T cells or null cells (Nakai & Hirai, 1981).
Following infection, serum  IgG levels are reduced and only monomeric IgM is 
produced (Ivanyi & Morris, 1976). Cells that express IgM have been shown to be 
susceptible to infection with IBDV (Hirai & Calnek, 1979) which suggests that 
IBDV has a preference for im m ature B cells. Since theses cells are undergoing 
rapid differentiation at this stage of their development, this may mean that the 
virus prefers actively dividing cells (Müller, 1986).
1.4 IBDV Life Cycle
The replication of the birnaviruses is not yet fully understood and most of our 
knowledge comes from studies of IPNV and the birnavirus replication is often 
com pared to the of the reoviruses as both have double-stranded RNA (dsRNA) 
genomes although the replication of reoviruses is conservative as opposed to the 
birnavirus, which is semi-conservative (see figure l.i).
Viral RdRp activity can be detected in vitro w ithout any treatm ent of the virion 
suggesting that the virus does not need to be uncoated to initiate replication 
(Mertens et ni, 1982, Spies et a l, 1987a, Spies et ni., 1987b).
Genome linked VP g has been dem onstrated for IBDV, IPNV and DXV (Mertens 
et nl., 1982, Persson & M acdonald, 1982, Revet & Delain, 1982, Spies et al., 1987a, 
Spies et ai, 1987b).
Three forms of IPNV intracellular RNA have been identified. The first form was a 
dsRNA that was distinguishable from the genomic dsRNA. This was proposed to 
be a complex of template RNA and its product and is the putative transcription 
intermediate. The second was 24S virus-specific ssRNA that could be resolved on 
a gel to show two bands of genomic length ssRNA, and is the mRNA. The third 
form is a 14S dsRNA that cannot be distinguished from the viral RNA (Somogyi 
& Dobos, 1980).
Figure l.i. A schematic diagram outlining the general replication of the reoviruses 
and the known steps in the birnavirus replication cycle. General replication strategies 
pertaining to both virus families are depicted with red type, those pertaining to the 
reoviruses in green type and those to the birnaviruses in blue type. The question 
marks in the birnavirus life cycle represent the areas of Üie replication strategy that 
are unclear. The ?j represents the metliod of entry into the cell. The ? 2  represents 
whether the virus needs to un coat before viral RNA can replicate as all the proteins 
required for this are present in the virion as it does in the reoviruses. The ?g 
represents the unclarity on the method of transcription. The ? 4  reprensents the 
unknown mechanism of the packaging of ihe viral proteins and the viral RNA.
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It was also shown that in IPNV the ssRNA was synthesised before the dsRNA 
and that radioactivity could be chased from the ssRNA to the dsRNA. This 
suggests that the ssRNA acts as a tem plate for the synthesis of the 
com plem entary strands of the progeny genome (Somogyi & Dobos, 1980). This 
acts as evidence for a sem i-conservative replication m echanism , w hich is 
different from the conservative mechanisms that the reoviruses use (Joklik, 1974).
Infection of cells w ith IBDV does not result in shu tdow n of cellular protein 
synthesis, determ ined by SDS-PAGE of newly synthesised proteins in infected 
and uninfected cells (Becht, 1980). This means that the virus m ust replicate in the 
presence of cellular proteins such as host cell pro teases that may cleave the virus 
proteins.
The mechanism for the packaging of RNA is still unknown, however the 3' non­
coding regions are conserved between segments and thus have been proposed as 
the packaging signals (M undt & Muller, 1995).
1.5 M olecular B io logy o f  IBDV
1.5.1 The Genome
The group is characterised by having a dsRNA genome (Brown, 1986) and an 
icosahedral, non-enveloped capsid (Hirai & Shimakura, 1974). The 2 segments of 
dsRNA are termed segment A (3.432Kbp) and segment B (2.796Kbp) (Azad et nl., 
1985, Becht et n i ,  1988, M üller & Nitschke, 1987a). The genome encodes 3 
polypeptides: (VPl (90KDa), the polyprotein  (108kDa) and VP5 (21kDa)). 
Segment A possesses 3 open reading frames (ORFs), the largest encoding a
11
polyprotein consisting of VP2-VP4-VP3 (see figure l.ii) (Azad ct nl, 1985, B echt, 
1980, Dobos, 1979, Dobos ct nl., 1979, Hudson ct nl., 1986b, M undt & Muller, 1995, 
Nick ct nh, 1976). The polyprotein is cleaved into 3 proteins: VPX (50kDa), VP3 
(32kDa) and VP4 (28kDa). VPX is co-translationally modified into VP2a and then 
into VP2b by a unknow n mechanism (Azad ct n i,  1985, Azad ct ni, 1986, Jagadish 
ct nl., 1988, Müller & Becht, 1982). However, in vitro studies on IPNV and IBDV 
suggest that this m aturation of VP2 is due to a host cleavage event as there was 
no presence of the m ature VP2 in the cell free system (Azad ct nl, 1985, Mertens 
& Dobos, 1982). This polyprotein is cleaved into its individual components by co- 
translational processing. VP4 has been dem onstrated to be responsible for these 
cleavages (Azad ct nl., 1987, H udson ct nl., 1986b, Jagadish ct nl., 1988). VP5 is 
encoded by another smaller ORF at the 5' end of segment A which overlaps with 
the major ORF and is in a -1 reading frame compared with the major ORF.
The 3rd ORF terminates immediately before the start of VP5 and has no protein 
assigned to it. Segment B possesses only one ORF, encoding VPl. Identical 
coding strategies are seen for DXV and IPNV (Huang ct n i, 1986, Nagy & Dobos, 
1984a). Virion composition by molar ratio is: VP2 (51%), VP3 (40%), VP4 (6%) and 
VPl (3%) (Dobos, 1979) VP5 was not detected suggesting that it is not a structural 
protein; it has only been detected in infected cell lysates (M undt ct nl, 1995) 
(figure l.ii).
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Figure l.ii. The genome organisation and proteolytic processing strategy of IBDV 
(Azad et a l ,  1985, Hudson et al., 1986b). The double lines represent the genomic 
dsRNA. The single lines and blocks, showing the ORFs and the proteins, represent 
the mRNA. VP5 is represented by yellow, VPX by dark green, VP2a and VP2b by 
progressively lighter green, VP3 as orange, the polyprotein and VP4 by blue and VPl 
in red. The protein VP4 has been shown to be involved in the primary cleavage 
events of the polyprotein (Jagadish et al., 1988). The question marks represent the 
maturation steps of VPX to VP2a and VP2b where the mechanism of maturation is 
unclear by proteolytic cleavage by VP4 or a host cellular protease.
13
Segment A
3632bp
3036bp
435bp
21KDa
I
lOSKDa
VP5
-mKÊÊÊÊÊKm. mmm*
Polyprotein I VP4
SOKDa 28KDa 32KDa
VPX VP4 VP3I
45KDa 
E- -  I
VP2a
*
40KDa
Segment B
~2900bp
-2680bp
*
90kDa
VPl
dsR N A
m R N A
Protein
VP2b
1.5.2 The Proteins of IBDV
1.5.2.1 VPl
VPl is a 90KDa protein encoded by the smaller segment B (Dobos, 1979). It forms 
a minor structural component of the virion and is the putative RNA-dependent 
RNA polym erase (RdRp). Although VPl has been show n to possess an RdRp 
activity in the presence of Mg2+ it does not have the standard  GDD motif found 
in RdRps (Koonin et al., 1989, Spies et a i ,  1987b). The V Pl protein does not 
appear to be processed after translation although the predicted size of the VPl is 
approximately 98kDa.
VPl was thought to be a multifunctional enzyme with guanyl transferase activity 
and methyl transferase activities, which are required for the production of a 5' 
cap (Spies & Muller, 1990) but this role of VPl as a capping enzyme is uncertain 
as the bond betw een VPl and GMP in the enzym e complex is an alkaline 
sensitive phosphodiester bond (Spies & Muller, 1990) whereas the GMP-enzyme 
complexes are usually formed using a phosphoam ine linkage (Mizumoto et ni., 
1982, Shuman, 1982). A study in IPNV show ed that a phosphodiester bond 
formed the VPl-GMP linkage and it cannot transfer the GMP moiety to GTP. A 
time course study  also revealed that there was a sequential non-reversible 
addition of GMP to VPl (Dobos, 1993). This suggests that VPl does not cap the 
RNA.
In vivo, VPl binds to the 5' or 3' ends of the dsRNA genome segments and the 
segments are circularised (Müller & Nitschke, 1987b), however it is not known 
whether both ends are bound. The complex formed is not destroyed by boiling in
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1.5% SDS. This suggests that VPl is covalently bound to the genome (Müller & 
Nitschke, 1987b) as also seen in IPNV. Birnaviruses are the only dsRNA viruses 
known to have this genome linked protein (VPg) (Calvert ct al., 1991). These VPg 
proteins, which are also seen in, for example, the picornaviruses, are proposed to 
act as a primer for RNA synthesis and as nuclease-like proteins necessary for the 
processing of replicative intermediates. They also provide RNase protection for 
the part of the RNA bound to the VPg protein (Tobin ct nl., 1989, Vartapetian & 
Bogdanov, 1987, Wimmer, 1982).
When VPl was expressed in E. coU no RdRp activity could be detected even 
though the product was immunologically reactive w ith chicken hyperim m une 
serum  (M acreadie & A zad, 1993). V Pl expressed in S. ccrevisne w as 
immunologically reactive to chicken antibodies to IBDV but did not exhibit any 
RdRp activity with an IBDV dsRNA template. A novel RNA polymerase activity 
was detected that was actinomycin-insensitive and absent from the wild type 
yeast. After CsCl centrifugation, the yeast-expressed V Pl, unlike the E. coli- 
expressed V Pl, was found in the pellet, which suggests that the yeast VPl was 
associated with RNA, possibly yeast killer dsRNA (Macreadie & Azad, 1993).
1.5.2.2 VP2
VP2 is the major structural protein of IBDV (Dobos ct nl., 1979). Pulse-chase 
studies with the Cu-1 strain show that VP2 is initially cleaved as a 50kDa protein 
from the polyprotein and then undergoes further cleavage to 45kDa and then 
finally to 40kDa representing the fully mature VP2 (Müller & Becht, 1982). This is 
also seen in the m aturation of VP2 in IPNV and DXV (Dobos, 1977, Nagy & 
Dobos, 1984b). Plowever, other studies have reported different sizes for VP2 and
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its precursors for different and the same strains of IBDV. Dobos (1979) used the 
same IBDV Cu-1 strain as (Müller & Becht, 1982) and found that VPX was 47kDa 
and m ature VP2 was 41kDa. Another strain, 002-73, gave rise to VP2 of 52kDa, 
VP2a of 41kDa and VP2b of 37kDa (Azad ct at., 1985, Fahey ct at., 1985a, Hudson 
ct at., 1986a, Jagadish ct at., 1989). It is thought that the translational modification 
of the SOlcDa VPX does not occur until the m aturation or assembly of the virus 
(Müller & Becht, 1982). The expression of the polyprotein from IBDV strain 002- 
73 in £. coli show ed that VP2 has a hydrophobic n atu re  and contained a 
conformation-dependent epitope (Azad ct at., 1987). Deletion studies showed that 
this epitope lay in a 145 amino acid region which contains a hydrophobic region 
flanked by two hydrophilic regions (Azad ct at., 1987). Deletion of either one of 
these two hydrophilic regions abolished the reaction betw een the VP2 protein 
and a monoclonal antibody (Mab), Mab 17/82, which m aps to this region. This 
means that the two hydrophilic regions may be im portant in the conformational 
epitope of VP2.
Amino acid comparisons of the polyprotein of four IBDV strains, PBC98, Cu-1. 
002-73 and 52/70 has revealed that VP2 is highly conserved by having only 2 
amino acid changes (Bayliss ct at., 1990) outside a "very variable" region, which 
coincides exactly with the major neutralising site (Azad ct at., 1987). Analysis of 
this region shows that the two hydrophilic regions are highly conserved but 
between these two regions is where the majority of the amino acid variation 
occurs (Bayliss ct at., 1990). Antibodies raised against the different strains of 
serotype I cross react indicating that some of the epitope is conserved (Wood ct 
at., 1988) possibly the two hydrophilic regions.
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Azad et a l  (1985) expressed the VP2 region as a fusion protein in E, coli and  
found that the m onodonals available at the time did not bind strongly to the 
fusion protein, suggesting that the conform ational epitope had not formed. 
Deletion m utations in the two hydrophilic regions at either end of the VP2 region 
indicated that these m ight be involved in the formation of the virus neutralising 
epitope (Azad ct al., 1987).
Over expression of the VP2 protein in cell culture using a recom binant vaccinia 
virus (VV) system in which VP2 was expressed from a T7 prom oter by the VV 
expressed T7 RNA polymerase has been shown to cause mammalian BSC40 cells 
to undergo apoptosis (Fernandez-Arias ct al., 1997).
1.5.2.3 VP3
VP3 is another capsid protein of IBDV and IPNV (Dobos, 1979). Studies on the 
amino acid sequence show that the C-terminal region is hydrophilic and basic 
and it has been proposed that this region may be involved in the packaging of the 
genome (Hudson ct al., 1986b).
The first antibodies to appear after infection are those to VP3 (Fahey ct al., 1985b). 
Mabs raised against VP3 recognise both serotypes of IBDV which has thus 
become know n as the group specific antigen (Becht ct al., 1988, Fahey ct al., 
1985b).
Monoclonal antibodies raised against VP3 do not neutralise the virus by virus 
neutralisation studies (Becht ct al., 1988, O ppling ct al., 1991a, O ppling ct al., 
1991b, Reddy ct al., 1992, Snyder ct al., 1988) However, monoclonal antibodies to 
VP3 have been shown to block binding of the virus to the cell which may be due
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to competitive binding between the monoclonal antibody binding to the virus 
and the virus binding to the receptor or by causing the viral particle to aggregate 
(Reddy, 1994, Reddy et a l ,  1992).
1.5.2.4 VP4
VP4 has reportedly been found in purified virus and thus is considered to be a 
structural protein (Dobos, 1979) although more recently VP4 has been associated 
with type II tubulin and has been suggested not to be part of the virus structure 
(Granzow et ah, 1997). Deletion experiments have shown that VP4 is involved in 
the proteolytic processing of the polyprotein and is therefore a viral-encoded 
proteinase (Azad et aL, 1987, Hudson et ah, 1986a, Jagadish et ah, 1988). VP4 
cleaves itself out of the polyprotein in an autocatalytic co-translational manner 
(Duncan et ah, 1987, Jagadish et ah, 1988). The proposed cleavage sites, based on 
the molecular weights of the proteins produced, are R452 R453 and K722 R723 
(Bayliss et ah, 1990, Jagadish et ah, 1988) although there are other dibasic residues 
found within the IBDV genome as shown in figure l.vi. Repeats of the sequence 
A-X-A-A-S had previously been suggested as possible cleavage sites (Hudson et 
ah, 1986b). Three such repeats can be found between the polyprotein residues 485 
and 504 and there is one at residue 754 (see figure l.vi). However there is no A-X- 
A-A-S motif in this position in IPNV but there are 2 copies of an A-G-G-R-Y 
repeat that are well conserved (Heppell et ah, 1993). VP4 is highly conserved 
between IBDV strains with a few changes but sequence comparison with other 
Icnown protease sequences has not given any convincing homology (Bayliss et ah, 
1990, Hudson et ah, 1986b).
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Expression of the complete large segment A polyprotein in E. coli has been the 
main expression system utilised (Azad ct al, 1985, H udson ct al, 1986b, Jagadish 
ct aL, 1988). They detected VP2, VP4 and VP3 proteins, confirm ing that the 
polyprotein consisted of these proteins and that the order was VP2-VP4-VP3. 
They also show ed that correct proteolytic processing occurred in E. coli but they 
could not tell w hether a viral protease or a cellular pro tease was involved. 
Deletion m utations w ithin the VP4 region affected processing at both the VP2- 
VP4 and VP4-VP3 junctions. An insertion of 10 codons near the presum ed N- 
term inus of VP4 did not affect processing but an insertion of 4 codons in the 
m iddle inhibited the correct processing of the polyprotein and produced mainly 
unprocessed polyprotein. Deletion m utations in VP4 show ed that VP4 was 
involved in processing of the VP4-VP3 junction but deletion mutations in the VP3 
did not affect the processing of the VP2-VP4 junction. In-phase insertions at the 
presum ed VP2-VP4 junction prevented the cleavage at this junction. As serine 
pro teases frequently cleave at dibasic residues, it was predicted that RR dibasic 
residues at 451-452 amino acids and KR dibasic residues at positions 721 and 722 
were the VP2-VP4 and VP4-VP3 cleavage sites, respectively. M utagenesis at the 
Lys-Arg cleavage site to non-basic residues of Ile-Cys inactivated processing 
functions (Jagadish ct al, 1988).
IPNV also encodes a viral pro tease at the same position as VP4, designated NS 
(Duncan ct a l, 1987, Nagy ct al., 1987). The homology between two IPNV strains 
(Jasper and N l) in the NS region is 79.9% at the amino acid level but between 
VP4 of IBDV and the NS of IPNV the homology is very low, (26% sequence 
similarity (Azad ct n/,, 1987, Havarstein ct al., 1990, H udson ct al., 1986b). The NS 
protein of IPNV bears no significant homology with known pro teases (Duncan ct
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nL, 1987). Deletion of the carboxy term inus of the IPNV NS strain results in 
incomplete cleavage which suggests that this sequence is crucial to the activity 
and may contain an active residue or im portant structural residues (Duncan et al., 
1987). Whereas IBDV VP4 was detected in the virion, the NS protein of IPNV is 
undetectable.
Drosophila X virus sequences in the same genomic position as the IBDV VP4 
encode a protein of 27kDa (Chung et al., 1996) which is also found in the virion 
and has been designated VP4 (Dobos et al., 1979). The N-term inal amino acids of 
the DXV protein, isolated from the virion, were sequenced and found to be 
ADSPL. This suggests that the cleavage between the VP2 and VP4 junction be 
between residues S500 and A501 (Chung et al., 1996). The N-term inus of VP3 was 
blocked and therefore the cleavage site could not be determ ined but several sites 
were proposed as possible cleavage sites.
This cleavage site seen for the VP2-VP4 junction in DXV does not relate to the 
potential cleavage sites suggested for IBDV and IPNV, how ever the VP4 protein 
may be sufficiently different between IBDV, IPNV and DXV that they may not 
cleave in the same position. The sequence sim ilarity at the amino acid level 
between VP4 from IBDV and DXV is 32%, which is higher than that between 
IPNV NS and IBDV VP4.
1.5.2.5 VP5
The fifth protein in birnaviruses, VP5, was first detected in IPNV infected cells 
using monoclonal antibodies raised against bacterially expressed VP5 (Magyar & 
Dobos, 1994). VP5 for IBDV has also been detected in IBDV infected cells by
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im m unoblo tting  and  im m unoprécip ita tion  and in infected chickens by 
im m unofluoresence using a VP5 polyclonal serum  raised in rabbits from 
bacterially expressed VP5 (M undt ct nl, 1995).
The predicted size for VP5 in IBDV is 17kDa but in infected cell lysates it is 
21kDa (M undt ct al., 1995) w hich m ay suggest som e post-translational 
modification. Com parison of the IBDV and IPNV predicted protein sequences 
shows very little homology, although three cysteine residues are conserved. 
These three cysteines are thought to be involved in the structure of the protein 
which suggests that VP5 in IPNV and IBDV play a similar role (Havarstein et ai, 
1990). A small ORF has also been discovered in the DXV genome (Chung et al., 
1996). This small ORF is larger than the IBDV and IPNV VP5 ORFs, giving a 
predicted size for the translated product of 27kDa. Its genomic location is also 
different as it is found w ithin the polyprotein sequence in a different reading 
frame over the VP4-3 junction (see figure l.iii). It has little homology with either 
IPNV or IBDV VP5, however it is arginine rich as is VP5 in IBDV and IPNV but 
the cysteine residues are not conserved.
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Figure l . ii i .  C om parison  of the genom e organisation  of segm ent A betw een  IBDV, 
IPNV and  DXV w ith  the different nom enclatures used for each virus. The turquoise 
an d  red areas in the IPNV gen o m e rep resen t  the areas be tw een  the p roposed  
cleavage sites of NS. The IBDV genom e organisation  is sh o w n  us ing  the dibasic 
residues as the p roposed  cleavage sites of VP4. The DXV genom e organisation  is 
show n using the cleavage site at the pVP2-VP4 junction as de te rm ined  from protein 
sequencing and the proposed  cleavage site at the VP4-VP3 junction.
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The antibodies used to detect IBDV VP5 by im m unoprécipitation, do not detect 
VP5 in purified virions by western blot and it has been suggested that VP5 is a 
non-structural protein (M undt et al., 1995). In contrast, the VP5 of IPNV is 
thought to be associated with the virions (Havarstein et al., 1990), the function of 
VP5 remains unknow n at this present time. A reverse genetics system for IBDV 
has been developed (M undt & Vakharia, 1996) providing a w ay of investigating 
the functional roles of the proteins in the virus. Using this technique, M undt et al.
(1996) showed that VP5 was non-essential for the replication of IBDV in cell 
culture but did slow down the replication rate of the virus.
1.6 Viral Viridence
Viral virulence is connected to the pathogenicity of related strains. A traditional 
understanding  of virulence is that the host and parasite co-evolve towards a 
benign symbiosis, and it is unusual for a parasite to increase virulence. This 
m eans that as the host population  continues to live then the parasite will 
continue to grow  (Ewald, 1993). C urrent theories, how ever, suggest that 
virulence is related to the m ode of transm ission. A parasite  that causes 
immobility in the host will limit its transmissibility to other hosts but if a parasite 
can rem ain stable in the environment, then greater pathogenicity and extensive 
replication of the parasite possibly leading to death of the host, may be a 
competitive advantage (Ewald, 1993). The emergence of the vvIBDV strains in 
the late 1980's may be due to the stability of the \Trus in the environment.
IBDV may exploit the "window of opportunity". The w indow  of opportunity is 
created when the maternal antibodies have decreased enough so that infection
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with virulent virus but not with the attenuated vaccine can take place. vvIBDV 
has been shown to be able to infect young chicks even in the presence of maternal 
an tibodies thus an increase in virulence w ould  allow  the "w indow  of 
opportunity" to be greater and make the replication of the virus more successful.
Changes in virulence may be due to changes in secondary structure of the RNA 
genome (e.g. poliovirus neurovirulence), changes in the viral-encoded pro tease 
activity (e.g. Bovine Viral Diarrhoea Virus (BVDV) cytopathogenicity), changes in 
the g row th  rate (e.g. P seudorabies v irus v irulence), or changes in the 
im m unogenicity of the virus (e.g. H antaan virus virulence). These changes in 
virulence are determ ined by the changes in the genome and can sometimes be 
attributed to a single base change. Several of these changes are potentially 
relevant to IBDV.
1.6.1 Examples of Increases in Viral Virulence
1.6.1.1 Poliovirus Neurovirulence
Poliovirus is the prototypic member of the picornavirus family and has a positive 
strand ssRNA genome of size of approximately 7.5 kbp. The genome has a VPg 
linkage at the 5' end of the genome.
Changes in the secondary structure of the 5' non-coding region of the virus have 
been linked to changes in the neurovirulence of attenuated vaccine strains. A 
m odel of the secondary structu re  of the 5' non-coding region has been 
determ ined  using com puter m odelling of polio and other picornaviruses 
(Skinner et al., 1989). This w ork was then supported by biochemical analysis of 
this region using chemical modification and ribonuclease cleavage. This work
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proposed that a long range interaction between regions 471-483 and 528-538 was 
im portant for neurovirulence.
Comparison of changes in the Sabin vaccine strain and a neuro virulent revertant 
strain  which occur in this region suggested that w ithin the neuroviru lent 
revertant strain there was a restoration of base pairing to make the secondary 
structure between the two regions more stabile (Skinner et a i,  1989).
It has also been shown that in the Sabin type 111 vaccine strain there is m utation 
which causes a coding change in the VP3 structural protein (Westrop et ai, 1989). 
The study of recom binant viruses showed that both this m utation and the one 
described above are required for full attenuation of the virus. The change in the 
VP3 structural protein gives rise to a tem perature sensitive {ts) phenotype, which 
may be im portant for attenuation.
1.6.1.2 Bovine Viral Diarrhoea Virus fBVDV) Cylopathogenicitv
BVDV is a member of the pestivirus genus, in the Flnvivlridne family. The genome 
of pestiviruses is positive single stranded RNA and there are no subgenomic 
RNA species produced. The genome organisation has been determ ined so that 
the entire polypeptide complement has been elucidated (Collett et al., 1991). The 
5' end of the genome encodes the structural components of the genome and the 
non-structural com ponents are encoded at the 3' end of the genome (Collett,
1992). There are two proteases encoded for by the BVDV genome: a p20 
responsible for cleaving itself out of the N -term inal end of the polyprotein 
(Wiskerchen et al., 1991) and a p80 or a p i 25 responsible for the cleavage of the 
non-structural proteins (W iskerchen & Collett, 1991). The p20 is a cysteine
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prolease similar to papain (Stark et nL, 1993) w hereas the p80 is a trypsin-like 
serine pro tease w ith a catalytic triad of His, Asp and Ser (Bazan & Fletterick, 
1989, Gorbalenya et nl., 1989, Wiskerchen & Collett, 1991).
There are two b io types of BVDV; the non -cy to p a th o g en ic  and the 
cytopathogenic, which is derived from the non-cytopathogenic by a variety of 
mutations. These m utations affect the proteolytic processing of the pl25 protease. 
Several mechanisms have been suggested for the change in biotype: insertion by 
recombination of one or more monomers of ubiquitin (Osloss, CPI and III-C) or 
the duplication and translocation of the p20 protease (Pe515c) or the p80 (CPI, 
III-c and Pe515c) (Meyers et. nl., 1992, Qi et ni, 1992) (see figure l.iv). In all cases 
these rearrangem ents result in the cleavage of the p80, which corresponds to the 
C terminal part of the pl25, and provides the only difference in the protein 
profile between the two bio types (Donis & Dubovi, 1987). The presence of free 
p80 in the cytoplasm is believed to be responsible for the cytopathogenicity. The 
p i 25 is suggested to be associated with membranes a n d /o r  nucleic acids through 
the N-terminal part of p i 25, p54.
With the cytopathogenic biotypes there is a cellular protein shutdow n late on 
in infection (Boulanger, pers. comm.). The p80 in the cytoplasm could access 
proteins that are not accessed by pl25 and could result in cytopathogenicity 
(Wiskerchen & Collett, 1991)
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Figure l.iv. A diagram showing the various methods of mutations employed by the 
cytopathogenic biotypes of BVDV. The top diagram shows the complete genome 
proteins for the non-cytopathogenic strains, with red blocks representing the p20, the 
yellow blocks representing the p54 protein that is cleaved in the cytopathogenic 
viruses, blue representing the p80 protease that is responsible for the cleavage of p80 
and p54 in the cytopathogenic strains, pink representing the plO protein and green 
representing ubiquitin (Ubq). In the Osloss strain of BVDV a single Ubq protein is 
added between the p54 Emd p80 proteins. In strain CPI there is a duplication of the 
p80 protease with two Ubq proteins separating the two p80 proteases. In strain III-C, 
p54 and p80 are duplicated with a single Ubq protein separating the duplicated 
proteins. In strain Pe515c, the p80 protease is duplicated witli additional plO and p20 
proteins separating the duplicated p80 proteases. Modified from Meyers et al., 1992 
and Qi et al, 1992.
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1.6.1.3 Pseudorabies Virus (PRVI Virulence
PRV is a m em ber of the a lphaherpesv irinae fam ily and encodes several 
glycoproteins including glycoprotein I (gl). This protein  was studied in the 
porcine system  by Jacobs et nl. (1993) and although it w as found to be non- 
essential for growth of the virus (Mettenleiter et nl., 1985), it has been shown to be 
im portant for the transneuronal transport of PRV in rats (Card et n i,  1992) and 
through the CNS of pigs (Kimman et nl., 1992). Jacobs et al. (1993) showed that 
deletion of valine 125 and cysteine 126 resulted in a decrease in virulence of PRV 
in pigs. A m utant with a deletion of glycine 59 and aspartic acid 60 showed wild 
type virulence and could be isolated from brain tissue unlike the m utant w ith 
decreased virulence and a m utant deleted for the whole gl protein, which could 
only be found in the trigem inal ganglion. Thus the gl protein is im portant for 
transport in the CNS or uptake of the virus.
1.6.1.4 Hantaan Virus fHV) Virulence
HV is the pro to y pic strain of the Hnntnvinis genus of the family Biini/nviridne and
is the aetiological agent of Korean haem orrhagic fever, which is a severe and 
possibly fatal disease of hum ans. Two clones of H antaan  76-118 have been 
isolated from Vero E6 (Tamura et ni., 1989). HVcl-1, which is virulent in mice, has 
a high titre in mice and induces cell fusion, and HVcl-2, which is a virulent, has a 
low titre and induces a cytotoxic T cell response unlike HVcl-1. Sequence 
comparisons of the 2 clones in the L, M and S segments revealed a single amino 
acid difference betw een them at residue 1124 of segm ent M, w ithin the G2 
glycoprotein (Isegawa et nl., 1994). This change is a serine residue in clone HVcl- 
1, also found in the w ild type virus, to a glycine in HVcl-2. As there is no
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difference in the mortality of SCID mice when infected with the 2 clones, Isegawa 
et n i, (1994) proposed that this change is the factor that affects the infectivity, CTL 
induction and the cell fusion. They also proposed that the nucleic acid sequence 
difference, per se, was not responsible for the differences in virulence but rather 
cause an altered immunological response in the host, nam ely an increase in T cell 
activity when infected with ITVcl-2.
1.7 The Role o f  Proteases in Virus Infection
N early every virus equires proteolytic processing during  its replication cycle, 
IBDV being no exception. Well stud ied  exam ples include picornaviruses, 
retroviruses, bacteriophage T4 and more recently the flavi- and pestiviruses. The 
proteinases involved in this processing can be either viral encoded or of host 
origin. Polyproteins that are formed in the cytoplasm are usually cleaved by a 
virus encoded protease. These polyproteins are usually  prim ary  translation 
products. Viral glycoproteins that are associated with the m em brane are usually 
processed by a host-derived protease during m aturation a n d /o r  transport (Rice 
& Strauss, 1981). C leavage of cytoplasm ic polyproteins by a viral-encoded 
pro tease has so far only been dem onstrated in RNA viruses and African swine 
fever virus (Simonmateo et a i,  1993), however DNA viruses such as adenovirus 
and bacteriophage T4, use their own encoded pro tease in the m aturation of their 
capsid proteins (Wellink & van Kammen, 1988).
1.7.1 Types of Proteases
Pro teases are enzymes that catalyse the hydrolysis of peptide bonds and are 
categorised according to their site of action. Exoproteases initiate the removal of
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amino acids from the amino- or carboxy-termini of proteins and usually continue 
this activity in a progressive fashion. Endoproteases, or proteinases, cleave 
specific peptide bonds located in internal portions of a protein or polypeptide 
substrates called the 'scissile bond ' (Dougherty & Semler, 1993).
Known proteinases are grouped into four classes: serine, cysteine (or thiol), 
aspartic and metalloproteinases.
1.7.2 Serine Proteinases
Structural and functional properties of serine proteinases have been studied 
extensively. There are four essential structural features involved in the catalytic 
cleavage of the scissile bond:
1. A catalytic triad consisting of His, Asp and Ser (see figure l.v). The His 
residue of the catalytic triad acts as a base that can accept a proton from the 
reactive Ser, causing formation of a covalent tetrahedral transition state.
2. The stabilisation of the tetrahedral transition state is achieved by the 
'oxyanion hole', which contains amino acid side chains that can form hydrogen 
bonds with the charged oxygen on the alpha-carbon next to the scissile bond 
(Cl). The positive charge formed on the His residue in the catalytic triad also 
stabilises the negatively charged transition state.
3. Residues in the enzyme that can hydrogen bond w ith the substrate to 
form a short antiparallel |3-sheet which enhances stabilisation whilst cleaving the 
bond.
33
F ig u re  l .v .  A schem atic  v iew  of the cata ly tic  triad of the se r in e  p ro tease  
c h y m o try p s in  w ith  the n u m b e rs  rep re sen t in g  the posi t ions  of the res idues  in 
chym otrypsin . The black spheres  represent carbon atoms, the red spheres  represent 
oxygen and the blue spheres represent nitrogen a toms (Voet & Voet, 1990).
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4. Specificity is achieved by the use of a "specific binding pocket' (SBP), 
which accepts the side chain t the N-terminal side of the scissile.
The catalytic triad is responsible for cleavage and is fixed in space by the three
dim ensional structure of the a-carbon backbone of the proteinase. The serine
residue is usually unreactive but in serine pro teases it acts as the nucleophile 
during catalysis, by a charge relay process (Dougherty & Semler, 1993).
The reaction proceeds in two steps; the first involves the formation of a covalent 
bond between C l and the hydroxyl group of the serine of the catalytic triad. This 
results in form ation of the 'acyl-enzym e interm ediate, a negatively charged 
transition state interm ediate, w here the bonds of Cl have tetrahedral geometry. 
During this step the scissile bond is cleaved, leaving one of the products still with 
the reactive serine group attached. The second step is the déacylation of the 
serine residue from the "acyhenzym e" interm ediate by hydrolysis with a water 
molecule (see figure l.vi).
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Figure l.v i .  The m echan ism  of action of serine proleases w h en  cleaving the scissile 
bond. E s tands  for en zy m e and  R indicates the position  of the s ide  chains of the 
am ino  acids at position P and P' at e ither  s ide of the scissile bond. M odified from 
Warshel ct nl. (1989).
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It was thought that serine proteinases contain the three invariant residues 
(histidine, aspartic acid and serine) of the catalytic triad (see figure l.v). 
However, it has now been show n that, for some serine proteinases, there is no 
histidine residue within the catalytic site and a lysine residue, usually upstream  
of the serine replaces the aspartic acid. This family of serine proteinases possess 
catalytic dyads rather than the classical triads (for review see Paetzel & Dalbey,
(1997)). The num ber of know n proteinases that have serine and lysine dyads is 
growing bu t the best studied include E. coli leader peptidase (involved in signal 
peptide cleavage), E. coli LexA (a repressor of the SOS system) and E. coli Tsp 
pro tease (a tail specific protease). Other catalytic dyads consist of a serine and a 
histidine as found in the esterase from Slreptomyces scabies (Wei et ai, 1995). When 
the structure of this pro tease was determ ined it was found that in the active site 
actually contained a tryptophan residue instead of the aspartic acid.
1.7.3 Serine protease inhibitors
Many of the studies on pro teases involve the use of pro tease inhibitors. Inhibitors 
can be chemical or other proteins that can interfere with the mechanism of action 
of the pro tease concerned. Many inhibitors are commercially available and easy 
to use. One of the m ost com m only used serine p ro tease inh ib ito rs is 
p he ny 1 me thy 1 s ul f 0 ny 1 f 1 uo r i d e (PMSF) w hich irreversib ly  inhibits serine 
proteases by the sulfonylation of the serine residue in the active site of the 
pro tease (Prouty & Goldberg, 1972). It does not inhibit the other classes of 
pro teases but does inhibit papain, a cysteine protease, though the inhibition is 
reversible by DTT (Prouty & Goldberg, 1972). PMSF is toxic, unstable at room 
tem perature w ith a half life of 1 hour at pH  7.5 and stock solutions m ust be
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prepared in anhydrous solvents (James, 1978). Other commonly used inhibitors 
include: (i) diisopropylfluorophosphate (DFP), which is highly toxic, has a short 
half life and acts in the same way as PMSF (Banerjee et al, 1991, Bharadwaj et al., 
1996, Prouty & Goldberg, 1972, Wilson & Walker, 1974), (ii) l-Chloro-3-tosyl-4- 
phenyl-2-butanone (TPCK), which inhibits chym otrypsin bu t not trypsin by 
alkylating the histidine residue in the active site (Prouty & Goldberg, 1972), (iii) 
(4-2-A m inoethyl)-benzenesulfonylfluoride hydrochloride (AEBSF), which is 
more stable than PMSF and inhibits by acylation of the active site of the enzyme 
(H ahm  et aL, 1995), and (iv) A protin in , a short-chain  polypeptide which 
reversibly inhibits by binding to the active site of the enzyme (Zyznar, 1981).
1.7,4 Examples of serine proteases
Serine pro teases have been classed in several types depending on the residues 
that comprise the catalytic sites (Neurath, 1984).
1.7.4.1 Serine proteinases 1
The proteinases of this family of serine proteinases have a catalytic triad 
comprising of histidine, aspartic acid and serine, in that order within the protein. 
The best know n proteinases of this family are chym o trypsin and trypsin. 
Chymo trypsin is the representative m em ber of the type 1 family and has a 
catalytic triad of His 57, Asp 102 and Ser 195 as determ ined by 3D structural 
analysis by X-ray crystallography (Birktoft et a!., 1970, Blevins & Tulinsky, 1985, 
Blow, 1969, Capasso et a i, 1997, Cohen et al., 1981, Henderson, 1970, M atthews et 
ai., 1967, Sigler et a!., 1968, Steitz et ai, 1969). The catalytic triad is the same for 
trypsin, elastase and pancreatic kallilkrein (Bode et al., 1983, Gaboriaud et ai.
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1996, H uang et al., 1994, Saw yer et al., 1978, Shot ton & W atson, 1970). 
Chym o trypsin  cleaves after arom atic L-amino acids and is inhibited by 
Aprotinin, PMSF, AEBSF and TPCK. Trypsin cleaves after arginine and lysine 
residues and is inhibited by AEBSF, Aprotinin, PMSF and DFP. Elastase cleaves 
after neutral amino acids and is inhibited by DFP.
1.7.4.2 ATP-dependent serine proteases
Putative members of this family are the bacterial Lon or La pro teases (hereafter 
referred to as Lon). The Lon pro tease is a product from the Ion gene and is an 
ATP-dependent cytosolic pro tease and a heat shock protein, which plays a role in 
intracellular protein degradation (Chung & Goldberg, 1981, Goldberg et al., 1994). 
The Lon gene product in E. coli is 783 amino acids in length and is a te tramer in 
the native form (Chung & Goldberg, 1981). It appears to be a serine pro tease 
(Eastgate et al., 1995) from m utational analysis in that the m utation of serine 679 
abolishes proteolytic activity. Compared with the classical serine pro teases of this 
family, it reacts slow ly w ith DFP, in common w ith  m any A TP-dependent 
proteases. There is a single ATP binding motif within the amino acid sequence of 
the Lon protease (Goldberg et al., 1994, Waxman & Goldberg, 1985) . It is an 
endoprotease, cleaving substrates at m ultiple sites to yield products of between 
5-20 amino acids long. Its m ain role is the inactivation of the Sul A protein 
involved in the SOS system in bacteria (Chung & Goldberg, 1981).
1.7.4.3 Serine proteinases II
The proteinases of this family have a catalytic triad of aspartic acid, histidine and 
serine, in this order within the protein. The best described pro tease of this family 
is subtilisin, first discovered in Bacillus subtillis bacteria. The catalytic triad of
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subtilisin is Asp 32, His 64 and Ser 221 as determ ined by X-ray crystallography 
(Estell et ni., 1988, Finzel et al., 1986, Kraut H al., 1972, N eidhart & Petsko, 1988, 
W right et a i,  1969). The im portance of the catalytic triad was examine by site 
directed m utagenesis (Carter & Wells, 1988). Replacing the m em bers of the
catalytic triad with alanines reduced the kcat of the enzyme by 2x10^ for S221A,
2x10^ for H64A and 3x10^ for D32A whilst only making a 2 fold difference in the 
Michaelis constant (Kni) (Carter & Wells, 1988). Combining m utations of S221A 
with H64A a n d /o r  D32A showed that the value of Kcat rem ained the same as the 
original S221A mutation. Combining D32A and H64A reduced the value of Kcat
by 3x10^ from that of wild type, less than that due to H64A alone. Subtilisin has a 
broad specificity to both native and denatured proteins and AEBSF, Aprotinin, 
DFP and PMSF inactivate it.
1.7.4.4 Proteinases with catalytic dvacis
The best described m em bers of this group are those from  E. coli: Leader 
peptidase, LexA and Tsp. Leader peptidase is an enzym e which is associated 
with the plasma membrane in E. coli. Secretory proteins have a 15-30 amino acid 
leader sequence, which is cleaved by either lipoprotein signal peptidase or by the 
leader peptidase (Dalbey & Wickner, 1985). Lipoprotein leader peptidase, as it 
nam e suggests, cleaves lipoproteins and is an integral protein of the plasm a 
membrane. Leader peptidase is a 37kDa protein w ith 5 domains. Three of these 
domains, H I, H2 and H3, are apolar domains and HI and H2 are associated with 
the membrane. H3 and the P2 polar domain protrude into the periplasm  (Dalbey 
& Wickner, 1986). By genetic analysis it has been show n that the HI apolar 
dom ain and the PI polar dom ain are not directly involved in catalysis (B il gin et
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ni., 1990). Leader peptidase is not inhibited by the classical serine pro tease 
inhibitors and cleaves after the consensus sequence Ala-X-Ala (von Heijne, 1989). 
M utations in the leader peptidase protein have show n that the histidine and 
cysteine residues are not im portant for catalysis in vitro. Sung & Dalbey, (1992) 
show ed that m utants w ith S90A, D99A, D153A, 8185A, D273A or D276A 
m utations have a very low activity //z vitro. H ow ever, using a tem perature 
sensitive leader peptidase m utan t strain  of E. coli, Sung and Dalbey (1992) 
showed that m utants with S185A, D273A or D276A m utations have comparable 
activity to the wild type, by the processing of ProOm pA in vivo. The D99A 
m utant protein has a very short half-life of 2 minutes in vivo, as determ ined by 
pulse chase. They therefore surm ised that S90A and D153A constituted part or all 
of the active site. S90 was also show n to be an active site residue by Black et al., 
(1992) who excluded D153 as part of the active site because the D153N m utant 
had similar activity to the wild type, thus suggesting that the D153A m utation 
changed the conform ation of the protein. Black et al (1993) also found that 
m utating K145 inhibited proteolytic activity w hereas m utating  other lysine 
residues did not.
A lthough the cleavage of LexA repressor required RecA protein it was in fact 
show n to be an autocatalytic event (Little, 1982). RecA is not a pro tease but 
stimulates the autodigestion of the LexA repressor at a conserved ala-gly bond 
(Little & Mount, 1982, Walker, 1984). Using site directed mutagenesis techniques 
Slilaty & Little, (1987) were able to show that the K156 and the SI 19 were 
required for the function of the pro tease.
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Tsp protein is a periplasmic pro tease in E. coli which has been implicated in the 
processing of the penicillin b inding protein 3 (PBP3) (Silber el al., 1992) and 
which cleaves the Arc and X repressors (Keller ct n i,  1995). Any known protease
inhibitors do not inhibit it. Keiler et al., (1995) purified 6-histidine tagged wild 
type and m utant Tsp pro teases which, were assayed for their ability to cleave the
X repressor and bind to FITC labelled bovine insulin B chain. It was found that
S430A, D441A and K455A all inhibited pro tease function but that they had 
similar structures by circular dichroism  and similar substrate binding activity. 
However the D441N m utation does not affect the activity of the enzyme (Black,
1993) suggesting that residues S430 and K455 are the active residues.
1.7.5 Viral Proteinases
The concept that proteinases could be involved in virus replication was first 
proposed for poliovirus and bacteriophage T4 (Showe & Black, 1973, Summers & 
Maizel Jr., 1968). The poliovirus work was based on labelling studies where the 
molecular weights of the proteins exceeded the coding capacity of the RNA. 
Pulse-chase experiments determ ined the relationship between the precursors and 
the final products (Jacobson & Baltimore, 1968). However it was not until 1978 
that it was discovered that a viral proteinase was responsible for this cleavage 
(Pelham, 1978). The first DNA virus to have proposed proteolytic processing was 
the bacteriophage T4 w here complex processing events are involved in the 
m aturation of the T4 prohead (Showe & Black, 1973).
After these initial observations, proteolytic processing has been described for 
many other viruses. The m ain technique used for these studies involved pulse-
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showing the relationship between products and precursors (Marcus et a l,  1968, 
Pelham  & Jackson, 1976). Rabbit reticulocyte lysate (RRL) and w heat germ 
extracts are now  used in the analysis of viral proteolytic processing, although 
these system s m ay contain inhibitors which can interfere w ith  processing 
(M avankal & Rhoads, 1991, Shih et al., 1987, V erchot et al., 1991). The 
developm ent of recom binant DNA technology has perm itted  the use of site 
directed mutagenesis to determine the active sites of the proteinase.
The enzym e-substrate interactions for the different viral serine proteinases are 
usually  highly specific for viral proteins and can produce viral proteins at 
different times in the replication cycle (Dougherty & Semler, 1993).
1.7.6 Examples of Viral Proteinases
1.7.6.1 Picornaviriis Proteolytic Processing
The genomes of picornaviruses consist of positive sti'and ssRNA molecule w ith a 
small protein, VPg, covalently linked to the 5-end and a poly (A) tail at the 3’-end 
(Wellink & van Kammen, 1988). The replication of picornaviruses is totally 
dependent on proteolytic processing. The picornaviruses consist of six genera; 
Enterovirus (e.g. poliovirus, echovirus, coxsackievirus and hepatitis A virus), 
Rhinovirus (e.g. the common cold virus), Apthovirus (e.g. foot and m outh disease 
virus (FMDV)) Hepatovirus, Parechovirus, and Cardiovirus (e.g. m engovirus and 
encephalomyocarditis virus (EMCV)).
Poliovirus infects cells and  shuts dow n the transcription and  translation of 
cellular mRNA thus causing cell death (Nicklin et ah, 1986). The infectious agent 
is a particle of approximately 28nm in diameter consisting of sixty copies of four
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polypeptides (Hogle et a l,  1985). Picornavirus proteins are translated as larger 
precursors and are produced as a result of proteolysis even ’while the translation 
p roduct is nascent (Summers & M aizel Jr., 1968). W hen the sequence of 
poliovirus was determ ined the case for a large polyprotein became established 
w hen  a large ORF w as found (Kitam ura et a l ,  1981). Tw enty-six viral 
polypeptides have been discovered of which 22 can be m apped to the sequence 
of the genome (Pallansch et a l ,  1984). The full length translation product of 
poliovirus RNA is not norm ally found in vitro or in vivo. Translation appears to 
give 3 translation products as a result of processing of the nascent polypeptide 
(Jacobson & Baltimore, 1968, Summers & Maizel Jr., 1968). In poliovirus, lABCD 
is the capsid precursor, 2ABC is a m iddle precursor and 3ABCD is the replicase 
precursor; all three can be found in infected cells (Pallansch et a l ,  1984). 
Individual virus proteins w ere m apped to the genom e by partial N-term inal 
sequencing of virus specific proteins isolated from infected cells that had been 
labelled w ith radioactive single amino acids. These proteins were then degraded 
on an autom ated sequencer and the position of the incorporated labelled amino 
acids determ ined (Anderson, 1982, Pallansch ef a l,  1984). Experiments with two 
or more amino acids were enough to establish the position of the amino terminus 
in the sequence. This established that the cleavage of the poliovirus precursors 
was betw een g lutam ine and  glycine (QG), tyrosine and  glycine (YG) or 
asparagine and serine (NS). Of the 13 QG pairs in the genome, only four have 
never been found to cleave (Nicklin et a l,  1986). Of the 10 YG pairs found in the 
genome, only two are ever cleaved. The cleavage events are generally the same 
for the other picornaviruses but the cleavage sites differ.
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Three different viral proteinases have been identified for picornaviruses. The 3C 
and 2A proteins appear to be serine-like proteinases but use a cysteine in the 
active site. The L proteinase encoded by the apthhoviriises is also a cysteine 
proteinase. Protein 3C is used throughout the picornavirus family and provides 
the main source of proteolytic activity (Nicklin ct al., 1986). The three dimensional 
crystal structure of the 3C proteinases has been determ ined for hepatitis A virus 
and rhinovirus 14 (Allaire et al., 1994, M atthews et ai, 1994). These structures 
showed that the 3C proteases adopt a two domain |3-barrel fold characteristic of 
chymo trypsin and trypsin. These structures also supported  the assignm ent of 
cysteine 147 and histidine 40 (poliovirus num bering) as the nucleophile and 
general base respectively. The use of cloned cDNAs m ade it possible to 
dem onstrate  the 2A proteinase w ith  the use of in vitro transcrip tion  and 
translation assays (Toyoda et al., 1986). The poliovirus capsid proteins (PI) are 
re leased  co transla tionally  as a 97kDa p recu rso r p o ly p ro te in  from  an 
intram olecular cleavage catalysed by the viral pro tease 2A (Toyoda et ai, 1986). 
PI is then further cleaved by the 3C proteinase to generate VPG, VP3 and VPl 
(Jore et al., 1988, Ypma-Wong et al., 1988).
1.7.6.2 Flavivirirs Proteolytic Processing
The flaviviruses are enveloped, positive strand ssRNA viruses. Representative 
m em bers of the Flavivirus genus include yellow fever virus and tick-borne 
encephalitis virus. The gene products of these viruses are encoded as a single 
polypeptide. At least one viral proteinase, NS3, plays a major role in the 
proteolytic processing of the polyprotein  (Rice et al., 1985). Site-directed 
mutagenesis studies on yellow fever virus NS3 putative active site demonstrated
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that it was indeed a serine-protease (Bazan & Fletterick, 1989, Cham bers et al., 
1990, Gorbalenya et ai, 1989, Preugschat et al, 1990).
1.7.6.3 Peslivirus Proteolytic Processing
Pestiviruses are enveloped ssRNA viruses that resemble the Flavivirus and form 
part of the family Flaviviridae (Francki et a l ,  1991). The genom e encodes one 
polyprotein that is cleaved by cellular and viral proteinases. The polyprotein is 
divided into two parts: the structural and non-structural proteins. The first third 
of the genome encodes the structural proteins; the rem ainder of the genome 
encodes the non-structural proteins. These viruses express 2 proteinases. The 
prim ary proteinase is the p l2 5 /p 8 0  protein required for the cleavage of the 
nonstructural proteins (W iskerchen & Collett, 1991). Sequence stud ies have 
show n that it is a trypsin-like serine protease (Gorbalenya et a i,  1989) and this 
has been confirmed experimentally with the localisation of the three amino acids 
of the catalytic triad (Wiskerchen & Collett, 1991). The second proteolytic protein, 
p20, was described in bovine viral diarrhoea virus (BVDV) (W iskerchen et a l ,
1991) and further characterised as a papain-like cysteine protease (Stark et a l ,  
1993).
1.7.7 IBDV Proteolytic Processing
No significant relationships have been dem onstrated between the birnavirus VP4 
sequences and any know n type of pro tease (Dougherty & Semler, 1993, Koonin,
1992). Koonin et a l, (1992) reported finding Tnarginal similarity to serine protease 
active centres' bu t no data was presented. The active site of the pro tease in IBDV 
has not been m apped. The putative IBDV proteinase, VP4, is proposed to be a
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serine protease (Brown & Skinner, 1996) as it possesses a catalytic triad common 
with the chymo trypsin spacing, i.e. H545, D589 and S652 (see figure l.vii) and 
also a catalytic triad common with subtilisin spacing of D513, H545 and S652 i.e. 
a serine protease II (Luke, unpublished). Interestingly both catalytic triads use 
the same His and Ser amino acids. This second catalytic triad cannot however be 
found in the IPNV VP4 unlike the serine pro tease 1 catalytic triad. This may mean 
that VP4 may fold into one or two alternative conformations, allowing it to use 
either, or possibly both, of these triads in the cleavage. There are, however, no 
docum ented examples of subtilisin-like proteinase in viruses. Likewise, there are 
no docum ented exam ples of viral pro teases w ith catalytic dyads (like leader 
peptidase in E. coli) bu t there are several lysines in VP4 appropriately placed to 
form part of a catalytic dyad w ith S652 (see figure l.vii). There are several 
changes in the vvlBDV UK661 strain in the VP4 region compared to other strains. 
A change from leucine to isoleucine at position 451 next to the proposed cleavage 
site of the VP2-VP4 junction could affect the cleavage of the polyprotein. A 
change N651S next to the serine of the postulated active site might also affect 
pro tease function There is also a substitution of His to Asp at position 752, just 
upstream  of the A-X-A-A-S postulated as the alternative VP4-VP3 cleavage site 
(Brown & Skinner, 1996). By affecting the polyprotein processing, such mutations 
could affect virus replication rate or may change the specificity of the pro tease so 
that it can target host proteins and hence affect virulence.
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Figure l.vii. A schematic diagram of the postulated active site residues and cleavage 
site residues for VP4. The plain text indicates the most likely residues for the sites 
whilst those in italics represent alternative suggestions. The numbers represent tire 
position of the sites in the IBDV genome. The green block represents the proposed 
VPX region of tlie polyprotein, the blue block represents the proposed VP4 region 
and the yellow represents the proposed VP3 region of the IBDV polyprotein. The red 
region depicts the proposed catalytic triad and the light blue depicts the proposed 
substrate binding pocket (SBP) (Brown and Skinner, 1996).
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1.8 The Aim s o f the Project
The broad aim of the IBDV project at the Institute for Animal Health is to identify 
the virulence determ inants of IBDV.
The initial aims of my project were to see if any of the vvIBDV-specific mutations 
could be implicated in the enhanced virulence of the virus. The prim ary area of 
study was to be the role of m utations that m ight affect proteolytic processing 
(either of the viral polyprotein or possibly of cellular proteins). However, as little 
was know n about VP4 and the cleavage sites it uses, it was necessary first to 
define the active site residues and cleavage sites.
1.8.1 Goals
1. To set up (i) in vitro and (ii) E. coli systems for analysis of proteolytic activity. 
The in vitro system  will use coupled transcrip tion /translation  to analyse the 
cleavage of the polyprotein. The E. coli expression system w ould make use of the 
lac Z promoter found in pBluescript expression plasmids.
2. To determine the N-terminus of VP3 by N-terminal sequencing of VP3 isolated 
from purified virions to identify the cleavage site at the VP4-VP3 junction.
3. M utagenesis of candidate active site residues and cleavage site residues for 
analysis in systems l(i) and l(ii).
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2. Materials and M ethods
2.1 Primer L is t
See A ppendix 1 for a full list of primers.
2.2 Viruses and Cells
The 2 IBDV strains used were PBG98, an attenuated tissue culture adapted 
vaccine strain (Intervet), and UK661; a very v iru len t field isolate from  
N orfolk.
Chicken Embryo Fibroblasts (CEP) were derived from Rhode Island Red 
chickens and Vero are derived from African Green M onkey kidney cells and 
both are kept as a prim ary cell culture at the Institute for Animal Health. E. 
coli strains used were TGI, XLl-Blue and BL21 and grown up to be 
electrocom petant and chemically competent.
2.3 Extraction o f  Virus fro m  Bursal M aterial
Bursae were hom ogenised in 0.5ml TE pH  7.5 (lOmM Tris pH 7.5, lOmM 
Ethylenediam inetetraacetic acid (EDTA))/bursa using a Griffiths tube. The 
hom ogenate was then stored at -70°C or use to prepare virus.
Viral extraction was adapted from (Bayliss ct al., 1990). Equal volum es of 
bursal hom ogenate and TE (pH7.5) were vortexed in a 50ml Falcon tube prior 
to centrifugation at 2 Krpm for 10 m inutes at 4°C in a Sorvall RT6000D. The
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supernatant was then rem oved to a fresh 50ml Falcon tube and the pellet 
resuspended in the same volum e of TE (pH7.5) as before. This was the 
recentrifuged as above. This was repeated twice, pooling all the supernatants. 
The supernatant was then extracted w ith an equal volum e of Arclone P 
(1, 1, 2, trichlorotrifluoroethane) and centrifuged at 2 Krpm  for 10 m inutes at 
4°C in an Sorvall RC-5B using 50 ml Falcon tubes. The supernatant was 
rem oved and the interface extracted twice m ore w ith Arclone . P before 
centrifuging the pooled supernatants at 10 Krpm for 10 m inutes at 4°C in a 
Sorvall RC-5B using the Sorvall SS34 rotor. The supernatan t was then layered 
onto a 40% sucrose layer, which was layered on top of a 60% sucrose layer and 
centrifuged at 30 Krpm for 3 hours at 4°C in a Sorvall OTD 65B with a Sorvall 
SW40T1 rotor. The viral band was rem oved using a Pasteur pipette and 
diluted to below 40% sucrose final concentration. This was then respun at 30 
K rpm  for 3 hours at 4°C in a Sorvall OTD 65B w ith a Sorvall SW40T1 rotor. 
Further purification using CsCl gradients were adapted from the m ethod  
described by Nick et al, (1979). The gradients were m ade by m aking up a 
1.32g/m lCsCl solution and then checking the refractive index. This so lu tion  
was then used to resuspend the viral pellets and spun  at 50krpm in the 
Sorvall TV1665 rotor for 22 hours. Fractions were rem oved by collecting 
0.5ml fractions from the bottom. The resulting viral pellet was resuspended 
in 0.5 ml PBS and stored at -70°C or used to extract the genome.
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2.4 Tissue Culture
2.4.1 Growth and Maintenance of CEF s and Vero cells
CEP's and Vero ceils were seeded at 8x 10^ cells /m l of 199 m edium  in T125
flasks or 5 xlO'^ cells /m l in 6 cm in diam eter petri dishes. These form ed 
confluent m onolayers after an overnight incubation at 37°C in a 5% CO2  
atm osphere. The grow th m edium  was then rem oved and replaced by Ix 
MEM m aintenance media.
2.4.2 Infection of Cell Lines with IBDV
The m aintenance m edia was poured off CEE m onolayers in T125 flasks. To 
the m onolayers was then added virus attenuated strain PBG98 at an m.o.i. of 
0.1 and 50 ml of 1x199 m edia (10 ml lOx 199 (Gibco BRL life technologies), 10 
ml new born calf serum , 10 ml tryptose phosphate broth and 5 ml 4.4% 
NaHCOg made up to 100 ml w ith Elgas tat water.- The flasks were then loosely 
capped and placed in a 37"^ C incubator gassed at 5% CO 2  for a num ber of days.
2.4.3 Passage of IBDV in Tissue Culture
Flasks that had been infected for a num ber of days were freeze thawed at -70°C 
three times before transferring the m edia and the cellular debris to 
uni versais. The cellular debris was then spun dow n at 3 Krpm at 4°C for 10 
m inutes in an Sorvall RC-5B centrifuge. The supernatan t was then used for 
protein visualisation as for the extraction of bursa or for titration of the virus.
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2.4.4 Quantification of IBDV by plaque assay
Aliquots of tenfold serial dilutions of virus, in Ix Eagles M inimal Essential 
Media (MEM) (10ml lOxMEM, 1ml L-glutamine, 4ml NaEICOg (4.4%), lOOU 
penicillin, streptom ycin and mycostatin made up to 100ml with Elgastat 
water) were plated onto confluent m onolayers of CEFs in 6 cm (diameter) 
petri dishes. Following a 1 hour incubation at 37°C, 5% CO2 , the tissue culture 
fluid was rem oved and the m onolayer overlaid w ith Ix MEM + 2% foetal calf 
serum  (ECS) in 1% low gelling tem perature agarose (at 42°C). Once the 
overlay had set the plates were incubated for 3 days at 37°C and 5% CO2 . After 
incubation plaques were then counted.
2.5 Protein  A n a lys is
2.5.1 The Determination of Concentration of Protein
The concentration of proteins in solution was calculated using the BCA 
protein assay kit (BioRad) according to m anufacturers instructions. Briefly the 
protein concentration was established using a BSA standard solution as a 
standard and the absorbance was m easured at 562nm.
2.5.2 Sodium Dodecyl Sulphate (SDS)-Polyaciylamide gel electrophoresis 
(PAGE)
Gels were m ade using Protogel (National Diagnostics) acrylamide and v irus 
samples were boiled in Laemmli sample buffer (2% SDS, 10% Glycerol, 60mM
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Tris (pH6.8), 0.01% brom ophenol blue) containing 2% p-m ercaptoethanol for 
3 m inutes. The BioRad m ini-protean gel kits were run  at 70 volts for 1.5 
hours and the large gels were run at 100 V for 4 hours both using Tris-Glycine 
running buffer (25mM Tris, 240mM Glycine, 0.1% SDS). The gels that were 
not to be blotted were stained with Coomassie Blue for 1 hour and then 
destained overnight and transferred to 7% acetic acid. The gels that were to be 
blotted were not stained.
2.5,3 W estern Blotting
2.5.3.1 Transfer
The gel holders were soaked in w estern blotting transfer buffer (WBTB) 
(25mM Tris, 200mM Glycine, 20% m ethanol) and assembled as follows: The 
gel holder was placed dark side down in a tray of WBTB and the foam pads 
squeezed in the buffer to remove any air bubbles. 2 sheets of W hatm an 3MM 
paper were soaked in the WBTB and placed on top of the foam pads. On top 
of these sheets of paper was placed the gel and the nitrocellulose m em brane. 
On top of the m em brane 2 more sheets of pre-wetted 3MM paper were placed 
and then the final foam pad. The holder was then placed into the transfer 
tank and WBTB added so that it covered the gel. The transfer was run at 70V 
for 4 hours at 4°C or overnight at 30V at 4^0.
57
2.5.3.2 Antibody probing
The m em brane was first washed with TBS (50mM Tris, 138mM NaCl, 2.7mM 
KCl, pH  7.5) + 5%BSA to block non-specific binding for 2 hours or overnight. 
An appropriate dilution of the first antibody in TBS was incubated w ith the 
m em brane for 1.5 hours. The m em brane was then w ashed with water for 5 
m inutes 3 times, then w ashed w ith TBS + 1% Tween 20 for 20 m inutes, then  
again with w ater 3 times, again w ith TBS + 1% Tween 20 and then again w ith  
water 3 times. The m em brane was then was then incubated w ith the 
appropriate dilution of the anti-chicken IgG for 1.5 hours and then washed 
w ith the above procedure. The blot was then developed using the 
Im m unopure BCIP/NCP developing kit according to m anufacturers 
instructions.
2.6 Genome Extraction and Purification from  Purified Virus
The viral pellet was then resuspended in 0.5ml RNA extraction so lu tion  
(lOmM Tris pH7.5, lOmM NaCl, lOmM EDTA pH7.5, 0.2% SDS and 0.1% 
DEPC) and digested w ith 25 pi proteinase K (0.5 m g / ml) for 1 hour at 37°C. 
Following phenol:chloroform :isoam ylalcohol (25:24:1) extraction the RN A  
was precipitated w ith 1/lO th volum e 3M sodium  acetate pIT5.2 and 3 
volumes 100% ethanol. The RNA was then resuspended in 50pl TE pH7.5.
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overlaid w ith 5 ml of 199 m edium  and left at 37^C  in a CO2  incubator for 16 
hours. The m edium  was then rem oved and the cells were then washed w ith  
IxMEM m edium  w ithout m ethionine (GIBCO). The cells were then starved 
of m ethionine for 2 hours in 5ml of IxMEM m edium  w ithout m e th io n in e  
(GIBCO). The 5ml of m edium  was rem oved and 2ml of IxMEM m ed iu m  
w ithout m ethionine (GIBCO) was added w ith lOOpCi of m e th io n in e  
(NEN Dupont) and left in the incubator for 2 hours. The cells were then  
washed w ith 2ml of PBS and then 2ml of RIPA buffer 1 (150mM NaCl, 1% 
Triton X-100, 0.5% deoxycholate, 0.1%SDS, 50mM Tris pH  7.5) w ith 2pi of 
PMSF was added and the flasks were left at room  tem perature for 10 m inutes.
This was then stored at -70°C. 10% v /v  protein A sepharose beads were 
incubated with either rabbit anti-chicken or rabbit anti-m ouse antibodies, 
depending on the antibodies that needed to be bound, for 30 m inutes at room  
tem perature. These beads were then washed three times in phosphate 
buffered saline (PBS) (lOmM sodium  phosphate, 2.7mM KCl, 137mM NaCl, 
pH  7.4) and then incubated w ith either polyclonal serum  or m onoclonal
antibodies directed at specific IBDV proteins for 1 hour at 4°C. These were 
then w ashed w ith PBS and preabsorbed w ith lOOpl of non-labelled n o n ­
infected cell lysates and incubated overnight at 40C. The beads were then
incubated w ith the radioactive lysates for 3 hours at and then w ashed 5 
times w ith RIPA buffer 1 and 3 times w ith RIPA buffer 2 (ISOmM NaCl, 
50mM Tris pH7.5).
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The beads were then boiled for 10 m inutes in SDS-PAGE loading buffer and
loaded onto a SDS-PAGE gel.
2.8 Iso la tion  and Purification  o f  P la sm id  D N A
2.8.1 Minipreparation ("Miniprep") of Plasmid DNA by Alkaline Lysis
A 2ml overnight culture was spun at 13 Krpm for 1 m inute in a bench 
centrifuge and the m edia rem oved. The cell pellet was resuspended in 150 p i 
cold solution I (50mM glucose, 25mM Tris (pHB.O), lOmM EDTA). Following a 
5 m inute incubation at room  tem perature 200pl of solution II (25mM Tris 
(pH8.0), lOmM EDTA, 200mM NaOFI, 1% SDS) was added and mixed by 
inverting several times. This was then incubated on ice for 5 m inutes prior to 
the addition of 150pl ice cold solution III (60ml 5M KAc (pH4.8), 11.5ml glacial 
acetic acid, 28.5ml water). The ininiprep was then vortexed inverted for 10 
seconds and incubated on ice for a further 5 m inutes. Following a 5 m in u te  
spin at 13 Krpm  in a bench centrifuge the supernatant was extracted w ith  
phenol:chloroform :isoam ylalcohol. The plasm id DNA was then precipitated 
w ith 2 volumes of ethanol before resuspending in 50pl TE (pH7.5).
2.8.2 Large Scale Preparation of Plasmid DNA
Glycerol stocks of plasm id were transferred to universals containing 10ml L 
broth w ith the appropriate antibiotic and incubated for 6hrs. These were th en  
transferred to 400 ml L broth containing the appropriate antibiotic. The 
overnight culture was centrifuged at 10 Krpm for 15 m inutes at 4°C in a
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Sorvall RC-5B using a Sorvall GSA rotor and the cells resuspended in 7.5ml 
solution I. The cells then underw ent the following alkaline lysis protocol. 
15ml of room tem perature solution II was added and incubated on ice for 10 
m inutes. After the addition of 11ml solution III and incubation on ice for 10 
minutes, the preparation was centrifuged at 15 Krpm for 30 m inutes at 4°C in  
a Sorvall RC-5B using a Sorvall SS34 rotor. To 28 ml of the supernatant was 
added 17ml isopropanol and this was left on the bench for 15 m inutes before 
centrifuging at 10 Krpm for 20 m inutes at 4°C in a Sorvall RC-5B using a 
Sorvall HB-4 rotor. The pellet was then resuspended in CsCl solution (density 
1.68g/ml) and loaded into a Beckman Ultracrim p tube along with 50pl 
e th id ium  brom ide (lOmg/ml). This was then centrifuged for 16 hours at 50 
Krpm at 25°C in a Sorvall OTD 65B using a Sorvall TVI665 vertical rotor.
The plasm id band was then rem oved by side puncture and the e th id iu m  
brom ide extracted w ith NaCl and water saturated isopropanol. The DNA was 
then precipitated w ith ethanol and w ashed w ith 70% ethanol before 
resuspending in 1ml water.
2.9 cD N A syn th es is  o f  Viral R N A
2.9.1 D énaturation of D ouble Stranded RNA
This m ethod was adapted from that of (Azad et al., 1985). To 10pi of RNA in  
5mM sodium  dihydrogen orthophosphate (pH6.8) was added 20pmole of both 
the forward and reverse primers. This was then heated to 100°C for 2 m inu tes  
before snap freezing with ethanol and dry ice. M ethylm ercury II hydroxide
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was then added to a final concentration of 2mM. Following a 10 m inute room
tem perature incubation, (3-mercaptoethanol was added to final concentration
of 55mM and the denatured RNA was then incubated at room  tem perature 
for a further 5 minutes.
2,9.2 cDNA synthesis
To the denatured RNA tem plate and prim ers was added, dithiothreitol (DTT) 
and dNTP mix (lOmM of each of dATP, dCTP, dCTP and dTTP) to a final 
concentration of 5mM and 0.5mM respectively, in Ix reverse transcriptase 
buffer (Boehringer-M annheim ). To this was added 2 U rRNasin (Promega) 
and 12.5 U AMV reverse transcriptase (Boehringer-M annheim ) before 
incubation at 42°C for 1 hour.
2.10 A inplif ica tion  o f  cD N A  by  the P olym erase  Chain R eaction  (PCR)
In all cases the first strand cDNA was am plified using the follow ing 
polym erase chain reaction (PCR) conditions w ith the only variable being the 
prim ers used in each reaction. To 5pi of the cDNA reaction was added 
lOpmoles of forw ard and reverse prim ers and dNTP mix to a final 
concentration of 0.2mM in Ix PCR buffer at containing 1.5mM MgCl2- To this 
was added 0.5U Taq Polymerase and the reaction cycled in a Hybaid therm o 
cycler using the program m e show n below. O ther PCR products were 
amplified from plasm id DNA in a similar m anner, w ith variations in the 
annealing tem perature depending on the prim er used.
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Temperature CO Time (minutes) Number of Cycles
94
94
45 25
72
72 10
2.11 Purification o f  PCR Products
2.11.1 Isopropanol Precipitation
To 50pl of PCR reaction was added 50pi of chloroform to dissolve the m inera l 
oil, followed by 50pl of phenol:chloroform :isoam ylalcohol (25:24:1). 
Following vortexing the sam ple was centrifuged at 13 K rpm  in a bench 
centrifuge for 2 m inutes. The aqueous layer was then rem oved to a fresh 
0.5ml eppendorf and the DNA precipitated w ith an equal volum e of 
isopropanol. This was im m ediately centrifuged at 13 Krpm  for 15 m inutes in  
a bench centrifuge and the supernatant rem oved. The DNA pellet was then  
resuspended in 50pi water.
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2.11.2 Agarose Gel Electrophoresis
The PCR product was removed from beneath the mineral oil and mixed with 
0.1 volumes loading buffer before loading onto a 1% low m elting point IxTAE 
(48.5g Tris-base, 16.4g sodium  acetate, 7.5g EDTA in 1 litre) agarose gel. The gel 
was then electrophoresed at 10V in a subm erged midi tank w ith  IxTAE buffer. 
The DNA band was then visualised by staining the gel w ith 0.5ng/m l 
ethidium  brom ide and illum inating w ith UV (wavelength 260nm). The band 
was then cut out of the gel and placed into a 1.5ml eppendorf before extraction 
of the DNA by using the Geneclean kit (Bio 101).
To the gel slice was added 3 volum es of 3M Nal solution (Ig of gel is 
equivalent to 1 ml of N al solution) in a 1.5ml eppendorf. This was incubated 
at 37°C until the gel slice had completely dissolved. To this was added lOpl of 
glassmilk, m ixed by gentle tapping before incubating on ice for at le a s t'10 
m inutes (mixing by tapping every 2 minutes). The glassmilk was then  
pelleted by briefly spinning in a bench centrifuge and the supernatan t 
discarded. The glassmilk was then washed 3x w ith ice cold N ew W ash before 
resuspending the glassmilk in 20pl of water. This was then incubated at 55°C 
for 5 m inutes to elute the DNA before spinning dow n the glassmilk in a 
bench centrifuge and transferring the DNA to a fresh eppendorf tube. This 
was repeated a second time and the elutants pooled.
Alternatively the gel slice was p u t onto a GenElute colum n (Invitrogen) and 
spun for 10 m inutes in a bench top centrifuge.
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2.12 Cloning o f p lasm ids
2.12.1 Restriction digestion
Generally 0.1-ljLtg of DNA was added to 2jLil of restriction enzym e buffer and
IjLil (10 units) of restriction enzyme and the reaction m ade up to 20pl w ith
water. The reaction was then incubated at 37^C for 2 hours before running  on  
an agarose gel in order to purify of the cut plasm id by the same m ethod as for 
the purification of PCR products in 2.11.2.
2.12.2 Ligation reactions
Generally a vectordnsert ratio of 1:3 was used in a lOpl ligation reaction 
containing insert and vector DNA, Ipl ligase buffer containing lOmM ATP 
(Boehringer-M annheim ) and Ip l Ligase (Boehringer-M annheim ). The 
reaction was incubated either at 25^C for 1 hour or at Ib^C overnight.
2.12.3 Electroporation
The electroporation of plasm id DNA into cells was carried out in accordance 
to Invitrogen protocol. Briefly the DNA, cells and electroporation cuvettes
w ere pre-chilled on ice. Then E. coli cells were added to the 2 jul of DNA and
then placed into the gap of the cuvette. The cells and DNA were then pulsed 
using the electroporator and 1ml of SOC (SOB, 50mM glucose, 50mM MgCl2,
65
50mM MgS04) added. The cells were then grown in SOC for an hour then  
plated out in appropriate dilutions on appropriate antibiotic plates.
2.13 S ite-D irected M utagenesis
Site directed m utagenesis was perform ed using the QuickChange Site 
Directed M utagenesis kit (Stratagene). Briefly 25ng of target DNA was added
to a 200jLil polyethylene tube with 2.5 units of native Pfii polymerase, 125ng of 
each forward and reverse prim ers containing the m utation, 5pi of lOx
reaction buffer, and Ip l of lOmM dNTP mix and m ade up to 50pl w ith water.
The tubes were then placed in the Progene (Techne) therm al cycler and  
subjected to the following cycles.
Temperature («C) Time (seconds) Cycles
95 30 1
95 30
55 60 16
68 720
After the cycles were complete, the tubes were placed on ice to cool dow n and 
then lu n it of Dpn\ was added and incubated at 37°C for 1 hour to digest the
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parental DNA template. 2pl of this reaction mix was then transform ed in to  
Epicurinn^^^ coli supercom petant cells (Stratagene).
2.14 T N T  In Vitro coupled Tra n scrip tion lTransia tiou  (Promega)
These reactions were perform ed in accordance to the m anufacturers protocol.
Briefly the following com ponents were added together in a 1.5ml screw cap 
polyethylene tube
C om ponent A m ount (pi)
Rabbit Reticulocyte Lysate (RRL) 25
TNT buffer 
Amino Acid Mix m inus 
M eth ion ine
rRNasin (Promega) 1
D N A
% -M eth io n in e  (N EN -D upont)
IPg
4pCi
Nuclease Free W ater to make up to 50 pi
RNA polym erase (Promega)
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The reaction was then incubated at 30^C for 60-90 m inutes in the Intelligent 
Heating block. 5pl was then added to 20pl of SDS-PAGE loading buffer and
boiled for 2 m inutes. lOpl of the reaction mix was then loaded onto a SDS-
PAGE gel and run at lOOV for 1 hour or until the dye front was near the 
bottom  of the gel. The gel was then fixed in fixing buffer (10% glacial acetic 
a c id /10% M ethanol) for 30 m inutes, washed w ith distilled w ater for 20 
m inutes and then in Sodium  Salicylate for 30 m inutes. The gels were then  
dried dow n for 1 hour and exposed to autoradiography film (Kodak).
2.15 Expression in E. coli
A 2ml culture of BL21 E. coli containing clone 34 or m utated forms was 
grown up overnight. 1ml of this culture was then added to 9ml of LB
containing lOOpg/ml of ampicillin and incubated w hilst shaking at 37°C u n til
an OD of 0.4. Then 10pi of IM  IPTG was added and these were then grown for
a further 2 hours. 1ml of the sam ple was placed into a 1ml eppendorf tube 
w ith and spun in a bench top microfuge for 30 seconds. The supernatent was
then rem oved and the pellet was resuspended in 50pl of water and 50pl of
SDS-PAGE sample buffer and boiled for 10 m inutes before loading onto a 
SDS-PAGE. The gel was then blotted onto nitro-cellulose and western blots 
were perform ed using either a rabbit polyclonal or a chicken h y p erim m u n e  
serum  preabsorbed on BL21 lysates, or using monoclonal antibodies.
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3. Sequencing, Database Analysis and Construction of Clones
3.1 Construction o f  Clones fo r  In  V itro Expression
Expression of genes in v itro  can be achieved using the bacteriophage T7, T3 
and SP6 RNA polym erase prom oters. High level translation of the 
synthesised RNA can be achieved by the inclusion, norm ally at the 5' end of 
the transcript, of an internal ribosomal entry site (1RES) sequence such as that 
from encephalom yocarditis virus (EMCV). 1RES sequences allow the efficient 
translation of mRNA, in eukaryotic translation systems, in a GAP- 
independent m anner 1RES sequences are incorporated into some com m ercial 
expression plasm ids, such as pCITE (Novagen), which allow expression u n d er 
control of the T7 prom oter. The pCITE plasm id also contains a T7 term inator 
sequence.
3.2 Creation o f  Clone 34
Clone 34 was assembled from three UK661 RT-PCR clones, m ade by Dr. M. D. 
Brown from  RNA isolated using the protocol outlined in  section 2. The RT- 
PCR products had been digested w ith appropriate enzym es and cloned in to  
pBluescript KS- (Stratagene). The three clones 74, 98 and 310 (figure 3.i) 
contained fragments amplified using prim ers MBR7 and MBR4, MBR9 and 
MBR8 or MBR3 and MAS-HIO, respectively. Clone 74 contains the whole VP3 
region of the IBDV genome plus part of the VP4 region from  nucleotide 
num ber 1759. Clone 98 contains part of the VP2 region and part of the VP4 
region spanning nucleotide num bers 539 to 1813. Clone 310 contains part of 
VP2 region from the N -term inus to nucleotide num ber 834. Clone 34
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contains the full polyprotein ORF. To assemble clone 34, clone 74 and clone 98 
were cut w ith Bam U l and the fragm ents indicated in figure 3.i were purified  
by agarose gel electrophoresis then ligated together using T4 DNA ligase 
(Boehringer), for 1 hour at room  tem perature, and electroporated into XLl- 
Blue. The resulting clones 94 and 310, were cut w ith  K p n l  and S tu l  and the 
fragments indicated in figure 3.i, were purified by agarose gel electrophoresis. 
These fragm ents were ligated together as described above and electroporated 
into XLl“Blue to give rise to clone 34. This expression clone contains the 
polyprotein ORF under the control of the T3 and LacZ prom oters.
3.3 Clone 34 Sequencing
3.3.1 M anual Sequencing
M anual sequencing of clone 34 DNA, purified by the large scale purification 
m ethod (see section 2.8.2), was perform ed using the Sequenase Version 2.0 kit 
(United States Biochemicals). To each of the wells of a 96 well plate (Falcon) 
labelled A, C, T and G, was added 0.5pg of DNA in 2pi nuclease free water. T hen  
to each well was added 2pi of the buffer/p rim er mix (Ip l Sequenase buffer, Ip l
0.5nM prim er, and 6pi water). The plate was then sealed and incubated at 55^0 
for 30 m inutes, before adding 2pl of the labelling mix (7.5pl water, 0.4pl DTT,
0.5pi ^^S-dATP, 0.4pi of labelling mix, 0.5pl Sequenase). The resealed plate was 
incubated for 10 m inutes at room  tem perature before adding 2pl of the 
appropriate term ination mixes. The plate was then incubated for 5 m inutes at 
3 7 0 c  before adding 4pl of the formide stop
The reactions were carried out using the Taq D y e D e o x y ™  Term inator Cycle 
Sequencing kit (Applied Biosystems). To Ipg  of DNA tem plate was added
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solution to each well. After a further incubation at SO^C for 20 minutes, 2pl was 
loaded onto a linear 6% acrylamide gel (see appendix 2 for the sequence data).
3.3.2 Cycle Sequencing Using Automated Sequencing Apparatus
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3.3.2 Cycle Sequencing Using Automated Sequencing Apparatus
The reactions were carried out using the Taq DyeDeoxy^^* Term inator Cycle 
Sequencing kit (Applied Biosystems). To Ipg of DNA template was added
3.2pmoles of primer, 9.5pl of terminator premix and water m ade up to a total
volum e of 20pl. The reaction mix was overlaid w ith 40pi of m ineral oil and 
incubated in a Progene (Techne) thermal cycler using the follow cycle times.
Temperature (^C) Time (Seconds) Number of Cycles
96 preheated
96 30
50 15 25
60 240
Imm ediately after the program m e was complete, the tubes were placed on ice
and the volum e increased to lOOpl w ith water. The m ineral oil was extracted
with an equal volum e of chloroform  and the term inators were extracted 
twice with phenol:chloroform :water (68:14:18). The extracted sample was then
ethanol precipitated, w ashed with 70% ethanol and resuspended in 4pl of
loading buffer (5pl deionised formamide, Ipl 50mM EDTA pHS.O). It was then
denatured at 90°C for 2 m inutes before loading onto the gel (see appendix 2 
for the sequence data).
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F igure  3.1. A schem alic représen ta  lion of the m ethod of construction of clone 34. 
Clones 98, 74 and 310 w ere cloned from RT-PCR products from the dsR N A  
genom e of IBDV stra in  UK66 J. The three clones had been sequenced three tim es 
(M. D. Brown, personal com m unication). The restriction enzym es sites show n 
w ere used for the d igestion  of the three clones as sta ted  in the text.
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Part VP2 Clone 98
Part VP4
BamMl T7 prom oter 
BamHl
Bam HI
Part VP4
Am p
VP3
Clone 74 Amp
BamHl prom oter
Cut with BamHl
VP4 Part VP2 Stul
r rClone 94 I
Clone 310Part VP2
prom oter
T7 prom oter
Cutwith Kpn I and 
Stul
Lac promoter
Kpnl
S tu l
T3 promoter
Clone 34
Amp
T7 promoter
BamHl
VP4 B m til VP3
3.4 Construction o f  a clone (1210) fo r  high level in  vitro expression
A  DNA fragm ent encoding the polyprotein was am plified from clone 34 by 
PCR with prim ers CJL12 and CJLIO, which contain N a t l  and EcoRI restriction 
enzyme sites, respectively, for cloning into pCTTE-4a (Novagen) (figure 3.ii). 
The PCR product and pCITE-4a were cut with Notl  and EcoRI ligated as before 
and transform ed into £. coli XLl-Blue. Clone 1210 contains the 1RES and 
sequence encoding the polyprotein. An ATG initiator codon is appropriately 
placed for highly stringent translation of the polyprotein ORF directed by the 
1RES. This means that the N -term inus of VP2 will be altered by 10 am ino  
acids. The sequence orientation of the insert of clone 1210 was checked by 
restriction enzyme digestion using BnrnHl, S tu l  and Pstl  (figure 3. iii).
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Figure 3 .ii. A schem atic rep resen ta tion  of the creation  of clone 1210 from PCR 
products, using prim ers CJL12 and CJLIO. The EcoR \/N o t\  d ig ested  PCR 
fragm ent w as gel purified  and ligated  into the E coR l/N otl  d igested  vector 
pCITE 4a (N ovagen)
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3.5. Construction of Deletion M utants
3.5.1 Creation of M utants pD ell-4  w ith  deletions in  VP4
In order to investigate the role of the VP4 in the processing of the polyprotein 
deletion m utagenesis was perform ed. The first deletion, pD ell, deletes from  
the H546 to D589 inclusive, pDel2 deletes from H546 to S652 inclusive, pDel3 
deletes from H546 to the end of the substrate binding pocket (SBP) and pDel4 
deletes from H546 into VP3 to residue 773, past the proposed KR722723 
cleavage site and past the A-x-AAS alternative cleavage site. These deletions 
were m ade to examine the role of these residues in the activity of the protease 
and to help determ ine where the cleavage site exists. The deletion of parts of 
VP4 was achieved using a PCR m ethod (see figure 3.vi). PCR, using p rim ers 
DelCJLl and CJLIO, DelCJL2 and CJLIO, DelCJL3 and CJLIO, and DelCJL4 and 
CJLIO (see appendix 1 for the sequence of these prim ers), am plified fragm ents 
from clone 34. The products were digested w ith restriction enzymes Sail and 
BglU and recloned into clone 34 digested w ith the same enzymes. The VP4 
sequences from  these deletion m utants were sequenced using the ABI 373A 
autom ated sequencer using prim ers VP4Fseq and VP4Rseq (see appendix 1 for 
the sequence of these primers) except for pDel4, w here the reverse p rim er 
used was MB27.
3.5.2 Creation of D eletion M utants pDel 6-11 at the VP4-3 junction
The m utants Del 6-11 were created using the QuikChange Site Directed 
M utagenesis kit (Stratagene) using prim ers Del6F, Del6R, Del7F, Del7R, Del8F, 
Del 8R, Del9F, Del 9R, DellOF, DellOR, D ell IF and D e lllR  (see appendix 1 for 
the sequence of these primers). These prim ers contain the polyprotein
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deletions over lObp the % m ism atch is not used, as the formula is no t 
designed for such large deletions.
3.6 Checking the Clones 34, 1210 and the Deletion M utan t s
The clones 34 and 1210 were checked for correct orientation by the use of 
restriction endonuclease and PCR analysis of the full length polyprotein. 
Clone 34 was sequenced using the ABI 373A autom ated sequencer (Applied 
Biosystems) using prim ers 34F, ATGF and VP2R and by m anual sequencing at 
the ligation junctions using prim ers MB2, MB22, MB14 and MBS (see 
appendix 1 for prim er data). The deletion m utants and site directed m u tan ts  
were checked by sequencing using the ABI 373A autom ated sequencer 
(Applied Biosystems) over the VP4 region (between residues 454 to 721, using 
prim ers VP4Fseq and VP4Rseq) or outside the VP4 region if the m utation fell 
outside this region (see figure 3.v). Deletion m utants 6-11 were sequenced 
using prim er MB27 (see figure 3.vi) (all sequence data can be found in  
appendix 2).
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Figure 3 .iii. R estriction d igestion  analysis  of clones 34 and 1210 along w i t h  
controls pB luescrip t KS- (S tratagene) (pBS) and pCITE-4a (N ovagen) (CITE) 
show ing  th a t D NA bands of the correct size are obtained from the re stric tio n  
d igestions BntiiHl, Sfiil and  Pstl. The products of restriction enzym e d igestion  
(lOpl) w ere subjected to e lec trophoresis  on a 1% TBE agarose gel and s ta in e d  
w ith  e th id ium  brom ide. The m olecular w eigh t s tan d a rd s  are a mix of À D N A  
cut w ith  H///D11I and  0X 174 DNA cut w ith  IlnclU. The sizes are g iven  in kbp.
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Figure 3.iv A  schem alic rep resen ta tion  of the deletion  m utants 1-4 (A) and  6-11 
(B) created  from clone 34, show ing the areas d ele ted . The colour coding is as 
follows: Green is VP2; blue is VP4; yellow  is VP3, purp le  show s the proposed 
ca ta ly tic  triad ; orange show s the specific ity  binding pocket (SBP). pVP3 
represents a p a rt of the VP3 sequence from the proposed KR722723 d ibasic  
c leavage site.
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Catalytic Triad
VP2
VP2
VP2
VP2
VP2
H is Asp Ser ,SBP
k  ■
Vl|4 I I I I
! S^r |,SB F
: ; ySBP
 "
VP4
VP4
VP4
VP3
VPt
WT
J pDell
pDel2
pDel3
J pDel4
6 pAP:
724 779
FPHNPRDWDRLPYD^l^YL^NAG^QYDlj^AA^EFKET^ELESAVRAMEAAANVD,
734 pDEL 6 753 ,
I I
I 744
I
pD el 10
I I
pD el |7
754
763
pDel 8 773
764 pD el 9 779
753 757
pD el 11
Figure 3.v. (A) PCR p roducts from the deletion  m utan ts using p rim ers CJL 10 and 
CJL13. The products w ere subjected to e lectrophoresis on a 1% TBE agarose gel 
and  sta ined  w ith  e th id ium  b rom ide at a concentration of Ip g /m l. The m olecu lar 
w eigh t s tan d a rd s  are a mix of X D N A  cut w ith  H in D ill and  0X 174 D N A  cut 
w ith  H ncIII. The sizes are given in kbp. (B) C hrom atogram s show ing  th e  
deletion  m u tan t sequences w ith  the arrow  m ark ing  the po in t of deletion .
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-ve Clone 34 pDell pDel 2 pDel3 pDel4
B Del
~ i n |  *• C A G A A 7  C C T C T A B T C B A C C 7
kc:v -
C C A A C C 7 C C A 7 C
Del 2
Del 3
C [  A B A A 7  C C T G 7  A G 7  E G A  C G C A 7  T T 5 A C G T  E A A
z C k i. KW7Del 4
C A B A A 7  C [  T G 7  A G T C E A  C ^ C  C A C 7  G 7  7  C C A A T  C
Figure 3 ,vi C hrom atogram s of the sequencing of the deletion  m utants pD el6-9  
show ing  the sequence of the deletion  m utants w ith  an arrow  m ark at the p o in t 
of the deletion.
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3.7 Sequence Conipavison o f  VP4 Sequences zvith other Knozvn Proteases  
VP4 has been identified as the protease responsible for the auto-catalytic co- 
translational cleavage of the polyprotein into its ind iv idual com ponents 
(Azad et ni., 1985; Azad et ni., 1987; H udson et ni., 1986b; Kibenge et ni., 1991; 
M üller and Becht, 1983). A lthough the exact cleavage sites and the pro tease 
active site have yet to be m apped, several proposals have been pu t forw ard for 
their locations. Two dibasic am ino acids at either end of VP4 have been 
predicted as possible cleavage sites based on the m olecular weights of the 
cleavage products (H udson et al., 1986b). All sequence analysis of VP4 has 
been perform ed using the sequence between the two dibasic residues 
(positions 454-723).
3.8.1 Comparisons of UK661 VP4 with other Known Birnavirus
Proteases
UK661 VP4 was aligned w ith  the other B irnavirus pro teases including DXV 
and IPNV to look for conserved regions using the LOCALPILEUP program  
(figure 3.VÜ) and a phylogénie tree was constructed using the DISTANCES 
and GROWTREE program s in the GCG W isconsin com puter packages (figure 
3.viii). All sequences were aligned as the full polyprotein sequence. For the 
phylogénie tree, VP4 sequences for IBDV were taken from  positions 454-723, 
for IPNV from 455-722 and for DXV from 501-714.
The sequence com parison of the birnavirus pro teases shows several 
conserved residues, several of which are potential targets for m utagenesis. 
The serine at position 652 of the whole polyprotein is conserved th ro u g h o u t 
the birnaviruses.
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Figure 3 .v ii. The aligned  sequences of the po lyp ro te in  from the IBDV stra in s : 
IBD706, IBD985, 661, KS-1, CU-1, PBG98, STC, 52/70, GLS, 002-73 and  23-82 
sh ow n  for the VP4 region. The NS pro te ins from  the IPNV strains Jasper and  N1 
and  the DXV pro  tease are included  in  the alignm ent. All these sequences can be 
fou n d  w ith in  the SWISSPROT database. T hose am ino acids th a t are conserved 
th rough  all the b irnav iru ses are show n in bold green. Those residues th a t a re  
conserved th ro u g h o u t the IBDV an d  IPNV are show n  in bold  b lue. The proposed 
catalytic triad  of 1-1546, D589 and  S652 are show n in bold w h ite . The su b stra te  
bm ding  pocket (SBP) is sh ow n  in blue.
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23-82 4 5 4 1 A V p V V s T L F P P A A P L A H A 1 G E G V D Y L L G D E A Q
Jasper 4 5 5 V A ‘K p V T L F P A P L F lG lA lA D  Q - - - 1= i [G D L t  KNI 4 5 5 V A A p V T L F P MA A P L 1 G M A D Q - - - F 1 K3 D L T K
Dxv 4 4 4 V A V pFA At Ft q V i F 1 G 0 A  D G L A N A 1FG D 8 0-
Ibd706
Ibd985
Pbg98vp4
Cu-1
GIs
002-73
5270vp4
Stc
661vp4
Ks-1vp4
23-82
Jaspervp4
N1vp4
Dxwp4
Ibd706
Ibd985
Pbg98vp4
Cu-1
Gk
002-73
5270vp4
Stc
661 v p 4
Ks-1vp4
23-82
Jaspervp4
N1vp4
Dxwp4
4 8 7
4 8 7
4 8 7
4 8 7
4 8 7
4 8 7
4 8 7
4 8 7
4 8 7
4 8 7
4 8 7
4 8 4
4 8 4
4 7 6
A S G t  A R A
A 8  G T A R A
A S G T A R A
A S G T A R A
A A 8  G T A R 
A A 8  G T A R 
A 8 G T 
A 8  G T 
A 8  G T A R 
A 8  Q T 
A 8  G T 
T T T |^ A  6  6 |R 
T N A A G  g | r 
8  G R P V G N
O  R A A S 
K A R A A 8 
K A R A A S 
K A R A A 8 
K A R A A S 
K A R A A 8  
K A R A A 8 
R A A S 
R A A 8  G 
R A A S G 
R A A 8  G
A S G
A S G
A S G
A S G
A S  G
A S  Q
A S G
A S G R Q  L
A S G
A S  G
A S G
A A B G R Y H D
A A a
A S G
H K D V
À A b  K G  Y 
A A D K G  V 
A A D  KG 
A AD  KG  
A AD  KG 
A AD  K G  
A AD K G  
A A D  K G  
A A D  KG  
A AD  K G  
T L A AD  K G p '  
SW |A |6 G 8 E A 
8  w W s  G G P D  A0
Ibd706 5 1 8 E V V A N L F Q V P Q N P V VD G 1 L A S P G 1 L R G A N L D C
Ibd985 5 1 8 E V V A N L F Q V P Q  N P V V D G 1 L A S P G 1 L R G A N L D C
Pbg98vp4 5 1 8 E V V A N L F Q V P Q N P V V D G 1 L A S P G V L R G A N L D C
Cu-1 5 1 8 E V V A N L F Q V P Q N P V V D G 1 L A S P G V L R G A N L D C
Gb 5 1 8 E V V A N L F Q V P Q N P V V D G 1 L A 8 P G 1 L R G A N L D C
002-73 5 1 8 E V V A N L F Q V P Q N P V V D G 1 L A S P G V L R G A N L D C
5270vp4 5 1 8 E V V A N L F Q V P Q N P V V D G 1 L A S P G V L R G A N L D C
SIC 5 1 8 E V V A N L F Q V P Q N P V V D 6  1 L A S P G V L R Q A N L D C
661vp4 5 1 8 E V V A N L F Q V P Q N P V V D G 1 L A 8 P G 1 L R G A N L D C
Ks-1vp4 5 1 8 E V V A N L F Q V P Q N P V V D G 1 L A 8 P G 1 L R G A N L D C
23-82 5 1 8 E V V a n | ü] f Q V P Q N P [T|v d g  I L A S P G 1 L R G A N L D C
Jaspervp4 5 1 4 G è y s k h l k t r l e s n n y e e V e L IP Ik p T^g I-
N1vp4 5 1 4 G K F S R A L K N R L E S A N Y E E V E L jP jp p s k [ ^ -
Dxwp4 5 0 0 8  A D S P 0 G E E H W L g ]N  E N  E N F N K F D 1 1 Y D -
Ibd706 5 5 1 V L A Ë G A 'f L ? P V V  1 t t  V E b a Wi t p k a l n s k  M - F A V
Ibd985 5 5 1 V L R E G A T L F p  V V 1 T T V E D A M T P K A L N S K M - F A V
Pbg98vp4 5 5 1 V L R E G A T L F P V V 1 T T V E D A M T P K A L N S K M - F A V
Cu-1 5 5 1 V L R E G A T L F p V V 1 T T V E D A M T P K A L N S K M - F A V
Gis 5 5 1 V L R E G A T L F p V V l T T V E D A M T P K A L N S K M - F A V
002-73 5 5 1 V L R E G A T L F p V V 1 T T V E D A M T P K A L N S K M . F A V
5270vp4 5 5 1 V L R E G A T L F p V V 1 T T V E D A M T P K A L N S K M - F A V
Sic 5 5 1 V L R E G A T L F p  V V 1 T T V E D A M T P K A L N S K | f - F A V
661vp4 5 5 1 V L R E G A T L F p V V 1 T T V E D A M T P K A L N S K M . F A V
Ks-1vp4 5 5 1 V L R E G A T L F p V V 1 T T V E D A M T P K A L N S K M - F A V
23-82 5 5 1 V L p v jE G A T L F p  V V 1 T t FlI e  d Ë T j T  P K A L N S K M - F A V
Jaspervp4 54 1 V 1 F p v lv H T  V e Is Â |-  P Q  e i a î F g Ts M V V 1N1vp4 5 4 1 - “ . . . - V 1 V p V|V H |T  V|K 8 ^  P Q  e [ ^ F  G ^ |l a 1 1 1
Dxwp4 5 2 7 3 ® H 8  8  M AjL F p  V 1 MM E H D K V I  P S D P E E L Y 1 A V 8  L
E G
I E G
I E G
I E G
I E G V
L Q P P 8t E G
I E G
I E Q
I E Q
I E G
I E G
P G A V
P N L NR K Q
R T L S G H R V  
R T L 8 G H R V  
R T L S G H R V  
R T L S G H R V  
R T L S G H R V  
R T L S G H R V  
R T L S G H R V  
R T L S G H R V  
R T L 8  g ] H  R V 
R T L 8  G H R V 
k  N D t | G - 0 
-  8
Y G
Y G
Y G
Y G
Y G
Y G
Y G
Y G
Y G 
Y G
Y G 
G|
G H R  V Y
A P D G  
A P D G 
A P D G  PDG PDG PDG PDG PDG 
A P D G 
A P D G  
A P D GÎTÊ
G E 
V 8  8
ptennETÊtor
jDj
 N S  N
Ibd706
Ibd985
Pbg98vp4
Cu-1
Gk
002-73
5270vp4
Stc
661vp4
Ks-1vp4
23-82
Jaspervp4
N1vp4
Dxwp4
tbd706
Ibd985
Pbg98vp4
Cu-1
Gk
002-73
5270vp4
Sic
661vp4
Ks-1vp4
23-82
Jaspervp4
N1vp4
Dxwp4
Ibd706
Ibd985
Pbg98vp4
Cu-1
Gk
002-73
5270vp4
Stc
661vp4
Ks-1vp4
23-82
Jaspervp4
N1vp4
Dxwp4
R D  Y T V
R D Y T I 0 0
R D  Y T I D D
D D
RD Y T
R D  Y T
R D  Y T I D D
R D  Y T
R D  Y T
R D  Y T I D Dn nMC Y T
PI FIE MC Y T K E I
P C=Y Q
676676676676676676676676676676676658658655
M O D S I M L S k  0  P 1 A
W D D S I M L S K D P 1 P
W D D S I M L S K D P 1 P
N D D S I M L S K D P ; d  P
W D D S I M L S K D P 1 p
N D D S I M L S K D P 1 P
N D D S I M L S K D  P 1 P
W D D S I M L S K D P 1 P
W D D S I M L S K D  P 1 p
WD D S I M L S K D P 1 P
W D D S I M L S Q D P 1 p
R N G N 1IV V E K I F  A G
R N G N l l v  V E K 1 F AG
- E G R L A g S T S P N
V O N  G N 
V G N ^ G  N
V G N G N
V Q N ^ G  N
V G N f  _ G N 
V G  N G N
V G N G N
V Q N $  G N 
V G |S ]  G N
L A I A Y M 
L A I A Y M 
L A I A Y M 
L A I A Y M 
L A I A Y M 
L A I A Y M 
L A I A Y M 
L A I A Y M 
L A I A Y M 
L | ^ I  A Y M 
L A I A Y M 
L a J T s T T  V N [TT 
Lp ^ L  S  L L V N D j I  
L Z I |Y J L A D g ] L  L
b V F T - P K V
D V F R P K V
D V F R P K V
0 V F R P K V
D V F R P K V
0 V F R P K V
0 V F R P K V
D V F R P K V
D V F R P K V
D V F R P K V
D V F R P K VDEGI  
E D g I v ] -  KS g|^L
V A M T G
V AM T G 
A M T G 
A M T G  
A M T G 
A M T G  
AM T G
V AM T G
V A M T G 
A M T G
V AM T G 
F T Q  E 
F T G E
3 f(TH1
A L N A
A L N A
A L N A
A L N A
# L  N A
A L N A
a [P |n  a
A T N A
A L N A
A L N A
A L N A
#  L G L K L 
R L G L K L 
R L G L K L 
R L G L K L 
R L G L K L 
R L G L K L
I A D D• ADD
h  à  t  K LrENfTs À t  A H
A T  AH
A T  AH
A T  AH
A T  AH
R S T K l A T  AHKIVS
A T  AH L G L K L 
iJ g  L k  L 
L G L 
L Q L
A T  AH
A T  AH
A T  AH
L QfMÏK LA T  AH
I Al AH 
I a |a h
Q L T D
E H G LEETVI  EETm,  ^
- S S ^ G  E g ] F  G
À G -  - nA G - i
A G -  - p
A G -  - p.
A G -  - i
A G -  - i
A G -  - 1
A G -  - iA G -  - 1A G -  - Ë
A G -  - P
1 G C Q P
1 Q N Q P
L Q N S P
Ibd706 707 a A F D V N T G S N W A T F 1 K R
Ibd985 707 Q A F D V N T G S NW  A T F 1 K R
Pbg98vp4 707 G A F D V N T G p N W  A T F 1 K R
Cu-1 707 S A F D V N T G p N W A T F 1 K R
Gk 707 S A F D V N T G p N W A T F 1 K R
002-73 707 S A F d [1 J^  t  G p N W A T F 1 K R
5270vp4 707 Q A F D V N  T G p NW  A T F 1 K RStc 70 7 a A F D V N T Q p N W  A T F 1 K R
661vp4 707 a A F D V N T G s N W A T F 1 K R
Ks-1vp4 707 a A F D V N T G s N W À  T F 1 K R
23-82 707 a A fŸ lD T i^ lT G p N W  A T f Tv Ik r
Jaspervp4 691 a V D T M V A N T S T U I g ^ H T 1 Q -
Nlvp4 691 a V D E E V R N T S  l (a |A H L 1 Q .
Dxwp4 687 a L V 0[V ]K |T]L T S L D K M
Figure 3 .v iii . A phy logenetic  tree of the b irnav irus p ro  teases using th e  
p rog ram s DISTANCES and  GROWTREE (GCG W inscosin). The s tra in s used a re  
those s ta ted  for figure S.viii. The d istance  from left to righ t ind ica tes th e  
am ount of divergence betw een the sequences aligned.
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The residues proposed by Brown and Skinner (1996) for the catalytic triad are 
as follows; H546, D589 and 8652. The serine at 652 is the only residue in this 
triad that is conserved. The alternative triad com prising of D525, H546 and 
S652 is also not completely conserved. A lthough the proteases of the 
b irnavirus family are similar in sequence it does not necessarily m ean that 
they will use the same residues. The proposed dibasic cleavage site of 
RR452453 is reasonably conserved throughout the b irnavirus proteases, 
how ever it has been show n for DXV, by N -term inal sequencing of VP4, that 
the cleavage site at the VP2-VP4 junction is between a serine at 500 and an 
alanine at 501 (Chung et al., 1996). The N -term inus of VP4 is, therefore, 
ADSPL (residues 501-505). There is a similar sequence (ADLNSPL) betw een 
residues 431 and 436 in the IBDV strains. These sequences need not, how ever, 
reflect prim ary cleavage events bu t only represent the final product. H ow ever 
there is no sim ilar site in the IPNV sequence. The proposed cleavage site at 
the VP4-VP3 junction (K722R723) is not conserved throughout the b irnav irus 
polyprotein sequences.
The phylogenetic tree (figure 3,viii) shows that DXV is m uch diverged from  
the other birnavirus sequences and therefore correlations between the DXV 
and IBDV sequences are difficult to infer and may be unreliable. The tree also 
shows that the IPNV strains and the IBDV strains fall into their own distinct 
groups. The vvIBDV strains (IBD985, KS-1 and UK661) form a distinct 
subgroup w ithin  the IBDV cluster. A ttenuated strain IBD706 is also grouped 
w ith the vvIBDV as it was derived from vv strain IBD 985.
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Of the IBDV sequences IBD985, UK661 and KS-1 are "very virulent" strains. 
IBD 706 is an attenuated strain derived from IBD985 by tissue culture passage 
(Yamaguchi et al., 1996). Strain 52/70 is a v iru len t field isolate; strains CU-1, 
GLS and 002-73 are m ild field isolates and strains PBG98 and STC are 
attenuated strains adapted for tissue culture. Strain 23-82 is a serotype II strain. 
Of the sequence changes between IBDV strains, one m utation  (namely P715S, 
w ithin the proposed VP4 sequence) is found in all the "very virulent" strains. 
M utations just upstream  of the dibasic residues RR452453 (L451I) and betw een 
the dibasic residues KR722723 and the AxAAS sequence at 753-757 (H751D) are 
also m aintained in all of the vvIBDV strains. The N651S, D624V and D632 
changes found in UK661 strain occurs only in that strain.
3.7.2 Sequence Comparisons of Birnavirus Proteases with other Pro teas es
UK661 VP4 sequence was entered into the BLAST and PASTA program s 
which search for matches in sequences w ith other proteins w ithin the w hole 
SWISSPROT, TREMBL and PIR databases. A lthough little hom ology was 
discovered there was some hom ology between UK661 VP4 and the Lon 
pro tease of bacteria. This m atch was in the C-terminal portion of the p ro te in  
in the region of the 'substrate binding pocket'. The C-term inal region of VP4 
has already been identified as being im portant in proteolytic processing of the 
polyprotein by deletion m apping experiments (Azad et. al., 1987) (Figure 3.ix).
The UK661 and CU-1 IBDV strains, IPNV jasper strain and the DXV proteases 
were then aligned w ith other representative mem bers of the different classes 
of pro teases: The Ion proteases from Haemophilus species and and E. coli, the 
HIV-1 retropepsin, Lactococciis me tallopro tease, the Clp pro tease from E. coli,
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poliovirus 3C protease. Tick borne encephalitis virus (TBE) pro tease. Bacillus  
siibtilis me tallopro tease, Lactococciis peptidase C, Proteinase K, T h e r m o p h i l u s  
species serine pro tease. Bacillus subtilis subtilisin, Xenopus  ,Drosophila and 
H um an furins, Sacchronnjces ccrivisae  Kex pro tease, Xenopus  trypsin, 
Trypanosom e Cysteine pro tease and P20 from BVDV (Figure 3.x). The 
phylogram  shows that the birnavirus sequences are m ore related to the Lon  
pro teases than the other classes. However, it m ust be pointed out that the 
statistical analysis, giving the probability of two sequences being related (P,J, of 
the line-up show ed that the b irnavirus sequences were totally unrelated to 
any pro tease other than those in the Lon protease family.
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Figure 3.ix. An a lignm en t of b irnav irus p ro  teases from IBDV, IPN V  and  DXV 
w ith  3 exam ples of the Lon protease sequences from  d ifferent stra ins of b a c te r ia ; 
Erwinia  (Lonerw ), I-Inenwphiltis fLonhae) and Mi/xococciis (Londm yx). T he  
o u tlined  boxes indicate regions of iden tity  and  the shaded  areas show  reg ions of 
hom ology.
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Figure 3.x. A phy log ram  of UK661 and CU-1 IBDV s I rains, IPNV jasp er s tra in  
and the DXV VP4 am ino acid sequences w ith  rep resen ta tiv e  pro  teases from 
o ther classes of p ro tease; The Ion p ro teases from H a em o p h ilu s  species and  and  
£. coli, the H IV -I re tropepsin , Lactococciis m eta llo p ro tease , the Clp  p ro  tease 
from £. coli, po liov irus 3C pro tease. Tick borne en cep h a litis  v irus (TBE) 
pro  tease. Bacillus subtilis m e ta llo p ro tease , Lactococciis p e p tid a se  C, 
P ro te inase  K, Thermophilus  species serine  p ro  tease. Bacillus subtilis su b tilis in , 
Xenopus , D rosophila  and H um an furins, Sacchromyces cerivisae  Kex p ro te a se , 
Xenopus  trypsin , Trypanosom e C ysteine pro  tease and P20 from BVDV T h e  
groups of p ro teases are as follows; Red, b irnav iru s VP4 sequences; Black, ATP- 
d e p en d en t serine pro teases; O range, aspartic  p roteases; Pink, m e ta lio p ro te a se s ; 
Purple, lype-I serine p ro  teases; Blue, cysteine pro teases; Green, type-Il serine  
p ro  teases.
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3.9 Site Directed Mutagenesis of VP4
The VP4 residues m utated were those that are conserved between IBDV and 
IPNV sequences or those that are conserved between IBDV, IPNV and DXV 
(see figure S.vii). Three other m utations, S651N, S715P and D751H, 'revert' 
the "very virulent" sequence to the canonical sequence. A list of all the 
m utations m ade can be found in table 6.i. Site directed m utants were created 
using the QuikChange'^'''"' Site Directed M utagenesis kit (Stratagene) according 
to the m anufacturers protocol outlined in chapter 2.10. Forward and reverse 
prim ers were designed to the recom m endations outlined in the protocol and 
are nam ed according to the format: original residue in single letter, then  
residue num ber, then m utated residue and then F or R depending on 
w hether it is a forward or reverse prim er, respectively (e.g. S652TF m eans 
forward prim er to m utate serine 652 to threonine (see appendix 1 for a full list 
of primers). The m utants were nam ed by the same notation (w ithout F or R). 
To facilitate screening for m utations, a new  restriction enzyme site was 
included (or an existing one was m utated) at, or near, the coding m utation . 
The m utants were then screened for the appropriate changes in restriction 
enzyme cleavage pattern (see figure 3.xi (B)). The presence of the m u ta tions 
was then confirmed by sequencing using the ABI 373A autom ated sequencer 
(figure 3.xi (A)) (see appendix 2 for all sequencing data).
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Figure 3.xi (A) C hrom atogram s of the area of m uta tion  of the S652A, S652T and 
S652C m utants created  by the ABI sequencer and d isp lay ed  using the ABI 
sequencing  softw are, SeqEd*-'". (B) A 1% TBE agarose gel stained w ith  e th id iu m  
brom ide show ing rep resen ta tiv e  restriction  enzym e digests of S652A, S652T, 
S652C and  K692N m u tan ts  w ith  Nnel,  /l^cl, Pu/dl and Sffd.
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4. Purification and N-terminal Sequencing of the IBDV Proteins
4.1 Grotufh o f  A tten u a ted  S tra ins in  Tissue Culture
Initially IBDV was isolated from  bursal hom ogenates (Dobos, 1979). W h e n  
field isolates were passaged through tissue culture systems they became 
attenuated. However, these adapted tissue culture strains were antigenically 
similar to the field isolates and were used for vaccination of chickens.
The replication kinetics of IBDV in tissue culture was investigated in order to 
optim ise production of the virus. In the first experim ent, CEFs (in e ither 
Eagles MEM or 199 m edium ) were infected w ith IBDV strain PBG98, at a 
m.o.i. of 0.1, and the yield of infectious intracellular and extracellular 
particles, at various times post-infection, was determ ined by plaque assay. In a 
second experiment, an m.o.i. of 10, in Eagles MEM was used (Figure 4.i).
From data presented in graph A, it can be observed that the virus yield, 
following infection at a m.o.i. of 0.1, is optim al at ~3 d.p.i. w ith  Eagles MEM. 
Following infection at a m.o.i. of 10 , in  Eagles MEM (Graph B), virus yield is 
maxim al at 24 hours post infection. Considering the results of both  
experim ents, it was apparent that the optim al virus yield (calculated as the 
ratio of virus produced to inpu t virus) was achieved in  Eagles MEM at 
24hours post infection.
4.2 P u rifica tion  o f  IB D V  P ro te in s and N -term in a l Sequencing o f  IB D V  P ro te in s  
The order of cleavage of the IBDV proteins from  segm ent A by VP4 is not yet 
known. Pulse chase studies on the course of infection have show n a 
polyprotein of 108-1 ISKDa being cleaved into VP2, VP3 and VP4 (Dobos et al.,
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polyprotein of 108-115KDa being cleaved into VP2, VP3 and VP4 (Dobos et al., 
1979). The cleavage of the polyprotein at the VP4-VP3 junction is dependent 
on the VP4 pro tease (Azad et al., 1985; Azad et al., 1986). The u ltim ate  
cleavage sites could be determ ined by purification of VP4 and VP3 by SDS- 
PAGE followed by N-terminal sequencing of the protein. The low abundance 
of VP4 in the virus particle m eans that it w ould be difficult to obtain it in  
sufficient quantities for sequence analysis. The best option, therefore, 
appeared to be to purify and sequence VP3, to elucidate the location of the 
cleavage site at the VP4-VP3 junction. The success of the approach is 
dependent on there being no post-cleavage m odifications (w hether 
subsequent cleavages or m odification of the N -term inal residue) of VP3, 
either by the cell or by VP4 itself.
The density of the IBDV particles is 1.33g/cnV on caesium  chloride gradients 
(Dobos, 1979).
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F igure 4.1. (A) The g row th  of IBDV stra in  PBG98 in CEFs over tim e infected a t 
an  m.o.i. of 0.1 an d  the differences in the m edia  used. 199 is 1x199 m ed ia , MEM 
is Ix Eagles m in im al essen tia l m edium  and S /N  is the amormt of v irus w ith in  
the su p ern a tan t a fte r a c learing spin  and  cells is the am ount of in tra c e llu la r  
v irus after freeze thaw ing  the cells three times. (B) The g ro w th  of IBDV s tra in  
PBG98 over tim e infected at an m.o.i. of 10 using Eagles MEM. The sam e 
abbrev ia tions ap p ly  as for g rap h  A.
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A  1 lî+ 08
B
lE + 0 7  -
B+06 -
ü E + 0 5 -  i
Ib + 04  -
lE + 0 3  -
E+02 -
lE+01
lE+00
1E +07
1E +06 -
c- l E + 0 5 -
1E+04-
IE +03
T im e (hours)
199 S/N A VG 
199 C ells AVG
■ MEM S/N AVG
■ MEM Cells AVG
s/n
ce lls
Tim e
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Several different m ethods have been described for the purification of w hole 
virions (Becht, 1980, Becht ct n i, 1988, Dobos, 1979, Dobos et al., 1979, Heine et 
al., 1991, Hirai & Shim akura, 1974, Lange et al., 1987). The purification 
m ethod used is adapted from Dobos, (1979). These m ethods used either
attenuated virus strains such as Cu-IM  grow n in CEF cells or bursal
hom o gena tes from experim entally infected chickens.
The virus can be purified by CsCl gradients from tissue culture or from bursal 
m aterial. Virus was grown in tissue culture (attenuated strain PBG98, 
In ter vet) or replicated in vivo (strain UK661).
Bursal m aterial from birds experim entally infected w ith strain UK661 was 
hom ogenised, extracted w ith 1,1,2-trichlorotrifluoroethane and then
centrifuged over a 40% sucrose cushion at 30krpm in a SW40ti (Beckman)
rotor. The resulting pellet was overlaid onto a preform ed caesium chloride
gradient (1.25 g / c m ^  to 1.45 g/cm ^) containing 10|.iM A protin in  (Sigma) and 
centrifuged overnight at 30krpm in a SW40ti (Beckman) rotor. After 
centrifugation, 0.5ml fractions were collected from the bottom  of the tubes 
and the total am ount of protein  in each fraction was determ ined using the 
protein detection kit (Pierce) (figure 4.ii). The fraction that had a density of
1.33 g/cin^ (with a total protein  concentration of 0.05 m g/m l) was then  
diluted with PBSa and centrifuged
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F igure  4.ii (A) A calibration curve of the concentration of knov\m BSA s ta n d a rd s  
using the BCA total p ro te in  concentration assay  kit (Pierce). The error bars 
show  the s tan d ard  dev iation  over four sam ples on the sam e 96 w ell p la te  (B) A 
g rap h  show ing  the to ta l am ount of concentration of p ro teins each of th e
fractions taken  from the CsCl g rad ien t. Fraction 6 has a density  of 1.33g/cm^ 
and  a total p ro tein  concentration  of 0 .05m g/m l.
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at 30K rpm  in a SW40ti (Beckman) rotor at 4^C for 1 hour. The resu lting  
pellet was resuspended in lOpl of w ater and lOgl of Ix SDS-PAGE sam ple 
buffer and boiled for 10 minutes. The entire sample was loaded on a 12% SDS- 
PAGE gel that had been left to polymerise for 24 hours and subject to 
electrophoresis at a constant voltage of lOOV until the brom ophenol blue dye
front was close to the bottom. The gel was then soaked for 10 m inutes in
IxCAPS buffer and then transferred onto Problot'^' PVDF m embrane. The 
Problot'^' PVDF m em brane was stained in Coomassie blue dye for 1 m in u te  
and then destained w ith 10% m e th a n o l/10% acetic acid solution for 1 hour. 
The band at the correct size for VP3 (32kDa) was excised from  the Problot 
PVDF m em brane and sent to Dr. Pat Barker at the Babraham  Institute for N- 
term inal sequencing using gas phase chrom atography. The protein in the 
PVDF was eluted and subjected to the Edm ann degradation m ethod. The 
interpretation of the data obtained from this N-term inal sequencing is show n 
below (see appendix 3).
1 2 3 4 5 6 7 8 9 10  11 12 13 14 15 16  17 18 19 20
G 7 G P D E L D I Q G  I  N D G X X X X X X
This data was quite poor and assignm ents were m ade on very little 
differences at high sensitivity.
The same experim ent was done using virus of strain PBG98 (propagated in  
Vero cells (twenty T175 flasks)). We have observed that higher yields of v iru s  
are obtained from Vero cells (P. G. Green, pers. comm.,). The flasks were 
infected at an moi of 10 and cells were lysed by freeze thaw ing once at 6 dpi.
109
The assignments of the data from this first N-term inal sequencing result were made in 
the presence of a high background (see appendix 3). The assignments were made on the 
highest peak obtained on the chroma to graph. However the presence of glycine in the 
Tris-Glycine buffer used to ru n  the SDS-PAGE m ay affect the results. The first 2 
assignments of G" m ay be due to this high level of glycine in the running buffer. 
This m ay be overcome by more extensive washing in CAPS buffer before the transfer of 
the protein onto the membrane or by the use of a Tris-Tricine running buffer.
The assignments were subject to a BLAST search against the SwissProt, Trembl and PIR 
databases and no significant matches were found. It m ay be that this protein is part of 
the IBDV proteins or a cellular protein that is associated w ith  the virus. It is also 
possible that there are 2 proteins w ithin this band or that some degradation of the 
protein has occurred and this is causing the liigh level of background.
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The supernatants were spun (at lOkrpm at for 30 m inutes in the GSA 
rotor using a Sorvall RC-5B centrifuge) to rem ove the cellular debris then  
ultracentrifuged at 15krpm in the Sorvall TFA 20.250 rotor at 40C overnight, 
to pellet the virus. This pellet was resuspended in 1ml of PBSa containing 
PMSF pro tease inhibitor. The resuspended pellet was subjected to 3 A rclone 
extractions as for the extraction from bursa and virus was purified as from the 
bursal hom ogenate. This time there were 3 distinct bands on the CsCl 
gradient and these were rem oved using side puncture w ith an 18 gauge 
needle. The band at the correct density of 1.33g/cnP was diluted w ith PBSa 
containing PMSF at lOgM and spun at 30krpm in a SW40ti (Beckman) rotor 
to pellet the virus, which was resuspended in lOOgl of PBSa/PMSF. Virus was 
assessed by Coomassie blue staining and W estern blotting (using the Mab B29 
m ade from purified virus (In ter vet)) of the SDS-polyacrylamide gels (figure
4.hi).
The 32kDa band on the Coomassie stained gel that co-mi grated w ith the VP3 
band seen on the w estern blot was then cut out and sent to Dr. Pat Barker at 
the Babraham Institute for electroelution and N -term inal sequencing using  
gas phase chrom atography. The sequence determ ination for the N  term inus 
of PBG98 VP3, based on the results of his analysis, are show n below (see 
appendix 3):
1 2 3 4 5 6 7 8 9 1 0
A P P X X P X N P X
L L P
Q L
A
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Figure 4.iii. A C oom assie blue sta ined  12% SDS-PAGE gel of 10^1 of the 1.33g/cm3 
CsCI purified  PBG98 aligned w ith  a w estern  blot of 1 pi of the sam e m a te r ia l  
p robed  w ith  M ab B29 show ing  the VP3 band at approxim ately  32 kDa.
I l l
kDa
Coomassie Blue 
Stained gel
Western
Blot
64 ----
50 —
36
30 —
21
VP2?
VP3
14
Again, the quality of the sample was poor and the yield was quite low but the 
first alanine was quit a definite strong peak (see appendix 3) which fits w ith  
the DXV VP2-4 cleavage site which shows that VP4 starts w ith an alanine. 
The gel was then rerun using twice the am ount of m aterial and the band that 
was seen before was cut out from the gel as before. A band at 28kDa, p resum ed 
to be VP4, was also excised for sequence analysis. The in terpretation  of the 
data from these 2 bands is show n below.
Putative VP3 (32kDa).
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
V?  P X E E P  S ?  S ?  P P  S ?  S ?  I  S ?  Y T  N P  T  S ?
S ?  Q V D V V L
A?  L
Putative VP4 (28kDa).
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
A ? P  P Q K X G ? V X G ? X Q V Y T  S ? L Q Y  S
As all these sequences have produced poor data the alignm ent against the 
correct sequence cannot be properly interpreted. H ow ever the h igh  
proportion of prolines, particularly in the PBG98 proteins, may make N- 
term inal sequencing difficult, as the Edm ann degradation m ethod used does 
not cleave very efficiently at prolines. The chrom atographs from the 
sequencing facility (see appendix 3) showed that there was a very h igh  
background and that the bands VP3 and VP4 and these were probably the 
same protein. None of the above sequences show any hom ology w ith any 
protein in either the SwissProt or Trembl databases.
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The virus hom ogenates were purified over a second CsCl gradient w ith a
density range of 1.26g/cm^ to 1.36g/cm^. Again three distinct bands w ere 
visible and each was rem oved using side puncture as before. The density of 
the three bands was checked using the refrac tome ter and were found to be
1.26g/cm^, 1.28g / c m 3 and l.SSg/cm^. A volum e of lOpl of the CsCl density 
1.33g/cm^ was boiled in SDS-PAGE buffer and run  on a 10% SDS 
polyacrylam ide gel that had been left to set for 24 hours. The sample was then  
blotted onto ProbloC'^' PVDF m em brane in IxCAPS buffer and then stained 
with Coomassie brilliant blue stain. To avoid contam ination a picture was 
not taken. The gel was then w rapped in SaranWrap'*'^' and sent to Dr. David 
Avila at the Basel Institute for Im m unology, Basel, Sw itzerland for N- 
terminal sequencing of the visible bands. Of the four bands that were visible, 
the two most intense bands provided sequence data. The band at 46kDa (called 
JK2) (see appendix 3) produced the clearest result of am ino acid sequence 
TNLQDQTQQIVP as the highest values after the background and lag 
subtractions had been made. This sequence corresponds to the PBG98 VP2 
sequence (M TNLQDQTQQIVP) from the N-terminus of the polyprotein. This 
show ed that the VP2 w ithin the virus is not cleaved at the N -term inus and 
therefore the initial cleavage and m aturation of VPX occurs at the C 
terminus. The initial m ethionine appears to have been rem oved as happens 
w ith m any eukaryotic proteins.
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Figure  4.iv. (A) A table sho w in g  the possible calls for the N -lerm inus of aihino 
acid sequence JK3. The position  re la tes to the sequence niuuber and  the columns 
rep resen t the calls for th a t position  w ith  1st call being the m ost like ly  am ino 
acid and the calls below in descending like lihood . The le tters  rep resen t th e  
stan d ard  one letter am ino  acid code w ith  X being any am ino acid. The bold blue 
le tters represen t those am ino acids th a t align  w ith  position 515 in the IBD V  
sequence. The bold green le tters represen t those am ino acids, w hich  align a t 
position  762 in the IBDV sequence. The g lu tam ic acid at position  5 aligns in 
bo th  sequences. (B) Show s the best possible m atch  of the sequence X-P-E-Y-E-V 
against PBG9S p o ly p ro te in  sequences using the DNA S trider program . T he  
program  w as allow ed  1 possible m ism atches a longside the "any  am ino a c id "  
(X) but no gaps. (C) A lignm ent of the 2 query sequences w ith  th a t of PBG98 
protein  sequence using the SeqVu program  Version 1.0 © G arvan  In stitu te  (1992- 
1995). The le tters rep resen t the s tan d a rd  one le tter am ino acid code w ith  X 
being any am ino acid.
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Position 1 2 3 4 5 6 7 8 9
1st call R F E Y £ V S N L2nd call S A S R G Y T S W
3rd call K V G L H R Q Q V4th call T M T I S X N A X
c
Query seq 1 
Query seq2
V AN L 523515
745 N A G R Q Y D L  AMA AS E F KE|
S AV  
S A V
G Y E V 
G YE V
T P E L E 
T P E L E
Pattern length 5 
Mismatches allowed 2
7 63 PELES 7 67
515  KGYEV 519
Search for "PEYEV"
2 matches found
PEYEV
PEYEV
9
769
The data for band JK3 was slightly m ore difficult to in terpret due to varying 
signal strengths (D. Avila, Per s. Comm, and appendix 3). It seems that this 
band contained two or m ore protein sequences. The m ost probable am ino  
acids in order of preference are show n in figure 4.iv (A).
The first am ino acid is often difficult to call as m ost of the con tam inants 
w ithin the protein bands tend to be eluted w ith the first amino acid. Dr. A vila 
suggested looking for the sequence X-P-E-Y-E-V. W hen this sequence was 
analysed against the PBG98 polyprotein sequence using the program  DNA 
Strider, two possible m atches w ere found both w ith 2 m ism atches (figure 4.iv 
(B)). The sequence data is consistent w ith the presence, in the excised band, of 
2 proteins w ith N -term ini represented by both of these alignm ents, as the 
alternative residues (shown in figure 4.iv, (A)), are also represented.
Aligning the sequences in this way produces a gap of 1 am ino acid in both  
alignm ents as show n in figure 4.iv (C).
It seems that band (JK3) m ay contain both VP3 and VP4 sequences. This 
w ould pu t the cleavage sites of VP4 between D514 and the lysine at position  
515 for the VP2-4 junction and glutamic acid at position 761 and the 
threonine at position 762 for the VP4-3 junction. Both these sites are 
dow nstream  of the Ax A AS proposed cleavage sites and produce predicted 
sizes of 27.9kDa for VP3 and 26.9kDa for VP4. These sizes are very sim ilar to 
each other and m ay not be separated on a small slab gel. H owever, these sizes 
are lower than those suggested in the literature (32kDa for VP3 and 28kDa for 
VP4 (Dobos et aL, 1979)).
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5. Expression of IBDV Proteins
5.1 In troduction
Efficient translation in the cell free system using rabbit reticulocyte lysates was 
first described by (Pelham & Jackson, 1976). Before this time, the presence of 
exogenous mRNA m eant that added inRNA could only compete for 
translation. This system has been refined to link both  transcription and 
translation into a single tube and has also been refined further to allow  
expression from several tem plates such as supercoiled plasm ids, linearised 
plasm ids and PCR products. Several prom oters have been also been used 
such as the T3 prom oter, SP6 prom oter and the T7 prom oter. Expression from  
linearised plasm ids and PCR products are not recom m ended from the T3 or 
SP6 prom oters. The use of translation enhancer elem ents such as the 
encephalom yocarditis virus internal ribosome entry site (EMCV 1RES) or cap- 
independent translation enhancer (CITE) can dram atically enhance 
translation efficiency of RNA (Elroystein et aL, 1989). The CITE sequence also 
results in a high stringency for the correct AUG initiation codon (Frances et 
1992).
Translation efficiency can also be affected by base pairings in the 5' 
untranslated regions, by RNA secondary structures blocking binding to the 
ribosome, by the presence of upstream  sequences not norm ally translated and
by the presence of RNases, Mg^+ and salts (Jackson, 1991a, Jackson, 1991b, 
Jackson, 1991c).
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Expression in £. coîi is relatively inexpensive and allows the expression of 
large quantities of protein  that can be easily regulated. Previous work on the 
expression of the polyprotein from IBDV in E. coli has shown that the 
polyprotein is correctly processed into the individual com ponents (Azad et 
nL, 1984, Azad et nl., 1985, Azad et nl., 1986, Azad et aL, 1987, Jagadish et al., 
1988, Jagadish et aL, 1989).
5.2 Expression o f  a Full Length Polyprotein
5.2.1 Expression in the Coupled T ranscription/T ranslation System
Clones 34 and 1210 were created as previously described. The full length  
polyprotein was expressed under the T3 and T7 prom oter in the coupled 
transcrip tion /translation  system (Pro mega) using clone 34 and 1210 
respectively (figure 5.i). This was achieved using the m ethod as described 
previously.
The expression of clone 34 using T3 polym erase shows a expression pattern  
similar to the proteins found in IBDV. There is a band at -33kDa which could 
be VP3 and a band below that could be VP4. The high intensity band ju st 
above the 21.5kDa band overlays a brown smear on the gel suggesting that it is 
haem oglobin that has bound either some of the proteins or free labelled 
m ethionine. The precursors could possibly translation products from  
incorrect start codons a n d /o r  interm ediates of the proteolytic processing 
pathw ay. There is no evidence of a m aturation of VPX to VP2 which has been 
show n before w ith denatured virion RNA from IPNV (Mertens et aL, 1982) 
and IBDV (Azad et aL, 1985).
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The expression of clone 1210 in the coupled transcrip tion/translation  system  showed 
that there is a weal expression and that some of the bands co-migrated w ith the bands 
from  the pCITE negative control. H ow ever there is some difference in the protein 
profile of the clone 1210 expression, nam ely the band at approxim ately 35kDa. This 
band m ay be due to the polyprotein expression but, as there is no precursor proteins or 
proteins that can be assigned to VP2 or VPX, this m ay be an artefact of the system.
H9A
5.2.2 Expression of the IBDV Polyprotein in E. coli
The polyprotein in clone 34 was also in frame for the LacZ prom oter that is 
induced by the addition of IPTG. Clone 34 was also expressed in the BL21 E. 
coli strain which is deficient in the Lon and Clp pro teases to p reven t 
degradation of proteins, under the LncZ prom oter and induced w ith IPTG. 
The proteins were blotted onto a nitrocellulose m em brane and developed 
w ith a polyclonal antisera raised in rabbits using the strain D78 (Intervet) (see 
figures 5.viii and 5.ix). This resulted in a properly cleaved polyprotein w ith  
similar interm ediates to the cell free system. H ow ever there is a presence of a 
45kDa band not seen in the first cell free system experim ent which m ay 
suggest that VPX is m atured to VP2 in E. coli. The m aturation of VP2 has also 
been shown before in the £. coli expression system (Azad et al., 1985, Azad et 
al., 1987, Jagadish et a i,  1988).
1 2 0
Figure 5.1. (A). Expression of clone 1210 under Ihe T7 prom oter run  on a 15% SD S- 
PAGE. (Lane 1) no D N A , (lane 2) pClTE, (lane 3) Ip g  of clone 1210, (lane 4) 
0.75|.ig of clone 1210, (lane 5) O.Spg of clone 1210, (lane 6) Luciferase control. (B) 
Expression of clone 34 im der the T3 prom oter run on a 15% SDS-PAGE. (Lane 1) 
no DN A , (lane 2) pB luescrip t KS- (S tra tagene) w ith  T3 po lym erase , (lane 3) 
Ij-ig of clone 34 w ith  T7 po lym erase , (lane 4) 0.5pg of clone 34 w ith  T3 
polym erase, (lane 5) Ip g  of clone 34 w ith  T3 polym erase, (lane 6) 2pg of clone 34 
w ith  T3 polym erase, (lane 7) Ijiig of clone 1210 w ith  T7 polym erase.
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5.2,3 Inhibition of Coupled Transcription/Translation Expression System  
with the T7 Polymerase
Expression of . the polyprotein in clone 1210 seems to be reduced than w ith  
clone 34. This is surprising as the T7 should enhance the transcription of the 
DNA and the CITE sequence should enhance the translation of the RN A. 
There is a band above the 30kDa m arker, which could be VP3, but all o ther 
bands seem to be present in the pCITE control. W hen the am ount of DNA is 
decreased there is an increase in intensity of a band just above the 14.3kDa 
m arker. This suggests that there m ay be some inhibition  of the expression 
system under the T7 prom oter. In order to investigate this an expression 
clone created by Mr. D. H ot in the lab that expressed V Pl under the T7 
prom oter in pBluescript KS- was co-expressed w ith clone 1210 using T7 
polymerase. Varying am ounts of pCITE and Clone 1210 were added to a 
standard 0.5pg of V Pl in pBluescript and a standard 0.5pg am ount of pCITE 
and clone 1210 was added to varying am ounts of V Pl in pBluescript (Figure
5.Ü). This result shows that clone 1210 inhibits the expression of the VPl in  
pBluescript and therefore is inhibiting either the transcription or translation  
in the cell free' system. The band at ~33kDa in clone 1210 comigrates w ith the 
band at -33kDa in clone 34 suggesting that this is a cleaved product. This 
suggests that a full length polyprotein is being produced w ith 1210 which is 
subsequently cleaved but the cleavage products produce an inhibitory effect 
on the expression system.
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Figure 5.ii A 12% SDS-PAGE show ing the co-expression of e ith e r  pCITE or 
C lone 1210 w ith  V Pl in pB luescrip t KS-. (lane 1) O.Sgg of pClTE, (lane 2) O.Spg 
of clone 1210, (lane 3) O.Sj-ig of V Pl in pB luescrip t, (lane) 4 0.25|Lig pCITE+ 0;5pg 
of V Pl in pB luescript, (lane 5) O.Spg pCITE + O.Spg V Pl in pB luescrip t, (lane 6) 
Ip g  pCITE + O.Spg V Pl in pB luescript, (lane 7) 0.25pg clone 1210 + O.Spg V Pl in 
pB luescrip t, (lane 8) 0.5pg clone 1210 + 0.5pg V Pl in pB luescrip t, (lane 9) Ipg  
clone 1210 + O.Spg V Pl in pB luescrip t, (lane 10) 0.25pg V Pl in pB luescrip t + 
0.5pg pCITE, (lane 11) 0.5pg V Pl in pB luescrip t + O.Spg pClTE, (lane 12) Ipg  
V Pl in pB luescript + O.Spg pClTE, (lane 13) 0.25pg of V Pl in pB luescrip t + O.Spg 
clone 1210, (lane 14) O.Spg of V Pl in pB luescript + 0.5pg clone 1210, (lane 15) Ipg  
V Pl in pB luescrip t + 0.5pg 1210, (lane 16) Ij-ig clone 34 w ith  T3 po lym erase , 
(lane 17) 0.5pg V Pl in pB luescrip t, (lane 18) 0.5|Lig clone 1210. pClTE is a 
com m ercially  av a ilab le  p lasm id  from N ovagen  and pB luescrip t from 
S tra ta g e n e .
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The inhibitory effect of the expression of the full length polyprotein has n o t 
been described before in the cell free system. Several reports have successfully 
produced a poly pro tein which is cleaved into its ind iv idual com ponents 
either by adding denatured viral dsRNA into the rabbit reticulocyte lysate or 
by expression of DNA from  a T7 prom oter (Azad et nl., 1985, M undt & 
Vakharia, 1996). These reports how ever used classical strains that were either 
attenuated or not. It m ay be possible that the expression of the UK661 strain  
polyprotein is in some way inhibitory to the expression system whereas the 
classical strains are not
In order to investigate which part of the polyprotein is responsible for the 
inhibitory effect of the UK661 strain expressed under the T7 prom oter, three 
PCR products were m ade from clone 34 using prim ers that contained the T7 
prom oter that expressed a full length polyprotein (T7VP243), VP4-3 from the 
proposed dibasic cleavage site at the VP2-4 junction w ith a start codon 
(T7VP43) and VP3 from the proposed dibasic cleavage site at the VP4-3 
junction with a start codon (T7VP3) in the linked T7 transcrip tion /transla tion  
kit (Amersham) (See A ppendix 1 for a full list of prim ers). A plasm id was also 
m ade by Dr. W. Thomas in the lab that contained a T7 prom oter plus the 
whole of strain UK661 segm ent A cloned into pUC18. This was expressed 
along side the PCR products (Figure S.iii A).
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Figure S.iii A. A SDS-PAGE gel of the expressed cell free PCR products 
T7VP243, T7VP43 and T7VP3 w ith  a luciferase p lasm id  control (C) and  a T7 
p lasm id  expressing the w hole  of segm ent A. B. C om parison of the p ro te ins 
expressed from T7VP3 and the cleaved VP3 from the full leng th  p o ly p ro te in  
expressed  in E. coli.
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These results show that a protein of -33kDa was expressed with the T7VP3 
PCR product but not w ith the T7VP243 and T7VP43 PCR products suggesting 
that it is the region between am ino acids 454 and 723 that is responsible for 
the inhibitory effect. As the cleavage sites of the polyprotein are not yet 
defined it is not possible to tell w hether it is just VP4 causing the inh ib ition . 
The protein from  T7VP3 PCR product in the cell free system was ran on the 
same SDS-PAGE gel as the full length polyprotein expressed in E. coli and 
blotted onto Hybond-C nitrocellulose (Amersham). The E. coli expressed 
polyprotein was visualised by W estern blotting w ith polyclonal antisera 
raised in rabbits using the strain D78 (Intervet). The part of the nitrocellu lose 
containing the radiolabelled T7VP3 expressed pro tein  was exposed to 
autoradiography film. The W estern blot of the cleaved polyprotein and the 
autoradiography film show ing the protein from T7VP3 was aligned using the 
m arkers on both the W estern blot and the autoradiography film (Figure S.iii 
B). It is possible to see from this SDS-PAGE gel that the size of the pro te in  
from T7VP3 is slightly larger than the cleaved VP3 suggesting that the dibasic 
residues at am ino acids 722 and 723 are not the correct cleavage site for the 
VP4-VP3 junction.
5.2,4 Analysis of the RNA Produced from the T7 and T3 Promoter
Clone 34, pBluescript KS- (Stratagene), clone 1210 and pCITE (Novagen) were 
pu t into a large scale in vitro transcription reaction using the appropriate 
polym erase (clone 34 and pBluescript using T3 polym erase (Promega); clone 
1210 and pCITE using T7 polym erase (Promega)). Equal am ounts of DNA was 
added as check using spectrophotom etry and visualisation on a 1% agarose
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gel stained w ith Ip g /m l eth id ium  bromide. The reaction was perform ed at 
37°C for 1 hour before boiling for 1 m inute w ith RNA loading buffer and 
loading on a 1% denaturing agarose gel containing form am ide and Ip g /m l 
eth id ium  bromide. The gel was run  overnight at 30V until the blue dye was 
near the bottom  of the gel. The gel was then exposed to UV light and a picture 
taken (Figure 5.iv).
The gel shows that clone 34 and pBluescript KS- produce RNA to the sam e 
intensity and that the RNA produced is of varying size due to the action of 
the T3 polym erase transcribing the whole plasm id and as there is not T3 
term inator this m eans that several "rounds" of the plasm id can be 
transcribed. Term ination of the T3 polym erase will only occur w hen the 
polym erase falls off the DNA or w hen all the ribonucleotides have been used. 
The pCITE plasm id produces 3 bands of RNA; a band of ~300 nucleotides, a 
band of -1000 nucleotides and a band of -3000 nucleotides. These bands can be 
assigned to the T7 prom oter to the T7 terminator w ith the CITE sequence and 
m ulti-cloning site (-300 nucleotides) and the T7 prom oter to the T7 
term inator once being round the entire plasm id (-3000 nucleotides). The 
-1000 nucleotide band cannot be explained w ithout further analysis. Clone 
1210 transcribes no RNA or RNA levels that cannot be detected w ith  
ethidium  brom ide staining.
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Figure 5.iv. A 1% agarose gel e lec trophoresis  show ing the in v itro  tra n s la tio n  
products from reaction mix containing no DNA (-ve), pB luescrip t KS- 
(S tratagene) (pBS), clone 34 (34), pClTE-4a (N ovagen) (pClTE) and  clone 1210 
(1210). The RNA lad d er (M) gives the sizes in kbp.
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This result cannot be easily explained. As the T7 prom oter is contained 
w ithin  the plasm id the possibility of a m utation  w ith in  this region is 
unlikely. It has been noted before that the T7 polym erase does not transcribe 
all RNA especially poly A's and T's (Britton, Pers. comm.) bu t due to the type 
of plasm id being transcribed if there were such sequences w ithin the insert 
w here the T7 w ould fall off the DNA there w ould still be the RNA from the 
T7 prom oter plus the CITE sequence as seen in the pCITE lane. One possibility 
m ay be that the RNA produced from clone 1210 m ay som ehow  bind to the T7 
polym erase and inactivate it in the initial stages of the reaction, thus 
inhibiting the subsequent RNA production.
5.2.5 Effect of IBDV Strain PBG98 on Cellular Protein Synthesis in Tissue
Culture
In light of the inhibition of the cell free expression system  by the full length  
polyprotein expressed under the T7 prom oter, the effect of IBDV replication 
in CEE cells was investigated. It has been reported that replication of IBDV in  
tissue culture did not shu t dow n cellular protein synthesis (Becht, 1980) by 
personal com m unication. This experim ent looked at the effect of the p ro te in  
concentration of CEE cell lysates after infection with IBDV by Coomassie blue 
staining of proteins. This experim ent, how ever, w ould  show only the 
concentration of total protein before and after infection and not specifically 
after infection thus any effect of the protein synthesis in the cell may not be 
seen. An experim ent was perform ed looking at infected and uninfected cell 
lysates by radiolabelling for 0-2 hpi, 2-4 hpi, 4-6 hpi, 6-8 hpi, 8-10 hpi and 10-12 
hpi (Figure 5.v A). This experim ent was perform ed using the IBDV strain
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PBG98 as strain UK661 doesn 't propagate in CEF cells. It is possible to see that 
there is no effect in the total protein concentration in these infected cell 
lysates show ing that IBDV strain PBG98 doesn 't inhibit cellular p ro te in  
synthesis. To see w hether the IBDV proteins are being expressed the sam ples 
were im m uno p reci pi ta ted using polyclonal antisera raised in rabbits using  
the strain D78 (Intervet) (Figure 5.v B). This shows that IBDV proteins are 
being expressed in the infected cell lysate but not in uninfected. The earliest 
detectable IBDV proteins were seen at 6 hpi. As the strain  used in the T7 
polym erase reaction is UK661 it cannot be ruled out that the changes w ith in  
the genome sequence may effect T7 polymerase. As strain  UK661 d o esn ’t 
grow in cell culture, the protein shutdow n w ith this strain is difficult to 
investigate.
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F igure  5.v. (A) A 12% SDS-PAGE gel show ing  the total cellu lar p ro te in s in CEF 
cell lysates in infected and  uninfected  (C) cells. The nu m b ei'S  are  the hours post
infection that the labe llin g  w ith  m eth ion ine  for 2 hours took place. (B) 
R ad io im m u n o p rec ip ita tio n  of the sam e sam ples using polyclonal a n tis e ra  
raised  in rabbits u sing  the s tra in  D78 (Intervet).
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5.3 A n a lys is  o f  the Expression P roducts
The composition of the bands in both expression systems is im portant so that 
the proteins can be identified. The lack of monoclonal antibodies that work in  
W estern Blotting led to problems in direct identification of the proteins in the 
E. coli expression system. A VPS specific m onoclonal that reacted w ith  
proteins in W estern blotting m ethod was only available at the end of project. 
A panel of Mabs was given as a kind gift from Dr. H. Becht, Giessen, 
Germany. From these, two VPS specific Mabs were used; Mab III/CS and Mab 
III/BIO. These m onoclonal antibodies react against different parts of the 
protein; Mab III/CS reacts against the N  term inal region of VPS and Mab 
III/BIO reacts against the C term inal region (Oppling et al., 1991). These Mabs 
and the VP2 specific Mabs, B69 and R6S, a kind gift from  A drian von Loon 
(Intervet) could also be used in the identification of the protein bands in the 
coupled transcrip tion/translation system  by RIPA.
Other m ethods, w hich were used to identify the indiv idual bands, are the 
insertion of epitopes for w hich there are commercially available Mabs, such 
as those that recognise a 6 histidine tag, and by deletion analysis.
5.3.1 Time Course of Expression of Clone 34
W hen studying proteolytic cleavage of a protease from a polyprotein it is 
som etim es possible to see the indiv idual cleavage events by studying a tim e 
course of the expression system. In order to investigate this, clone 34 was 
expressed in the coupled transcrip tion /translation  system  (Promega) and the 
reaction was stopped at the individual time points by the addition of SDS-
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PAGE buffer and putting  on ice (Figure 5.vi). It is possible to see that all the 
products of cleavage are co-translationally cleaved and that the in d iv id u a l 
cleavage events cannot be seen.
5.3.2 Immunoprécipitation of Expression Products in the Coupled
Transcription/Translation System
In order to see w hether any of the specific proteins in the coupled 
transcrip tion /transla tion  system  can be im m unoprecipitated , a chicken 
hyperim m une serum  raised against UK661 in chickens vaccinated w ith  
PBG98, the rabbit polyclonal raised against D78 (Intervet) or the Mabs B29 
(anti-VP3) or R63 (anti-VP2) (Intervet), were used. The coupled transcrip tion / 
translation (Promega) reaction mix of either pBluescript KS- or clone 34 was 
preabsorbed on Protein A Sepharose beads and then incubated w ith Protein A 
Sepharose beads bound w ith the chicken hyperim m une serum . H ow ever it 
was found that none of the polyclonal sera nor the Mabs im m unop recipi ta ted 
the proteins from the expression reaction. This m ay be due to the 
conform ation of the proteins in the coupled transcrip tion /transla tion  
reaction or due to incorrect processing of the polyprotein in this expression 
system. Also it had  not been determ ined w hether the polyclonal antibodies or 
the Mabs could im m unoprecipitate UK661 proteins, as UK661 cannot be 
grown in tissue culture. Therefore it may be that the antibodies will n o t 
recognise the UK661 strain proteins as they differ in conform ation from the 
"classical" strains.
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Figure 5.vi. A lime course experim ent on the expression of clone 34 in the coupled 
tra n sc rip tio n /tra n s la tio n  expression system  (Prom ega) in m inutes a fte r th e  
ad d itio n  of the T3 polym erase.
139
minutes
kDa
69
M 5 10 15 20 25 30
46
32.5
B kDa
97.4 — 
69 — 
46 —
minutes
M 30 90 120 150 M
32.5
72K
VP3?
Am p?
72K
VP3?
Amp?
5.3.3 Pulse Chase Studies on the Expression of Clone 34
In order to show the precursor to product relationship w ith the coupled 
transcrip tion /translation  system the reaction mix was set up  as before and 
then incubated for 10 m inutes at 30°C. Then, unlabelled m ethionine was 
added to a final concentration of Im M  and 5pi of the reaction was taken ou t 
at the following time points after the addition of unlabelled m ethionine: 0, 5, 
10, 15, 30, 45, 60, 90 and 120 m inutes. The samples w ere added to an equal 
volum e of SDS-PAGE loading buffer and boiled for 4 m inutes before loading 
the entire sam ple onto a 10% SDS-PAGE gel. The gel was run at 150V for 1 
hour and then fixed in 10% m eth an o l/10% acetic acid for 30 m inutes. The gel 
were then soaked in Amplify'^''’ (Amersham) for 30 m inutes and then dried 
onto W hatm an 3MM paper using a BioRad gel drier under vaccum and 
exposed to autoradiography film overnight. The gel can be seen in figure 
5.VÜ.
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F igure  S.vii The au to rad io g ram  of the pu lse  chase experim ent on the expression 
of the po lypro te in  from the T3 p ro m o ter in clone 34 at time po in ts  of 0, 5, 10, 15, 
30, 45, 60, 90 and 120 m inu tes after the add itio n  of the labelled m eth ionine. T he  
chased p ro d u c t is m arked  w ith  the arrow .
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From this it seems that only 1 band can be chased from ~37kDa to ~25kDa. A ll 
the other bands rem ain the same suggesting that there is no precursor 
p roduct relationship w ith  any of these proteins or that the processing is co- 
translational and  therefore highly rapid  so that processing cannot be followed. 
How ever processing can be followed by pulse chase in CEF cells and this 
shows a full length polyprotein being chased to VPX, VP4 and VP3 and VPX 
can be chased to m ature VP2 (Müller & Becht, 1982). In this rabbit reticulocyte 
lysate system no full length polyprotein can be detected. It m ay be possible 
that the products m ay be proteins from internal in itiation at a lternative 
ATG's.
5.3.4 Insertion of 6 Histidines in VP2
In order to identify which proteins contain VP2 and VPX a polylinker was 
constructed that cloned 6 histidine residues into the Clal site in the m iddle of 
VP2. This m utan t was sequenced using the ABI 373A autom ated sequencer 
using the ABI prism  cycle sequencing reaction. This was then expressed in E. 
coli and either stained w ith Coomassie blue (Figure S.viiiA) or W estern  
blotted using the chicken hyperim m une serum  (Figure S.viiiB). The 
Coomassie stained gel shows a decrease in the am ount of polyprotein cleaved. 
The w estern blot shows that the band at ~72kDa is shifted to -80kDa and a 
band at ~45kDa shifted to SOkDa. This shows that the 72kDa and 45kDa band 
contain VP2. As it has been show n w ith the deletion m utagenesis studies 
show n later in the thesis, the 72kDa band contains both VP2 and VP4 
suggesting that this band is one of the precursors VP2-4. The difference in  
sizes between the bands w ith and w ithout the 6 histid ine residues could be 
due to affecting the cleavage pattern of VPX to VP2 or affecting the m igration
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of the bands along the SDS-PAGE. There is how ever still faint bands at the 
original positions that have not been shifted by the insertion suggesting that 
the 6 histidine residues are affecting the cleavage pattern  of VPX to VP2. If 
this is so than this w ould m ean that the band at 45kDa is the m ature VP2, the 
band at SOkDa is VPX, the band at 72kDa is VP2-VP4 and the band at SOkDa is 
VPX-VP4. There is no effect in the size of VP3.
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F igure S.viii (A) A 12% C oom assie blue sta in  po lyacry lam ide gel of E. coli IPTG 
induced cell lysates expressing the p lasm ids pB luescrip t (pBS), p o ly p ro te in  
(WT) from clone 34 or the 6 h is tid in e  insertion  w ith in  VP2 po ly p ro te in  (H is ) . 
The A rrow  indicates the position  of the full length  poly pro tein . (B) A w estern 
blot of the sam e £. coli lysates probed w ith  the rabbit po lyclonal serum D78 
(Intervet). The VP3 and  VP2 conta in ing  p ro te in s are m arked  w ith  the arrow s.
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5.3.5 Detection of E. coli Proteins by Mabs
Because of the nature of m ost VP2 Mabs, which recognise conform ational, 
neutralising epitopes, the panel of VP2 Mabs that were available to me did 
not work on W estern blots. The VP3 specific Mabs, III/C3 and III/BIO 
m entioned above, were used to identify which bands contained VP3 specific 
sequences. Mab III/C3 was used in the W estern blotting procedure at a 
dilution of 1 in 1000 whereas the Mab III/BIO was used at a dilution of 1 in  
5000, as advised by Dr. H. Becht.
Mab III/C3 binds to 3 bands, a band at 72kDa, a band at 33kDa and less 
intensely a band at approximately 60kDa. The band at 33kDa is VP3 and the 
other bands are either precursor products or artefacts from  the expression 
system, such as internal initiation. I have already show n that the 72kDa band 
contains VP2 but, w ithout a direct comparison, it is no t possible to determ ine 
w hether this is the same protein. Mab III/BIO presents a m ore complicated 
pattern of bands that is similar to that of the rabbit polyclonal serum  and was 
therefore not used.
5.3.6 Comparison of E. coli Expression Products with Purified Virus
In order to see w hether the correct expression is being produced from the £. 
coli expression system the products were run  next to the purified virus, used 
in chapter 4 for the protein sequencing, from PBG98 and semi purified 
Faragher 52/70 (F52/70) and UK661 were analysed by 10% SDS-PAGE and 
blotted onto nitrocellulose and developed w ith a polyclonal raised in rabbits 
against strain D78 (Intervet) (Fig 5.ix).
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From the W estern blot (figure 5.ix) it is possible to see that the VP3 from the 
purified virus seem to be smaller in size than that of the E. coli expression 
system. This may be due to post cleavage m odifications in the CEF cells, that 
does not happen in the E. coli expression system. Flowever the VP3 band in  
the F52/70 track is slanted. The other precursor products in the £. coli 
expression system do not seem to be present in the purified virus tracks. This 
suggests that these products are artefacts of the E. coli expression system.
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Figure S.ix A w estern  blo t of clone 34 expressed E. coli ly sa tes (clone 34), 
pu rified  PBG98 IBDV stra in  (PBG98), and sem ipurified  F52/70 and  UK661 
IBDV stra ins w hich  w as p ro b ed  w ith  the rabb it polyclonal D78 (Intervet).
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5.4 Effect o f  Protease Inhibitors on the Coupled Transcription/Translation  
System
Protease inhibitors have been used extensively to investigate the different 
types of proteases. These inhibitors and their uses have already been discussed 
in chapter 1. The range of pro tease inhibitors used were: PMSF (Sigma), 
which inhibits serine proteases except those in the leader peptidase family 
and some cysteine pro teases, AEBSF (Sigma), which acts in the same way as 
PMSF but is slightly more stabile in non-organic solvents, A protinin (Sigma), 
a peptide which inhibits some of the serine proteases bu t is stabile for several 
hours, TPCK (Sigma), which inhibits some of the serine protease family by 
binding to the histidine in the catalytic triad, E64 (Sigma), which inhibits 
cysteine pro teases, EDTA (Sigma) which inhibits metalloproteases. All the 
protease inhibtors were used at a final concentration of lOpM except EDTA, 
which was used at a final concentration of ImM. The inhibitors were added at 
the beginning of the reaction (Figure 5. x). 5pi of the reaction was added to an  
equal volum e of SDS-PAGE buffer and boiled for 4 m inutes. 5pi of this was 
loaded onto a 10% SDS polyacrylamide gel and run  at 150V until the dye front 
was near the bottom. The gel was then fixed in 10% m e th an o l/10% acetic acid 
and washed in Amplify''^' (Amersham) for 30 m inutes. The gel was then  
dried onto W hatm an 3MM paper using a BioRad gel drier under vaccum.
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Figure 5.x An au to rad iog ram  of clone 34 expressed in the coupled 
tra n sc rip tio n /tra n s la tio n  expression system  (Prom ega) using T3 po lym erase in 
the presence of lOpM PMSF, lOpM AEBSF, lOpM A protin in , lOpM TPCK, IO jllM  
E64, C om plete inhibitor set (Boehringer M annheim ) and  Im M  EDTA.
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This autoradiogram  shows that the PMSF lane is different from the wild type 
with a band at ~37kDa decreasing in intensity and a band at ~50kDa increasing 
in intensity. However the addition of AEBSF which should work in the sam e 
way as PMSF doesn’t affect the processing of the polyprotein. The stock 
solution of PMSF is m ade up in m ethanol and is diluted 1 in 1000 at the final 
concentration whereas the AEBSF stock solution is m ade up in water and is 
more stabile. It m ay be the presence of the m ethanol in the reaction that 
causes this effect. However, the stock solution TPCK is also made in  
methanol and is also diluted 1 in 1000 at the final concentration. As the final 
concentrations of the methanol in both these reactions is equal then the effect 
of the m ethanol concentration should not affect the processing ability. 
A nother inhibitor that affects the processing is the Complete'^''' inhibitor set. 
In this lane there seems to be no proteins present at all and it is probable that 
this protease inhibitor cocktail affects the reaction in some way by possible 
affecting the salt concentrations so that the polym erase can no longer 
function. Unfortunately, the exact composition of the pro tease cocktail w ould 
not be disclosed.
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6 Expression of Deletion and Site Directed Mutant Sequences in E. 
Coli  and Coupled Transcription/Translation Expression Systems
6.1 Expression o f  Deletion M utan ts
The deletion m utants pD ell, pDel2, pDel3 and pDel4 were expressed both in  
the coupled transcrip tion/translation system (Promega) and in £. coU (Figure 
6.i). In both expression systems, the band at 72kDa is no longer present but 
bands corresponding, in size, to the am ount of VP4 deleted are visible, w hich 
suggests that this band contains VP4. In the £. coli expression system there is a 
decrease in the intensity of VP3 (-33kDa) in the deletion m utants but it is no t 
totally abolished until the deletion goes over the VP4-VP3 junction. This is 
not the case how ever in the coupled transcrip tion/translation  system, w here 
there is a change in the cleavage patterns w hen H546-S652 of the proposed 
catalytic triad (pDel2) is deleted but not when Î-I546-D589 (pDel 1) is deleted, 
suggesting that there is an im portant residue or residues between D589 and 
S652 for the cleavage of the interm ediates. W hen H546 to the end of the 
substrate binding pocket is deleted (pDel 3) no interm ediate cleavage occurs. 
However cleavage is not totally abolished by any of the deletions.
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Figure 6.1 (A) A fluorograph  of the expression of the deletion  m utan ts p D e li-4  
under the T3 prom oter in the coupled tra n sc rip tio n /tra n s la tio n  system  w ith  
pB luescript KS- (S tratagene) as a control (pBS) subjected to 12% SDS-PAGE. 
(B) A W estern b lo t of the £. coli expressed deletion  m utants p D ell-4  com pared 
w ith  the expression from  clone 34 (WT) w ith  pB luescrip t KS- (S tratagene) as a 
control (pBS) subjected to 12% SDS-PAGE, transferred  onto n itrocellu lose and 
developed  using  the rabbit polyclonal D78 (Intervet)
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6.2 Expression o f  M u tan ts  Created by  Site D irected M utagenesis
The m utation of specific residues of VP4 was perform ed by the use of the 
QuikChange m utagenesis system (Stratagene). Initial targets for m utagenesis 
were the proposed catalytic triad (H545, D589 and S652) and the dibasic 
residues at the beginning and the end of VP4. Also K692 was m utated as this 
lysine is conserved w ithin the birnavirus families and also between IBDV 
strains and the Lon pro tease. Primers were designed so that restriction 
enzyme sites were engineered into the m utations w ithout affecting 
surrounding residues other than the specific m utation desired (See appendix 
1 for all prim er inform ation). These were then expressed in E. coli and 
western blotted using polyclonal antisera raised in rabbits using the strain D78 
(Figure 6.ii). This W estern blot shows that the m utation  S652T completely 
abolishes the proteolytic processing ability of VP4 suggesting that this is a 
reactive serine. However w hen this m utation was sequenced (see appendix 2 
for all sequence data) it was found that this m utation has an extra adenine 
inserted into the sequence. This causes a +1 fram eshift after the S652T 
m utation. The other m utations do affect the processing ability of VP4 but do 
not completely abolish the function of the VP4. Examples of site directed 
m utants of the subtilisin showed that m utating the active residues did n o t 
completely abolish function.
Sequencing of the K692N m utant revealed that the glycerol stock from w hich 
this m utation was grown contained both w ild type and m utan t sequence and 
thus was streaked out on a LB am picilin (lOOmg/ml) plate and then colonies 
picked and then sequenced.
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The m utation S652T was rem ade along w ith S652C and S652A as mutations at 
active site serines in the proteases to a threonine and cysteine can restore some of 
the activity of the enzyme bu t m utating to an alanine should almost completely 
destroy the function of the protein. Also the K692N w ithout any wild type 
plasm id present was also expressed. W estern blots developed with the polyclonal 
serum  against D78 in rabbits (Intervet) and autoradiogram s of these m utations 
expressed in E. coli or the coupled transcription / translation system respectively, 
can be seen in figure 6.iii. From the E. coli expression system  it can be observed 
that, upon m utating the S652 to A, no VP3 or VP2 can be detected. In the case of 
S652T, S652C and K692N it is possible to see a faint VP3 band and faint VP2 band. 
In the coupled transcrip tion/translation system, the S652A m utation shows that 
the intensity of the -60kDa and the 72kDa bands is increased. This change in the 
processing of the polyprotein is a similar to that seen in w hen PMSF is added to 
the coupled transcrip tion/translation mix (figure 5.ix). The m utations, S652T, 
S652C and K692N all produce the same effect of an increase in the 72kDa band in 
the coupled transcription/translation expression system. This w ould suggest that 
all the m utations effect the processing ability w ith the S652A m utation producing 
the m ost drastic effect, however, there is no change in the intensity of the bands 
previously determ ined to be VP3, in all the m utations shown. This m ay be due 
to internal initiation at an AUG present near the start of VP3. There is a 
m ethionine at the AMAAS pattern  at position amino acid position 754. This 
methionine is encoded by an AUG at nucleotide position 2389-2391 (UK661 
numbering) in the sequence GCCATGG (2386-2392) which has a Kozak consenus 
sequence of (A/G)XXATG(A/G) (Kozak, 1983).
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Figure 6 .ii A W estern  b lo t of the £. coli expression system  of the site  d irec ted  
m utants D589K, H546V, S652T+1, K692N and  KR722723MH and  pB Iuescrip t 
KS- (pBS) developed  using rabb it polyclonal serum raised  against s tra in  D78 
(Intervet). A ltho u g h  a w ild  type lane is not show n the H546V m u tan t has th e  
sam e p a tte rn  as w ild  type.
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There is also an increase in the intensity of the bands 68kDa, the doublet at 
SOkDa, and 47kDa and a slight increase in intensity in the bands at 36kD and 
30kDa in all the m utations. All this data w ould suggest that the S652A 
m utation affects the processing more than the S652T and S652C m utations. 
This suggests that the serine at this position is involved in the processing as it 
is possible to restore, albeit very partially, the processing ability of the 
pro tease, VP4, by the m utations S652T or C, which is characteristic of serine 
proteases. The effect of the K692N m utation suggests that this lysine may be 
involved in the processing but it is not clear w hether this change is a 
structural effect on the polyprotein or w hether it is a reactive residue. 
A lthough the effect of the m utation at S652A seems to be more dramatic than  
the m utations S652T and S652C, this effect may be due to the am ount of total 
protein loaded in the sample. This may have been exam ined by Coomassie 
blue staining the total E. coli cell lysate concentration of the proteins in the
gel-
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Figure 6.ill (A) W estern blot of the £. coli expression system  of the site  d irec ted  
m utan ts, S652A S652T, S652C and K692N and from clone 34 (WT) and 
pB Iuescript KS- (pBS) developed  using rabbit polyclonal serimi ra ised  a g a in s t 
stra in  D78 (Intervet). (B) A n au to rad iog ram  of the sam e m utations expressed in 
the coupled  tran sc rip tio n /tran s la tio n  system  separa ted  by 10%SDS-PAGE
164
kDa
98
66
50
CD
COÛ.
< I— U ZCVJ CM CM CMin in in OCO CO CO COCD CD CD
72K
VP2
36
30
VP3
B I— < O Z
CD CM CM CM CMin in m G)CD % CO CO CO COCl CD CD CD
kDa
97.4
69
46
32.5
72K
65K
VP3
30K
Further m utations were made for other conserved residues between know n 
IBDV, IPNV and the DXV sequences (see figure 3.vii for the line up of the 
sequences used to determ ine the conserved residues and table 6.1 for a full list 
of all m utations w ithin the VP4 region). The m utations that were deem ed 
correct after autom ated sequencing of the VP4 region were analysed by 
expression in both the coupled transcrip tion/translation  system and the E. 
coli expression systems (see figures 6.iv-6.viii). The effects on the processing 
of all the m utations were scored as follows: -, no effect; +, little effect; ++, 
some effect; +++, major effect on the processing (see table 6.i for the list of 
m utations and the score given to each of the mutations).
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T able 6.1. A table show ing all the po in t m utations m ade on the conserved 
residues w ith in  the IBDV, IPNV and DXV sequences show n in the p ileup  in 
figure 3-vii. A ll the m uta tions w ere correct over the VP4 region a lre a d y  
discussed in chap ter 3 and the sequence d a ta  for all m utations can be found in 
append ix  2. The scores given for the effect of the m utation  on the p ro teo ly tic  
processing are show n below  the m utation  as follows: -, no effect; +, little  effect; 
++, som e effect; +++, m ajor effect. The m utation  m arked  w ith  * ind icates effect 
only seen in the coupled tra n sc rip tio n /tra n s la tio n  expression system  and those 
m arked  w ith  § indicates effect only seen in the £. coU expression system .
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S460C D483N S494A R505A R507A
R545A D549N H546V E554Q D589K
- - - ++ +
T565C Q595E S598T D615N E621Q
- ++ ++^ - +
Y627F D633N SK641641PM S651N S652A
- - ++ - +++
S652T S652C K692N K666M H697D
-j—[- ++ + + - ++
D711N K703M S715P Y741W D751H
- - - ++^ ++
M utational analysis of conserved residues shows that m utations other than  
those described above also affect the processing of the polyprotein. Of these 
m utants, E475Q-1, E554Q, D589K, Q595E, E621Q, S652T+1, K692N and H697D 
affected the processing of the polyprotein in the two expression systems. 
E475Q-1 and S652T+1 show the most marked changes. However, these 
m utations cause frameshifts, of -1 and +1 respectively, just after the m utated  
am ino acid and it is probably due to these frameshifts that the processing 
ability of the protease is destroyed. The E475Q-1 m utation gives rise to a stop 
codon at position 476. The S652T+1 m utation gives rise to a stop codon at 
position 683. These fram eshift m utations will m ost likely cause pro tein  
instability and major conformation changes. The VP3 specific Mab III/C3 does 
not detect any protein when the frameshift m utants are expressed.
The three m utants, E554Q, D589K and Q595E, show a decreased intensity in  
the VP3 band and in a band at ~68kDa. Due to the close proximity of these 
three m utations it may be inferred that these residues lie in an im portan t 
structural region. The E621Q m utant shows a m arked decrease in the 
intensity of all the proteins detected using Mab III/C3, how ever this effect is 
not seen w ith the rabbit polyclonal serum  raised against D78 (Intervet). The 
m utant, H697D, shows a decreased intensity of the VP3 and the band at 
~68kDa. As serine and cysteine proteases often have a histidine w ithin their 
catalytic triads, the EI697 may be part of a catalytic triad. However, there have 
been no reports of a catalytic triad where the histidine is found dow nstream  
from the reactive serine. W ithin the polyprotein sequence, there is a serine 
that is dow nstream  of H697 at S715 before the previously proposed dibasic
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cleavage site KR722723, however this serine is not conserved throughout the 
IBDV strains.
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Figure 6.iv A nalysis of the p ro teo ly tic  cleavage of the po lypro te in  by s ite  
d irected  m utants S460C, E475Q-1, S494A, H545V, E554Q, D589K, Q595E, 
D615N, E621Q, Y627F, D633N, S651N, S652T+1, K692N, H697D, K703M and 
KR722723MH com pared  w ith  the w ild  type (WT) sequence expressed in £. coli, 
induced by Im M  IPTG, subjected to 12% SDS-PAGE, w estern b lo tted  and  probed 
w ith  either M ab 1II/C3 (A) or w ith  the rabbit polyclonal D78 (Intervet) (B)
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Figure 6.v A nalysis of the p ro teo ly tic  cleavage of the po lyp ro te in  by s ite  
d irected  m utants S460C, E475Q-1, S494A, H545V, E554Q, D589K, Q595E, 
D615N, E621Q, Y627F, D633N, S651N, S652T+1, K692N, H697D, K703M and 
KR722723MH com pared w ith  the w ild  type (WT) sequence expressed in th e  
coupled tra n sc rip tio n /tra n s la tio n  system  (Prom ega) using T3 po lym erase , 
subjected to 12% SDS-PAGE and  fluorography.
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However, the data from the S652 m utations suggests that it is this serine that 
is reactive. W ithin the UK661 IBDV polyprotein amino acid composition, a 
N651S change is found which differs from all other IBDV strains (Brown & 
Skinner, 1996). A S651N m utant was created to see w hether this strain specific 
change had any effect on the processing w ithin the expression systems used. 
However, the S651N m utan t polyprotein expression profile does not differ 
from that of the UK661 strain polyprotein.
The m utants, D483N, R505A, R507A, R543A, D549N, T565C, S598T, S641P,
K666M, D711N, S715P, Y741W and D751H investigated further analysis of the 
conserved residues Of these additional m utants, 3 affected the processing of 
the polyprotein the E. coli expression system: S641P, Y741W and D751H (see 
figures 6.vi and 6.vii). However, in the coupled transcrip tion /transla tion  
expression system there are 4 that affect the processing (see figure 6.viii): 
S598T, K666M, D711N and D751H. W hen S641P was sequenced (see appendix 
2) it was discovered that a m istake in the reverse prim er caused a K642M 
m utation also m aking this m utation SK641642PM. Due to time constraints of 
the project R505A, D549N and T565C were only analysed by E. coli expression 
detected using the rabbit polyclonal (Intervet).
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Figure 6.vi. W estern  b lot analysis of the m utants D483N, R505A, R507A, 
R543A, D549N, T565C, S598T, S641P, K666M, D711N, S715P, Y741W and 
D751H. These m utants w ere expressed in E. coli and crude cell lysates w ere 
subjected 12% SDS-PAGE and transferred  onto a n itrocellulose m em brane. T he 
IBDV pro teins w ere detected  using a rabb it polyclonal serum ag a inst IBDV 
stra in  D78 (In tervet), goat anti rabbit polyclonal antiserum  conjugated w ith  
alka line  p h o sp h a tase  (Sigma) and v isua lised  using N B T/B C IP su bstra te  
(P ierce).
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Figure G.vii. W estern blot analysis of the m utants D483N, R507A, R343A, 
S598T, K666M, D7V1N, S715P, Y741W and D75IH. These m utants were 
expressed in £. coli and crude cell lysates w ere subjected 12% SDS-PAGE and 
transferred  onto a nitrocellulose membrane. The IBDV proteins w ere detected  
using Mab 111/C3, goat anti-m ouse IgG polyclonal antiserum  conjugated w ith  
a lk a lin e  pho sp h a tase  (Sigma) and v isualised  using N BT/BCIP substra te  
(P ierce).
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Figure ô .v iii. C oupled tra n sc r ip tio n /transla tion  expression of the m utants 
D483N, R507A, R543A, S598T, K666M, D711N, S715P, Y741W and D751H. 
These m utants were expressed using the T3 polym erase (Prom ega) and th e  
reaction lysates w ere subjected 12'\i SDS-PAGE and visualised  by f lu o ro g rap h y  
using A m plify  '' '^ (A m ersham ) and exposed to au to rad io g rap h y  film (K odak) 
overn igh t at -70°C.
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The Y741W m utation yields no detectable proteins in the E. coli expression 
system and shows a different pattern in the coupled transcrip tion /translation  
expression system. In the latter expression system, there is a band at -48kDa 
which is not present in the wild type protein profile. There are also bands at 
~72kDa and ~68kDa seen in the wild type sequence but not in the Y741W 
m utant. Tryptophan is the largest am ino acid w ith a m olecular weight of 204 
g /m ol and is hydrophobic whereas tyrosine, although still quite large with a 
m olecular weight of 181.2 g/m ol, is not as hydrophobic as tryptophan. The 
difference between these two amino acids may be such that the conform ation 
of the polyprotein is comprimised. However, the Y741 cannot be excluded 
from the possibility of being an active residue. The D751H shows a sim ilar 
protein pattern to the wild type sequence when expressed in £. coli, exam ined 
by western blot and developed using the polyclonal antibody, albeit w ith  
reduced intensity than the wild type. W hen the western blot was developed 
using the Mab UI/C3, no proteins can be detected. If D751 is within VP3 i.e. the 
residue is after the VP4-3 cleavage site then the residue may be part of the 
epitope that the monoclonal antibody recognises. However, the antibody was 
raised against the Cu-1 IBDV strain and, as this residue is a potential 
virulence m utation found in UK661, the histidine is present in the Cu-1 
strain. As the total protein concentration seems to be reduced, the protein 
concentration on the gel may be too little to be able to be detected by the 
m onoclonal antibody. Loading more of the sample onto the gel could test 
this. However, in the coupled transcrip tion/translation  expression system, a 
protein profile that is different to the wild type is observed. There is a band at 
~52kDa which is not seen in the wild type and the bands at ~72kDa and
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~68kDa are not present suggesting some effect on the processing ability of the 
protease.
6.3 A nalys is  o f  the Cleavage Sites
Several sites have been postulated as being the cleavage sites for IBDV; the 
dibasic residues at R452R453 and K722R723 based on molecular weight 
determ ination and the AxAAS repeat sequences (485-503 and 753-757) (Brown 
& Skinner, 1996, H udson et aL, 1986).
6.3.1 Analysis of the Dibasic Residues
To investigate the role of the dibasic residues in the cleavage events two site 
directed m utants changing RR452453MH and KR722723MH were created 
using the Q uikChange'^' site directed mutagenesis system (Stratagene) (see 
appendix 1 for the complete prim er list) as previously described and analysed 
in the £. coli expression system and the coupled transcrip tion /translation  
system (Promega) as previously described. The products were both analysed by 
10% SDS-PAGE. The £. coli expression system was analysed by W estern blot 
developed using a polyclonal antisera raised against strain D78 in rabbits 
(Intervet) and by Mab III/C3. The coupled translation/transcrip tion was 
analysed by fluorography as previously described.
The m utant RR452453MH, which changes the dibasic residues at the proposed 
VP2-4 junction, results in no production of the band at 45kDa, previously 
designated as being m ature VP2, nor the 50kDa band (see figure 6.viii), 
designated as being VPX by the insertion of the 6 histidine tag (see figure
5.VÜ), in the £. coli expression system. Other differences seen in the £. coli 
expression system include the disappearance of a band at ~66kDa and -63kDa
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which have yet to be assigned. However from the m onoclonal there is no  
change in the cleavage of VP3 suggesting that this m utation is not affecting 
the general pro tease function.
The m utation, KR722723MH, does not affect the processing ability in both 
expression systems nor does it affect the cleavages that produce VP3 (see 
figure 6.Ü). Jagadish et al. (1988) showed that the m utation KR722723CI 
abolished activity of the VP4, however, this m utation adds an extra cysteine 
into the protein, which may cause major structural changes; there is one 
cysteine in the proposed VP4 region and two within the VP2 region in the 
UK661. In the strain CU-1, used by Jagadish et al. (1988), there is an extra 
cysteine in the proposed VP4. This m utation may cause extra disulphide 
bridges to be formed spontaneously affecting the processing ability of the 
protease.
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Figure 6.ix. W estern blot analysis of the RR422423MH m utation com pared w ith  
the expression of the polypro tein  from clone 34 (WT) and the control 
pB luescript KS- (S tratagene) (pBS), expressed  in £. coli, induced by ImM IPTG, 
and detected w ith  e ither Mab III/C 3 (A) or w ith  the polyclonal raised in 
rabbits against IBDV stra in  D78 (Intervet) (B).
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6.3.2 Analysis of the AxAAS Sequence at the VP4-3 Junction
In order to determ ine the cleavage site at the VP4-3 junction deletion 
m utants 6-11 were expressed in both £. coli and the coupled transcription 
system as previously described. These deletion m utants were created as 
show n in figure 3.iv and in the legend of figure 6.x. The m utants were 
sequenced using the ABI 373A autom ated sequencer (see appendix 2 for all 
the sequence data). The samples were analysed by 10% SDS-PAGE. The 
W estern blots were developed with the rabbit polyclonal serum  (Intervet) and 
Mab 1II/C3, The coupled transcrip tion/translation system was analysed by 
fluorography as previously described.
Deletion m utants 6, 7, 8 and 11 seem to abolish the production of VP3 and
also the production of the VPX and VP2. Deletion 11 deletes the AM A AS
sequence suggesting this is either a recognition sequence or the cleavage site is
contained w ithin this sequence. Also, with this deletion, the expression is
weak in £. coli when detected using the polyclonal (figure 6.x (B)) but not the
Mab III/C3 (figure 6.x (A)). Deletion 6, which only deletes the first A of the
AMAAS sequence, also shows no VP3 production suggesting that this residue
is im portant for the cleavage of VP3. Also in deletion 6 the 72kDa band,
previously shown to contain both VP2 and VP4, cannot be detected but a band
at -70kDa is detected. This band is the right size for the 72kDa band w ith the
deletion w ithin VP4. Deletions 7 and 8 show that the band at 72kDa,
previously show n to contain both VP2 and VP4, cannot be detected but there
is the appearance of a band at -68kDa. It is not know n w hether these bands
are related and the difference in sizes is too much to account for the am o u n t
deleted. Also the two bands at -60kDa and 62kDa disappear and 2 bands at
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-52kDa and ~55kDa appear. Again, it is not possible to tell w hether these 
bands are related. Deletion 9 shows that VP3 is cleaved from the polyprotein, 
however it is decreased in size by ~2kDa, which is approximately the right size 
for the am ount deleted. Interestingly the band at 45kDa, previously 
determined to be VP2, cannot be detected but a band at ~43kDa can be seen.
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Figure 6.x W estern blot analysis of the £. coli expressed deletion  m utants 
pD el6-l l com pared  w ith the w ild type expression pa tte rn  (WT) and  the control 
pB luescrip t KS- (S tratagene) (pBS) and  deve loped  w ith  e ither Mab III/C 3  (A) 
and  the polyclonal raised in rabbits against D78 (Intervet) (B).
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7, Discussion
7.1 C om puta tional analysis o f  the UK661 IB D V VP4 sequences
Alignment w ith the Lon protease sequence using the LOCALPILEUP program  
shows an alignm ent of a reactive serine in both the IBDV sequences and the 
Lon pro tease (see figure 3.ix p95). There is also a conserved lysine in the 
birna virus sequences and the Lon pro teases dow nstream  of the reactive 
serine. Serine pro tease inhibitors of chy mo trypsin inhibit the Lon protease. 
The presence of catalytic dyads has been found in some bacterial proteases 
consisting of a serine and a lysine, with the lysine upstream  of the reactive 
serine (Paetzel & Dalbey, 1997). Proteases of this type, such as (3-Lactamase and 
Tsp, form a new type of serine pro tease group. The classical serine pro tease 
inhibitors do not inhibit the pro teases with these catalytic dyads. As the 
UK661 sequences do not seem to have a conserved conventional catalytic 
triad it may be possible that this protease has a catalytic dyad of a serine and 
lysine.
If the catalytic dyad is the active site then this will be the first case of a v irus 
protease being of this nature. Possible serine pro tease inhibitors, such as the fV 
lactam com pounds, that inhibit the Tsp pro tease of £. coli may inhibit the 
IBDV protease.
7.2 Expression o f  the polyprotein and the m utan ts
In this study I have made use of two expression systems, coupled 
transcrip tion/translation (Promega) and £. coli, allowing more reliable
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analysis of the residues involved in catalysis of the cleavage. The coupled 
transcription /translation  system has the advantage of being able to be m ore 
quantitative than the E. coli system as the W estern blot depends on the 
presence of antigen binding sites and m utations w ithin a protein may affect 
these. However, the coupled transcrip tion/translation  system has a distinct 
disadvantage of internal initiation.
W ithin the polyprotein there are 24 methionines in strain UK661 in the sam e 
frame as the proposed start; 9 within the proposed VPX sequence, 5 within the 
proposed VP4 sequence and 10 w ithin the proposed VP3 sequence. This 
would mean that the VP4 sequences would have half the intensity of VP3 or 
VPX. However there are other possible start codons that are not necessarily 
within the polyprotein ORF. These can be seen in figure 7.i.
Apart from the polyprotein and the ampicilin resistance gene there are no 
large ORFs. The (3-Lactamase gene would produce a protein of 31.5kDa, w hich 
is similar to the reported size of VP3.
19!
Figure 7.i An ORF m ap of clone 34 from the program  DNA S lrider in all th re e  
fram es from the T3 prom oter. The sho rt bars ind icate  ATG sta rt codons and th e  
larger bars indicate stop codons. The polypro te in  ORF can be seen from 
nucleotide 25 to 3063. The am picilin  resistance gene, |3-Lactamase, ORF can be 
seen from 3925 to 4785.
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The inhibition of the T7 expression with the UK661 polyprotein is an 
interesting phenom enon (see section 5.2.3 ppl23-129). The pCITE (Novagen) 
expression system used should express more RNA than the T3 system. The 
RNA levels between the T3 and T7 expression systems were investigated by 
in vitro transcription and showed that RNA could not be detected from clone 
1210 (see section 5.2.4 ppl29-133), how ever it may have been better to do a 
com petitive experim ent as done for the protein expression (see figure 5.ii 
p i 24)/ to see w hether any RNA being produced from clone 1210 could cause 
the same inhibition of the other in vitro  transcription reactions. The effect of 
the polyprotein on the T7 expression is not due to the cleavage products 
affecting the T7 polymerase as the /// vitro transcription experim ent (see 
figure 5.iv pl31) has no translation step.
To further investigate whether VP4 has any affect on the expression of the 
UK661 polyprotein under the presence of the T7 prom oter, a T7VP2 PCR 
product could also be expressed with the T7VP243, T7VP43 and T7VP3 to see 
w hether this had any effect on the transcription and translation systems. As 
the inhibition by the poly protein has not been reported for the classical strains 
this m ay show a difference between the strains.
It is also interesting to note that VP4 has not been detected in either the 
coupled transcription translation or the E. coli expression systems. This may 
be due to the instability of the protein in these systems or as the N term inal 
sequencing data suggest that the VP3 and VP4 migrate at the same position. If 
the latter were the case, then in the deletion m utants, pDell-4, (section 6.i pp 
156-158) a band would decrease in size w ith the deletion. No such band could
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be seen, thus suggesting that VP4 is not stable in either system, not being 
detected by w estern blot in the £. coli system.
It has been reported that VP4 does not cleave in trans (Becht, 1980). The 
deletion m utagenesis of VP4 in the E. coli system seems to show that the 
cleavage pattern of VPX to VP2 changes w hen the substrate binding pocket is 
rem oved.
Of the site directed m utants created, 11 affect the processing of the 
polyprotein, outlined in table 6.1 (p i67). The m ost p rom inent of these is the 
m utation of the serine at position 652 (see figure 6.ii pl64). W hen this residue 
is m utated to an alanine, the proteolytic activity of VP4 is abolished, w ith no  
significant production of VPX or VP3. M utation of this residue to a th reon ine 
or a cysteine does not completely abolish the processing ability, suggesting 
that a threonine or a cysteine can replace the functionality of the serine 
residue. The effect of the S652A m utation in the coupled 
transcrip tion/translation  expression system has a sim ilar protein profile to 
the effect of adding PMSF to the clone 34 expression. These data w ould 
suggest that VP4 is a serine protease w ith the reactive serine at position 652.
Other m utations that affect processing and could be part of an active site 
include D589K, K692N, H697D and D711N. The D589K m utation  is in close 
proxim ity to the m utations E544Q and Q595E and does not affect the 
processing as much as these m utations suggesting that these m utations are in  
an im portant structural region. However, the aspartic acid residue acts as a 
"rate enhancer" for the serine proteases, i.e. the aspartic acid allows enhanced 
proton transfer between the histidine and the serine (Voet & Voet, 1990). In
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some serine pro teases the aspartic acid is not required for the cleavage ability 
of serine pro teases and m utation of the aspartic acid usually results in only a 
small decrease in the Michaelis constant (K,J (Voet & Voet, 1990). It may be 
that the aspartic acid at position 589 is part of the active site and that the 
m utation to a lysine affects the rate of proton transfer. The D711N m uta tion  
affects the processing similarly to the D589K m utation and may also be part of 
the active site for the reasons described for D589. However, there has not been 
any docum ented cases where the aspartic acid or histidine residues in a 
catalytic triad, within a serine protease, that occur dow nstream  of the reactive 
serine. The H697D m utation affects the processing as much as the S652T or C 
m utations. This m utation could be considered part of a catalytic triad, but as 
already stated, there are no docum ented examples of histidines that are part of 
the catalytic triad and dow nstream  of the reactive serine. The K692N 
m utation affects the processing sim ilarly to the S652T or S652C m utations. 
These lysine residues are dow nstream  from the proposed reactive serine 
residue in a similar position to the example of catalytic dyads described in  
section 1.6.4.4. A role for lysine 692 as part of a catalytic dyad could account for 
the data described for the serine pro tease experiment, except for the PMSF 
data, as "classical" serine protease inhibitors do not inhibit the catalytic dyads.
The order of cleavage of the VPX and VP3 proteins cannot be determ ined
from the data presented in this thesis. Therefore we do not know w hether
VPX or VP3 is cleaved first. However, it may be possible that as the
polyprotein is being translated, the first cleavage event occurs, thus changing
the conform ation of the rem aining polyprotein, and exposing an alternative
active site. The RR452453MH m utant data where the VPX cleavage or the
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m aturation does not seem to occur, would fit this hypothesis. This may also 
mean that the pro tease has two different cleavage sites, one at the dibasic 
residue and one in the A-x-AAS sequence. A lthough the order of cleavage 
cannot be determ ined from these experiments, it is possible that there is a 
hierarchical order of cleavage and these steps must occur for the others to take 
place. For example, cleavage at the VP4-3 AMAAS sequence may first be 
required to take place before the cleavage at the VP2-4 junction. The 
RR422423MFI m utant produces a cleaved VP3, therefore suggesting that, if the 
dibasic is a cleavage site, the VP4-3 cleavage is not dependent on the VP2-4 
cleavage, fiow ever, deletions within the AMAAS (pDel 6, 7, 8 and 11) do not 
produce any VPX or VP2 species (see figure 6.x pl90), thus suggesting that the 
order of cleavage events may be VP3 then VP2. If this is the case, when the 
polyprotein is processed the VP4-3 cleavage event would release free VP2-4 
whilst. This may explain that the dibasic residues RR422423 affect cleavage of 
the VP2-4 junction (see figure 6.ix p i 86) and not the KR722723 (see figure 6.ii, 
6.iv and 6.v ppl62, 172 and 174 respectively).
M utational analysis of the potential virulence associated residues 565IN
(figures 6.iv and 6.v, p i72 and pl74), S715P and D751H (figures 6.vi, 6.vii and
6.viii ppl77, 179 and 181), showed that the 5651, found only in the UK661
IBDV strain, and the 5715, found in all "very virulent" strains, do not affect
the polyprotein processing when m utated to the "classical" sequence of an
asparagine. The D751FI m utation, however, does affect the processing by
possibly reducing the stability of the protein as it is being translated or by
reducing the processing ability of VP4. The latter of these is unlikely, as this
w ould increase the levels of the precursor proteins, which were not detectable
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by western blot of the E. coli expressed D751H plasm id (figures 6.vi and 6.vii 
ppl77 and 179). However, in the coupled transcrip tion/translation  expression 
system there is a change in the protein profile, which cannot be explained at 
this time. In order to investigate this further, a panel of Mabs needs to be 
developed that will im m unoprecip i ta te the proteins from the coupled 
transcrip tion/translation expression system in order to identify the proteins 
in the D751H protein expression.
The deletion mutagenesis experiments w ithin VP4 do not show a full length 
polyprotein when deletion past the reactive serine. This may be explained by 
the presence of other residues in the N -term inus of the protein, which may 
serve as alternative active residues.
7.3 A nalysis  o f  the cleavage sites
The N-terminal sequencing data shows that m ature VP2 purified from IBDV
strain PBG98, grown in Vero cells, is not processed at the N-terminus. This
means that the maturation of VPX to VP2 m ust occur at the C-terminus. The
presence of the three A-x-AAS repeats at the C-terminus at positions 485-489,
492-496 and 499-503 mean that if VPX was m atured from these sites then the
predicted sizes of VPX, VP2a and VP2b would be 53kDa, 52kDa and 51 kDa
respectively. Analysis of the RR422423MH m utation shows that VPX and VP2
are not cleaved when expressed in £. coli, whilst there is no change in the
cleavage of VP3. This may mean that the dibasic is the cleavage site for the
VPX-4 junction, or it is a recognition sequence for the protease, or it is an
im portant structural region of the polyprotein. If, however, the dibasic
residues, RR452453, were also used for the final m aturation of VPX to VP2,
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the predicted size of the m ature VP2b would be 48kDa, Thus cleavage at the 
A-x-AAS sites followed by cleavage at or near, the dibasic site would result in 
the production of a precursor (or precursors) of 53, 52 or 51kDa finally cleaved 
to a m ature VP2b of 48kDa. The actual observed sizes of VPX and VP2b by 
SDS-PAGE are -50 and ~45kDa, close to the predicted sizes. The pro tease of 
course may cleave sequentially at the A-x-AAS sites from the C-terminus or it 
m ay be able to cleave at any of them. However, the RR422423MH m u tan t 
(figure 6.ix pl86) w hen expressed in E. coli seemed to inhibit the cleavage of 
VPX and VP2b. It may be possible that the RR422423MH m utation affects the 
conform ation of the polyprotein such that the cleavage site of the VP2-4 
junction is no longer accessible to the pro tease.
The deletion m utants, pDelS (H546-G705) and pDel4 (H546-D779) (figure 6.i
pl58) show that cleavage of the polyprotein is how ever due to VP4 and that
the cleavage site is between positions 705-779. The cleavage site for the VP4-
VP3 junction, however, is likely to be between 724 and 779 as the expressed
PCR product from T7VP3 is larger than that of the cleaved VP3. This w ould
suggest that the m ature VP3 be cleaved after the dibasic residue KR722723.
The KR722723MH m utant shows no change in the proteolytic processing
pattern, which also suggests that the KR722723 is not the cleavage site for the
VP4-3 junction. Analysis of the deletion m utants pD el6-ll (figure 6.x pl90)
shows that cleavage site for the VP4-3 junction is w ithin the AMAAS (753-
757). The N -term inal sequence data for the VP3/4 sequences have a lim ited
interpretation as poor quality data was obtained from the degradation
reaction, possibly due to post-translational modifications of the protein, such
as, m éthylation, acétylation and glycosylation. It was also suggested by o ther
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workers that the N- terminus of VP4 and VP3 was blocked [Dobos, 1979 #852] 
M undt, E pers. comm.). This means that the signals obtained could have 
resulted from m inor products that have lost the N -term inus and therefore 
the blocking agent. Thus the cleavage site may be upstream  of the sequence 
that was obtained.
In order to investigate the role of the A-x-AAS sequence as a cleavage sites, 
m utational analysis of the three A-x-AAS sequences at the VPX-4 junction  
would have to be performed. This would mean that each combination of 
deletions would have to be made i.e. each A-x-AAS sequence deleted 
separately, two A-x-AAS sequences being deleted together and all three A-x- 
AAS sequences would have to be deleted. In order to investigate w here 
within the A-x-AAS sequence the cleavage occurs, further work would be 
needed using additional VP3 sequencing with a mass spectrom eter and VP2 
or VP4 C-terminal sequencing, although C-terminal sequencing is m uch  
more difficult than N-term inal sequencing. Further m utational analysis 
could be perform ed by m utating each residue of the A-x-AAS sequence, but 
this may have limited success as it may be possible that all the residues are 
required for correct cleavage. As the protease does not seem to work in trans, 
the use of synthetic peptides containing the A-x-AAS and dibasic sequences 
cannot be employed.
7.4 Conclnsions
In conclusion, the work presented in this thesis conforms that VP4 is
responsible for the cleavage of the polyprotein and also suggests that VP4 is
responsible for the m aturation of VPX to VP2. The processing of the VPX is
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from the C-terminus. It also suggests that the cleavage sites be within the A-x- 
AAS sequences found at the N- and C-termini of VP4. The data also shows 
that the serine at position 652 is a reactive residue and, although no definite 
catalytic triad or dyad has been found, that VP4 is a serine protease with a 
possible catalytic dyad of S652 and K692. If this dyad is the active site then VP4 
w ould represent the first member of a new class of serine pro tease. It will be 
interesting to see whether further members are found in other viruses or their 
hosts.
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Appendix 1. Primer list
A list of the primers used in the PCR, sequencing and mutagenesis experiments with 
the sequence given the experiment they were used for and the name of the primer. 
W ithin the mutagenesis primers, the restriction enzymes m ade by silent m utations 
are described in the comments section.
prod. ref. Del 1F size 32 sense +
sequence GGGGACGTCGACCTCCAACCTCCATCTCAAAG
comments Cliffs Forward primer to delete His & Asp of VP4 catalytic triad 
(clone PGR fragment into Sal1-Bgl2)
prod. ref. Del 2F s ize  29 sen se  +
sequence GGGGAGGTCGAOGGAAAGCTAGGGATAGO
comments Gliff's Forward primer to delete His, Asp & Ser of VP4 catalytic 
triad (clone PGR fragment into Sal1-Bgl2)
prod. ref. DelSF s ize  30 sen se  +
sequence GGGGAGGTGGAGGGAI I IGAGGTGAAGAGG
comments Gliff s  Forward primer to delete His, Asp, Ser catalytic triad & 
substrate binding pocket of VP4 (clone PGR fragment into
prod. ref. Del 4F s ize  29 sen se  +
sequence GGGGAGGTGGAGGGAGTGTTGGAATGTGG
comments Gliffs Forward primer to delete His, Asp, Ser (catalytic triad) & 
substrate binding pocket of VP4 and VP4/3 junction, KR722-3
prod. ref. DELSF s ize  29 sen se  +
sequence GAGGTTTATGAAAGGTGGGAATGGAGGAG
comments Deleting Areas of VP3 to find cleavage site 
care with Tm
prod. ref. DEL5R size 29  sense —
sequence GTCCTGCATTGGGACGI I iGATAAACGTC
comments Deletion primer for mapping VP4-3 cleavage junction 
Care with Tm
prod. ref. DEL6F s ize  2 5  sen se  +
sequence GAGTGGGACAGGATGGCCGCTTCAG
comments DELETION PRIMER FOR MAPPING VP4-3 CLEAVAGE SITE 
CARE WITH TM
prod. ref. DEL6R size  2 5  sen se  —
sequence GTGAAGGGGGGATGGTGTGGGAGTG
comments DELETION PRIMER FOR MAPPING VP4-3 CLEAVAGE SITE 
CARE WITH TM
prod. ref. DEL7F s ize  2 7  sen se  +
sequence GTTGGATAGGTTGGAGAAGTGGAGAGG
comments DELETION OLIGO FOR MAPPING VP4-3 CLEAVAGE SITE 
CARE WITH TM
prod. ref. DEL7R s ize  2 7  sen se  —
sequence GGTGTGGAGTTGTGGAAGGTATGGAAG
comments DELETION PRIMER FOR MAPPING VP4-3 CLEAVAGE SITE 
CARE WITH TM
prod. ref. DEL8F size 25 sense +
sequence GTACGACCTGGCAGCAGCAGCCAAC
comments DELETION PRIMER FOR MAPPING VP4-3 CLEAVAGE SITE 
CARE WITH TM
prod. ref. DEL8R size  2 5  sen se  —
sequence GTTGGCTGCTGCGGCCAGGTCGTAC
comments DELETION PRIMER FOR MAPPING VP4-3 CLEAVAGE SITE 
CARE WITH TM
prod. ref. DEL9F s ize  3 0  sen se  +
sequence GTTCAAAGAGACCCCCCCACTGTTCCAATC
comments DELETION PRIMER FOR MAPPING VP4-3 CLEAVAGE SITE 
CARE WITH TM
prod. ref. DEL9R s ize  3 0  sen se  —
sequence GATTGGAACAGTGGGGGGGTCTCI I IGAAC
comments DELETION PRIMER FOR MAPPING VP4-3 CLEAVAGE SITE 
CARE WITH TM
prod. ref. DEL10F s ize  2 5  sen se  +
sequence CCCCTACCTCAACCAGTACGACCTG
comments DELETION PRIMER FOR MAPPING VP4-3 CLEAVAGE SITE 
CARE WITH TM
prod. ref. DEL10R size 25  sense —
sequence CAGGTCGTACTGG11GAGGTAGGGG
comments DELETION PRIMER FOR MAPPING VP4-3 CLEAVAGE SITE 
CARE WITH TM
prod. ref. DEL11F s ize  25  sen se  +
sequence CCAGTACGACCT G GAGTT CA A AG AG
comments DELETION PRIMER FOR MAPPING VP4-3 CLEAVAGE SITE 
CARE WITH TM
prod. ref. DEL11R s ize  2 5  sen se  —
sequence CTCI I IGAACTCCAGGTCGTACTGG
comments DELETION PRIMER FOR MAPPING VP4-3 CLEAVAGE SITE 
CARE WITH TM
prod. ref. D 589R  size  2 8  sen se  —
sequence CGCACGCTCTl T1CGAAGI IGGAGGTAG
comments REVERSE PRIMER FOR CHANGE D589N  
INTRODUCES HINDIII RE SITE
prod. ref. H545VF size  2 6  sen se  +
sequence CCG GCG GTG C AGTTA ACCTCG ACT G C
comments FORWARD PRIMER FOR H545V CHANGE 
INTRODUCES HPAI RE SITE
prod. ref. D483N F size 24 sense +
sequence CCTGCTGGGCAATGAGGCACAGGC
comments Adds Extra BsrD1 RE site
prod. ref. D483NR s ize  2 4  sen se  —
sequence GCCTGTGCCTCATTGCCCAGCAGG 
comments Add extra BsrD1 RE site
prod. ref. R493AF s ize  29 sen se  +
sequence GCTTGAGGAACTGGTGGAGGGGGGTGAGG 
comments Adds extra Pst1 RE site
prod. ref. R493AR s ize  30 sen se  —
sequence GCTGAGGO GGCTGGAGCAGTTCCTGAAGG 
comments Adds extra Pst1 site
prod. ref. R505AF s ize  31 sen se  +
sequence GAGCTGOGTGAGGGGOCATAAGGCAGCTAAC 
comments Adds extra Nar 1 RE site
prod. ref. R507AR size 30  sense +
sequence CGGCGAGAGTCAGCTGCGCTATGCGGCCTG
comments Adds extra Pvu II RE site
Be Aware that on the data sheet they have written this primer as
prod. ref. R505AR s ize  30 sen se  —
sequence GTTAGGTGCCTTATGGCGCCTGAGGCAGCT
comments Reverse Primer
Ghanges R505 A Inserts a Nar 1 site by silent m utagenesis
prod. ref. R507AF s ize  3 0  sen se
sequence GAGGGGGGATAGGGGAGGTGAGTGTGGGGG
comments Forward Primer 
Ghanges R507A
prod. ref. R543AF s ize  30  sen se
sequence GGGGGGATAGTGGGGGGGGGAGAGAAGGTG
comments FORWARD PRIMER 
GHANGES R543A
prod. ref. R543AR s ize  3 0  sen se  —
sequence GAGGTTGTGTGGGGGGGGGAGTATGGGGGG
comments Reverse primer 
Ghanges R543A
prod. ref. T565DF size 30  sense +
sequence CCTGTGGTCATCACGTGTGTGGAAGATGCC
comments Forward primer 
C hanges T565S
prod. ref. T565SR s ize  30  sen se  —
sequence GGCATCTTCCAGAGACGTGATGACCACAGG
comments Reverse primer 
G hanges T565S
prod. ref. S577TF s ize  38 sen se  +
sequence GGGATGAGAGGGAAAGGGGTGAAGAGGAAAATGTTTGG
comments Forward primer 
Ghanges S577T
prod. ref. S577TR s ize  38 sen se  —
sequence GGAAAGATTTTGGTGTTGAGGGGTTTGGGTGTGATGGG
comments Reverse Primer 
Ghanges S577T
prod. ref. E588QF size  31 sen se
sequence GAAGGGGTGGGAGAGGATGTGGAAGGATGTG
comments Forward Primer 
Ghanges E588Q
prod. ref. E588QR size 31 sense —
sequence CACATGGTTGGAGATCCTGTCGCACGCCTTC
comments Reverse Primer 
Changes E588Q
prod. ref. K666MF s ize  33 sen se  +
sequence GTGTTTGGACCCATGGTCCCGATCCATGTGGCG
comments Forward Primer 
Ghanges K666M
prod. ref. K666MR s ize  33  sen se  —
sequence GGGGAGATGGATGGGGAGGATGGGTGGAAAGAG
comments Reverse Primer 
G hanges K666M
prod. ref. S715P F  s ize  24  sen se  +
sequence G A AG AGG G G G G GG A ACT G G G G G AG
comments Forward primer
Ghanges S745P  - Very virulent to Classical change
prod. ref. S715P R  s ize  24  sen se  —
sequence GTGGGGGAGTTGGGGGGGGTGTTG
comments Reverse Primer
Ghanges S745P  - Very virulent to Classical change
prod. ref. S 598TF size  36  sense +
sequence CCATCTCAAAGAGGAACCTTCATACGAACTCTCTCC 
comments Forward Primer 
C hanges S598T
prod. ref. S652TFM s ize  35  sen se  +
sequence CCTATTGTGGGAAGCACCGGTAAGGTAGOGATAGG 
comments Forward Primer 
C hanges S652T
prod. ref. S652TRI1 size  35 sen se  -
sequence GGTATGGGTAGGTTAGGGGTGGTTGGGAGAATAGG 
comments Reverse Primer 
G hanges S652T
prod. ref. S652G F s ize  35  sen se  +
sequence GGTATTGTGGGGAGGTGGGGAAAGGTAGGGATAGG 
comments Forward Primer 
G hanges S652G
prod, ref. S652G R s ize  35 sen se  -  I
sequence GGTATGGGTAGGTTTGGGGAGGTGGGGAGAATAGG I
comments Reverse Primer 
G hanges S652G
prod. ref. S652A F size 35 sense +
sequence CCTATTGTGGGAAGCGCCGGCAACCTAGCCATAGC
comments Forward primer 
C hanges S652A
prod. ref. S652AR s ize  35  sen se  —
sequence GGTATGGCTAGGTTGCGGGCGCTTGCCACAATAGG
comments Reverse Primer 
G hanges S652A
prod. ref. D751HR s ize  27  sen se  —
sequence GGGGGATGGGGAGGTGGTAGTGGGGTG
comments Reverse primer
Ghanges D751H - Very virulent to classical change
prod. ref. Del12F size  27  sen se  +
sequence GTGGTGGGGGATGAGGGGATAAGGGAG
comments Forward Primer
Creates 3xAxAAS del at VP2-4 Junction - Didnt work - tried
prod. ref. Del 12R s ize  27  sen se  —
sequence GTGGGTTATGGGGTGATGGGGGAGGAG
comments Reverse Primer
Creates 3xAxAAS del at VP2-4 Junction - Didnt work - tried
prod. ref. Y741W F size 32 sense +
sequence CTCAACCTTCCATGGCTTCCACCCAATGCAGG
comments Forward primer 
C hanges Y741W
prod. ref. Y741Wr s ize  3 2  sen se
sequence CCTGCATTGGGTGGAAGGGATGGAAGGTTGAG
comments Reverse primer 
Ghanges Y741W
prod. ref. D751HF s ize  27  sen se  +
sequence GAGGGGAGTAGGAGGTGGGGATGGGGG 
comments FORWARD PRIMER 
Ghanges D751H - Very virulent to classical change
prod. ref. S598TR s ize  3 6  sen se  —
sequence GGAGAGAGTTGGTATGAAGGTTGGTGTTTGAGATGG 
comments Reverse Primer 
Ghanges S598T
prod. ref. K642MF s ize  3 5  sen se  +
sequence GAGAGGATTATGGTGGGTATGGAGGGGATAGGTGG
comments FORWARD PRIMER
GHANGES K642M AND 8 6 4 1 P BECAUSE OF A MISTAKE IN
prod. ref. K642MR size 35  sense +
sequence GGAGGTATGGGGTCCATAGGCAGCATAATGCTGTC
comments REVERSE PRIMER
CHANGES K642M AND S 641P  BECAUSE OF A MISTAKE IN
prod. ref. pCITET7F2 s ize  19 sen se  +
sequence GTTTTCCCAGTCACGACGT
comments Forward primer for the amplification of PCR products from 
pCITE with T7 promoter still misprimes
prod. ref. S460C R  s ize  29  sen se  —
sequence GGGAACAGTGTACAGACCACCGGCACAGC
comments reverse primer 
C hanges S460C
prod. ref. E475QF s ize  3 3  sen se  +
sequence GATGCAATTGGGCAAGGTGTTGACTACCTGCTG
comments Forward primer 
Changes E475Q
prod. ref. E475QR s ize  3 3  sen se  —
sequence CATGCAATTGGGCAAGGTGTTGACTACCTGCTG
comments reverse primer 
changes E475Q
prod. ref. S494ARII size 27  sense —
sequence TCTTGCTTTTCCTGCCGCGGCTCGAGC
comments reverse primer
changes S 497A  - not 494
prod. ref. D615NF s ize  3 9  sen se  +
sequence GGATATGCTCCAAATGGAGTACTTCCACTGGAGACTGGG
comments Forward primer 
C hanges D615N
prod. ref. D711NF s ize  3 3  sen se  +
sequence GGTCCCGGTGACTTTAACGTTAACACCGGGTCC 
comments Forward primer 
C hanges D711N
prod. ref. H697DF s ize  3 5  sen se  +
sequence CCAAGCTCGCCACTGCCGATCGACTTGGCCTCAAG 
comments Forward primer 
C hanges H697D
prod. ref. H697DR s ize  3 5  sen se  +
sequence CTTGAGGCCAAGTCGATCGGCAGTGGCGAGCTTGG
comments Reverse primer 
C hanges H697D
prod. ref. E621QR size 28  sense —
sequence CTCTCCCAGTCTGCAGTGGAAGTACCCC
comments Reverse primer 
Changes E621Q
prod. ref. Y627FF size 34  sense —
sequence CTGGGAGAGTTTTCACGGTGGTCCCAATAGATGG
comments Forward primer 
Changes Y627F
prod. ref. Y627FR size 33  sense —
sequence CCATCTATTGGGACCACCGTGAAAACTCTCCCA
comments Reverse primer 
Changes Y627F
prod. ref. Q595ER size 38  sense —
sequence GTTCGTATGAAGGAACCTCTTTCAGATGGAGGTTGGAG
comments Reverse primer
Changes Q595ER
prod. ref. D615NR size 39  sense -
sequence CCCAGTCTCCAGTGGAAGTACTCCATTTGGAGCATATCC
comments Reverse primer 
C hanges D615N
prod. ref. S651N F size 42  sense +
sequence CCTCCTATTGTGGGAAATAGCGGAAACCTCGCCATAGCTTAC
comments Forward primer 
Changes S651N - 661 to Ciassical and other VV seq s
prod. ref. S651N R  size  4 2  sen se  +
sequence GTAAGCTATGGCGAGGTTTCCGCTATTTCCCACAATAGGAGG
comments Reverse primer 
Changes S651N - 661 to Classical and other VV seq s
prod. ref. K703MR s ize  31 sen se  —
sequence GACCAGCCAACATGAGGCCTAGTCGGTGTGC
comments Reverse primer 
C hanges K703M
prod. ref. Q595EF s ize  3 8  sen se  +
sequence CTCCAACCTCCATCTGAAAGAGGTTCCTTCATACGAAC 
comments forward primer 
C hanges Q595E
prod. ref. K703MF s ize  31 sen se  +
sequence GCACACCGACTAGGCCTCATGTTGGCTGGTC 
comments forward primer 
C hanges K703M
prod. ref. E621QF size 28 sense +
sequence GGGGTACTTCCACTGCAGACTGGGAGAG
comments forward primer 
Changes E621Q
prod. ref. D633NF size  29 sen se
sequence CCGTGGTCCCAATAAACGGTGTCTGGGAC
comments Forward primer 
C hanges D633N
prod. ref. E554QR s ize  31 sen se  —
sequence GGGAATAGCGTGGCGCCCTGTCTCAACACGC 
comments reverse primer 
Changes E554Q
prod. ref. S460C F s ize  29  sen se  +
sequence GCTGTGCCGGTGGTCTGTACACTGTTCCC
comments Forward primer 
C hanges S460C
prod. ref. T461RF s ize  27  sen se  +
sequence CCGGTGGTCTCTAGACTGTTCCCACCC
comments Forward primer 
Changes T461R
prod. ref. T461RR size  2 7  sen se
sequence GGGTGGGAACAGTCTAGAGACCACCGG
comments reverse primer 
Changes T461R
prod. ref. E554QF s ize  31 sen se  +
sequence GCGTGTTGAGACAGGGCGCCACGCTATTCCC
comments Forward primer 
Changes E554Q
prod. ref. RR452453M s ize  26 sen se  —
sequence GCACAGCTATATGCATTAGGGCCCGG
comments reverse primer 
Repiaces RR452453MHR that was wrong
prod. ref. D633NR s ize  2 9  sen se  —
sequence GTCCCAGACACCGTTTATTGGGACCACGG
comments Reverse Primer 
C hanges D633N
Appendix 2. Sequence data
Sequencing of clone 34, using primers 34-F, ATG-F, MB2, VP2R, MB 14, 
MB22 and MBS. The dotted lines indicate the regions of clone 34 that 
were not sequenced. The clone 34 sequence is that of the correct 
plasmid, if the cloning was correct, as determ ined by the CadCene 2.0 
(SciVision) program. Editing and alignm ennt of the sequences was 
achieved using the SeqEd™ (ABI Biosystems) software. The letter N 
shows the bases for which a designation could not be assigned.
34-F 1
Clone 34 1
34-F 34
Clone 34 34
34-F 67
ATG-F 1Clone 34 67
34-F 100
ATG-F 3
Clone 34 100
34-F 133
ATG-F 36
Clone 34 133
34-F 166
ATG-F 69
Clone 34 166
34-F 199ATG-F 102
Clone 34 199
34-F 232
ATG-F 135Clone 34 232
34-F 265
ATG-F 168Clone 34 265
34-F 298ATG-F 201
Clone 34 298
34-F 331
ATG-F 234Clone 34 331
ATG-F 267
Clone 34 364
ATG-F 300Clone 34 397
MB2 1
Clone 34 595
MB2 21Clone 34 628
MB2 54
Clone 34 661
MB2 87Clone 34 694
MB2 120Clone 34 727
A T T A C G C C A A G C G C G C  A A T G G A C C C T G A C T A N A  3 3  
A T T A C G C C A A G C G C G C  A A T G G A C C C  T C A C T A T A  33
 G C A G C G  A T G A C  A A A C C  T G C A A G A T C  A A A C C C  A A  9 9
.................................................................................................................................. A A 2 G C A G C G  A T G A C  A A A C C  T G C A  A G A T C  A A A C C C  A A  99
C A G A T T G T T C C G T T C A T A C G G A G C C T T C T G A T G  132  
C A G A T T G T T C C G T T C A T A C G G A G C C T T C T G A T G  35 
C A G A T T G T T C C G T T C  A T  A C G G  A G C C  T T C T G A T G  132
C C A A C  A N C C G G A C C G G C G T C C  A T T C C  G G A C G  A C  ^55 
C C A A C  A A C C G G A C C G G N G T C C  A T T C C G G A C G A N  6 8  
C C A A C  A A C C G G A C C G G C G T C C  A T T C C G G A C G A C  165
A C C C T  A G A G A A G N A C  A C T C T C  A G G T C  A G A G A C C  193
A C C C T  A G A G A A G C A C  A C T C T C  A G G T C  A G A G  A C C  101
A C C C T  A G A G A A G C A C  A C T C T C  A G G T C  A G A G A C C  193
T C G T C C  T A C A G  T T N G  A C T G T G G G G G  A C A C  A G G G  231
T C G A C C  T A C A A T N G G A C T G T G G G G G A N A C A G G G  134 
T C G A C C  T A C A A T T T G  A C T G T G G G G G  A C A C A G G G  231
T C A G G G C T A A T T G T C  T T T T T C C C T G G C T T C C C T  264 
T C A G G G N T A N  T T G T C  T T T N N C C C T G G N T T C C C T  157  
T C A G G G C T A A T T G T C  T T T T T C C C T G G C T T C C C T  264
G G C T C  A A T T G T G G G T G C T C A C  T A C A C  A C T G C  AG 297 
G G N T C A A T T G T G G G T G C T C A C  T A C A C  A C T G N  A G 2 OO 
G G C T C  A A T T G  T G G G T G C T C A C  T A C A C  A C T G C  A G 297
A G C A A T N G G A A C T A C  A A G T T C G A T C  A G A T G C  T C  330  
A G C A A T G G G A A C T A C  A A G T T C G A T C  A G A T G C  T C  233 
A G C A A T G G G A A C T A C  A A G T T C G A T C  A G A T G C  T C  330
C T G A 3 3 4
C T G A C T G C C C A G A A C C T A C C G G C C A G T T A C  A AC 266 
C T G A C  T G C C C  A G A A C C  T A C C G G C C  A G C T A C  A AC 363
T A C T G C  A G G C  T A G T G  A G T C G G  A G T C  T C AC AG T G 299 
T A C T G C  A G G C  T A G T G  AG TC G G A G  T C T C AC A G T G 396
A G G T C  A A G C A C  A C T C C C C T G G T G G  323
A G G T C A A G C A C A C T C C C T G G T G G C G T T T A T G C A  429
- - - - - - ..............................G A C T C G G T G A C C C C A T T C C C
C T T G G G  T A T G T G A G A C  T C G G T G A C C C C A T T C C C
G C T A T A G G G C T C G A C C C A A A A A T G G T A G C A A C A  
G C T A T A G G G C  T C G A C C C A A A A A T G G  T A GC A A C  A
T G T G A C  A G C A G T G A C  AG GC C C A G A G T C T A C  A C C  
T G T G A C  A G C A G T G A C  A G G C C C  A G A G T C T A C  A C C
A T A A C T G C A G C C G A C G A T T A C C A A T T C T C A T C A
A T A A C T G C A G C C G A C G A T T A C C A A T T C T C A T C A
20
627
53
660
86
693
119
726
C A G T A C C A A G C  A G G T G G G G T  A A C A A T C A C A C  T G  ^52 
C A G T A C C A A G C  A G G T G G G G T  A A C A A T C A C A C T G  759
MB2 153Clone 34 760
MB2 186
Clone 34 793
MB2 219
Clone 34 826
MB2 252Clone 34 859
MB2 285
Clone 34 892
VP2-R 1Clone 34 1090
VP2-R 22Clone 34 1123
VP2-R 55
Clone 34 1156
VP2-R 88
Clone 34 1189
VP2-R 121
Clone 34 1222
VP2-R 154
MB14 1
MB22 1
Clone 34 1255
VP2-R 187
MB14 16MB22 14
Clone 34 1288
VP2-R 220
MB14 49
MB22 47
Clone 34 1321
VP2-R 253
MB14 82
MB22 80Clone 34 1354
VP2-R 286MB14 115
MB22 113
Clone 34 1387
MB14 148
MB22 146
Clone 34 1420
MB14 181Clone 34 1453
T T C T C  A G C T A A T A T C G A T G C C  A T G A C  A A G C C  T C  
T T C T C  A G C T A  A T A T C G A T G C C  A T C A C  A A G C C  T C
A G C A T C G G G G G A G A A C T C G T G T T T C A A A C A A G C  
A G C A T C G G G G G  A G A AC T C G T G T T T C  A A AC A A G C
G T C C A A G G C C  T T A T A C  T G G G T G C T A C C A T C  T A G  
G T C C A  AG GC C T T A T A C  T G G G T G C T A C C A T C  T A G
C T T A T  A G G C T  T T G A T G  G G A C  T G C G G T A A T C  A C C  
C T T A T  A G G C T  T T G A T G G G A C  T G C G G T A A T C  A C C
A G  A G C  T G T G G C C G C A G A C A A
A G A G C T G T G G C C G C A G A C A A T G G G C T G A C G G C C
185
792
218
825
251
858
284
891
304
924
.................................................... G G G G C C C T C C G T N C C G T C  A C A
G G C  A AC T A T C C  A G G G G C C C T C C G T C C C G T C  A C A
C T AG T A G C C T  A C G A A A G A G T G G C A A C  A G G A T C T  
C T AG T A G C C T  A C G A A A G A G T G G C A A C  A G G A T C T
G T C G T T A C G G T C G C C G G G G T G A G C A A C T T C G A G
G T C G T T A C G G T C G C C G G G G T G A G C A A C T T C G A G
C T G A T C C C A A A T C C T G A A C T  A G C A A A G A A C C  T G  
C T G A T C C C A A A T C C T G A A C T  A G C A A A G A A C C  T G
G T C A C  A G A A T A C G G C C  G A T T  T G A C C C A G G A G C C
G T C AC A G A A T A C G G C C  G A T T  T G A C C C  A G G A G C C
A T G A A C  T A C A C  A A A A T T G A T  A C T G A G T G A G A G G
 A T  A C T G A G T G A G A G G
....................................................................    - A C T G A G T G A G A G G
A T G A A C  T A C A C  A A A A T T G A T  A C T G A G T G A G A G G
G A C C G T C T T G G C A T C  A A G A C C G T A T G G C C A A C A  
G A C C G T C T T G G C A T C A A G A C C G T A T G G C C A A C A  
G A C C G T C T T G G C A T C  A A G A C C G T A T G G C C A A C A  
G A C C G T C T T G G C A T C A A G A C C G T A T G G C C A A C A
A G G G A G T A C A C  T G A C  T T T C G C G A G T A C T T C  A T G  
A G G G A G T A C A C  T G A C  T T T C G C G A G T A C T T C  A T G  
A G G G A G T A C A C  T G A C  T T T C G C G A G T  A C T T C  A T G  
A G G G A G T A C A C  T G A C  T T T C G C G A G T  A C T T C  A T G
G A G G T G G C C G A C C T C  A A C T C  T C C C C  T Q A A G A T T  
G A G G T G G C C G  A C C T C  A A C T C  T C C C C T G A A G A T T  
G A G G T G G C C G A C C T C  A A C T C  T C C C C T G A A G A T T  
G A G G T G G C C G A C C T C A A C T C T C C C C T G A A G A T T
G C A G G A G C A T  T T G G C  T T C
G C A G G A G C A T T T G G C T T C A A A G A C A T A A T C C G G  
G C A G G A G C A T  T T G G C T T C A A A G A C A T A A T C  A G T  
G C A G G A G C A T T T G G C T T C A A A G A C A T A A T C C G G
G C C C T  A A G G A G G A T A G C T G T G C C G G T G G T C  T C T  
G C C C T  A A G G A C  G A T A G C T G T G C C G G  
G C C C T A A G G A G G A T A G C T G T G C C G G T G G T C T C T
A C AC T G T T
A C A C T G T T C C C  A C C C G C C G C  T C C C C  T A G C C C  A T
21
1122
54
1155
87
1188
120
1221
153
1254
186
15
13
1287
219
48
46
1320
252
81
79
1353
285
114
112
1386
303
147
145
1419
180
170
1452
188
1485
MBS 1 - C C G C G T C A G G A A A A G C A A G A G C T G C C T C A G G C  32
Clone 34 1552 G C C G C G  T C A G G  A A A A G C A A G  A G C T  GC C TC A G G C  1584
MB8 3 3  C G C A T  A A G G C  A G C T A A C T C T C G C C G C C G A C  A A G  65
Clone 34 1585 C G C A T  A A G G C  A G C T A A C T C T C G C C G C C G A C  A A G  1617
MB8 66  G G G T A C G A G G T A G T G G C G A A T C T G T T C C A G G T G 9 8
Clone 34 1 6 I8 G G G T A C G A G G T A G T C G C G A A T C T G T T C C A G G T G  1650
MBS 99  C C C C A G A A T C C T G T A G T C G A C G G G A T T C T C G C T  131
Clone 34 1651 C C C C A G A A T C C T G T A G T C G A C G G G A T T C T C G C T  iggg
MB8 132 T C A C C C G G G A T A C T C C G C G G T G C A C  A C A A C C  T C  164
Clone 34 1684 T C A C C C G G G A T  A C T C C  G C G G T  G C A C  A C A A C C  T C  1716
MB8 
Clone 34
MBS 
Clone 34
MB8 
Clone 34
MBS
Clone 34
165
1717
198
1750
231
1783
264
1816
G A C T G C G T G T T G A G A G A G G G T G C C A C G C T A T T C  
G A C T G C G T G T  T G A G A G A G G G T G C C A C G C T A T T C
C C T G T G G T C A T C A C G A C A G T G G A A G A T G C C A T G
C C T G T G G T C A T C A C G A C A G T G G A A G A T G C C A T G
A C A C C C  A AA G C  A C T G  A A C A G C  A A A A T G T T T G C T  
A C A C C C  A AA G C A C T G  A A C A G C  A A A A T G T T T G C T
G T C A T  T G A A G G C G T G C G A G A A
G T C A T T G A A G G C G T G C G A G A A
197
1749
230
1782
263
1815
284
1836
Sequence data from the site directed m utants and deletion mutants. 
All mutants were sequenced over the region first deemed to be VP4 
using prim ers VP4F and VP4R, i.e. betw een the dibasic sites 
RR452453 and KR722723 (nucleotide num bers 1483-2298). M utants 
whose m utations fell outside this area w ere further sequenced 
using  add itional prim ers as s ta ted  in  the chap ter 3. The 
nomenclature for the mutations is as follows: wild type sequence- 
nucleotide num ber-m utation. The nucleotide num ber is given as 
the num ber from the very 5' end of the IBDV UK661 genome. 
Those mutations shown in bold affect the amino acid translation of 
the codon. Those that are in plain text are silent mutations. The 
underlined mutations are those that occurred by either mistake in 
the primer sequence or as a mistake of the Pfii DNA polymerase. A
indicates a base deletion and + indicates a base insertion. For 
reference a nucleotide and amino acid composition of IBDV strain 
UK661 is included behind the sequence data. The nucleotide 
sequence is separated into codons and the amino acids for each 
codon is shown beneath it.
M utant Name Nucleotide Sequence Changes
RR452453MH G1484T, G1487A
S460C A1510G
E475Q-1 A1551G. G1552C, A1560T
D483N G1576A
S494A T1616G
R505A C1642G, G1643C
R507A A1648G, G1649C, A1656G
R543A C1756G, G1757C, T1761G
H545V C1765G, A1766T, C1767T
D549N G1774C
E554Q G1789C, T1794C
T565C A1819T, C1820G
D589K G1894A, T1896G, C1899T
Q595E C1912G, A1920T
S598T C1923G
D615N G1969A, G1974A
E621Q G1987C
Y627F A2003T, C2007G
D631N G2020A, T2022C
SK641642PM T2050C. C2052T, A2054T, A2055G
S651N G2081A, C2082T, A2094C
S652A A2083G, G2084C, A2088C
S652C A2079C, A2083T
S652T T2043A. G2084C. A2088T
S652T+1 G2084C. +2088T
K666M A2126T, A2127G
K692N A2203G
H697D A2217C, C2218G, C2220T
K703M T2226A, A2234T
S715P T2272C
KR722723MH A2294T, A2295G, G2297A
Y741W A2351G, C2352G
D751H G2380C
pDell A1729-1896
pDel2 A1729-2085
pDel3 A1729-2250
pDel4 A1729-2466
pDelô A2329-2388
pDel7 A2359-2418
pDel8 A2389-2448
pDel9 A2419-2466
pDellO A2345-2374
p Del 11 A2387-2401
1 GATACGATCGGTCTGACCCCGGGGGAGTCACCCTGGGACAGGCTGGCAAGGCCTTGTTCCAGG ATG GAA CTC CTC 75
1 M E L L 4
TGA TGGTTAGTAGAGATCAGACAAACGATCGCAGCG ATG ACA AAC CTG 141
H T M L  4
76 CTT CTA CAA TGC TAT
5 L L 0 C Y
142 CAA GAT CAA ACC CAA
5 Q D Q T 0
2 02 CCG GCG TCC ATT CCG
25 P A S I P
2 6 2 TAG AAT TTG ACT GTG
45 Y N L T V
32 2 GGC TCA ATT GTG GGT
65 G S I V G
38 2 ATG CTC CTG ACT GCC
85 M L L T A
44 2 AGT CTC ACA GTG AGG
10 5 S L T V R
50 2 AAC GCC GTG ACC TTC
12 5 N A V T F
562 ATG TCT GCA ACA GCC
14 5 M S A T A
622 ACC GTC CTC AGC TTA
16 5 T V L S L
682 CCC GOT ATA GGG CTC
185 p A I G L
74 2 GTC TAG ACC ATA ACT
2 05 V y T I T
8 02 GTA ACA ATC ACA CTG
2 2 5 V T I T L
8 62 GAA CTC GTG TTT CAA
2 4 5 E L V F 0
9 22 GGC TTT GAT GGG ACT
2 65 G F D T
982 GGC ACT GAC AAC CTT
2 3 5 G T D N L
10 4 2 ATC ACA TCC ATC AAA
305 I T S I K
11 0 2 ATG TCA TGG TCA GCA
32 5 M S W S A
11 6 2 GCC CTC CGT CCC GTC
3 4 5 A L R p V
12 2 2 GTC GCC GGG GTG AGC
36 5 V A G V S
1 2 8 2 ACA GAA TAC GGC CGA
335 T E Y G R
1 3 4 2 AGG GAC CGT CTT GGC
40 5 R D R L G
1 4 0 2 TAG TTC ATG GAG GTG
42 5 Y F M E V
1 4 6 2 AAA GAC ATA ATC CGG
44 5 K D I I R
1 5 2 2 CCC GCC GCT CCC CTA
46 5 P A A P L
1 5 8 2 GCA CAG GCT GCT TCA
485 A Q A A S
1 6 4 2 CGC ATA AGG CAG CTA
50 5 R I R Q L
1 7 0 2 CAG GTG CCC CAG AAT
52 5 Q V P 0 N
1762 GCA CAC AAC CTC GAC
TCA GAG ACC TCG ACC 261
S E T S T 44
TTC CCT GGC TTC CCT 321
P P G F P 64
GTT AGC TAC AAT GGG TTG 561
V S Y N G L 144
CTA GTA GGG GAA GGG GTA 621
L V G E G V 164
AGA CTC GGT GAC CCC ATT 681
R L G D P I 184
AGC AGT GAC AGG CCC AGA 741
S S D R P R 204
CAG TAC CAA GCA GGT GGG 801
Q Y Q A G G 224
AGC CTC AGC ATC GGG GGA 861
S L S I G G 244
GCT ACC ATC TAC CTT ATA 921
A T I Y L r 264
GAC AAT GGG CTG ACG GCC 981
D N G L T A 284
AGC GAG ATA ACC CAG CCA 10 4 1
S E I T 0 P 304
GGT CAG GCG GGG GAT CAG 1 1 0 1
G Q A G D Q 324
GGT GGC AAC TAT CCA GGG 11 6 1
G G N Y P G 344
ACA GGA TCT GTC GTT ACG 1 2 2 1
T G S V V T 364
CTA GCA AAG AAC CTG GTC 1 2 8 1
L A K N L V 384
AAA TTG ATA CTG AGT GAG 134 1
K L I L S E 404
TAC ACT GAC TTT CGC GAG 1401
Y T D F R E 424
GCA GGA GCA TTT GGC TTC 146 1
A G A F G F 444
GTC TCT ACA CTG TTC CCA 152 1
V S T L F P 464
TAC CTG CTG GGC GAT GAG 1581
Y L L G D E 484
GCA AGA GCT GCC TCA GGC 16 4 1
A R A A S G 504
GTA GTC GCG AAT CTG TTC 17 0 1
V V A N L F 524
CCC GGG ATA CTC CGC GGT 176 1
P G I L R G 544
TTC CCT GTG GTC ATC ACG 18 2 1
54 5 A H N L D C V L R E G A T L F P V V I T 564
1822 ACA GTG GAA GAT GCC ATG ACA CCC AAA GCA CTG AAC AGC AAA ATG TTT GCT GTC ATT GAA 1 8 8 1
565 T V E D A M T P K A L N S K M F A V I E 584
18 8 2 GGC GTG CGA GAA GAT CTC CAA CCT CCA TCT CAA AGA GGA TCC TTC ATA CGA ACT CTC TCC 1 9 4 1
58 5 G V R E D L Q P P S Q R G S F I R T L S 604
19 4 2 GGA CAT AGA GTC TAT GGA TAT GCT CCA GAT GGG GTA CTT CCA CTG GAG ACT GGG AGA GTT 2 0 0 1
605 G H R V Y G Y A P D G V L P L E T G R V 624
2 0 0 2 TAC ACC GTG GTC CCA ATA GAT GGT GTC TGG GAC GAC AGC ATT ATG CTG TCC AAA GAC CCC 2 0 6 1
625 Y T V V P I D G V W D D S I M L S K D P 644
2 0 6 2 ATA CCT CCT ATT GTG GGA AGC AGC GGA AAC CTA GCC ATA GCT TAC ATG GAT GTG TTT CGA 2 1 2 1
645 I P P I V G S S G N L A I A Y M D V F R 664
2 1 2 2 CCC AAA GTC CCC ATC CAT GTG GCC ATG ACA GGA GCC CTC AAC GCC TAT GGC GAG ATT GAG 2 1 8 1
665 p K V P I H V A M T G A L N A Y G E I E 684
2 1 8 2 AAT GTG AGC TTT AGA AGC ACC AAG CTC GCC ACT GCA CAC CGA CTT GGC CTC AAG TTG GCT 2 2 4 1
685 N V S F R S T K L A T A H R L G L K L A 70 4
2 2 4 2 GGT CCC GGT GCA TTT GAC GTG AAC ACC GGG TCC AAC TGG GCG ACG TTT ATC AAA CGT TTT 2 3 0 1
7 0 5 G P G A F D V N T G S N W A T F I K R F 724
2 3 0 2 CCT CAC AAT CCA CGC GAC TGG GAC AGG CTC CCC TAC CTC AAC CTT CCA TAC CTT CCA CCC 2 3 6 1
7 2 5 P H N P R D W D R L P Y L N L P Y L P p 74 4
2 3 6 2 AAT GCA GGA CGC CAG TAC GAC CTG GCC ATG GCC GCT TCA GAG TTC AAA GAG ACC CCC GAA 2 4 2 1
7 45 N A G R Q Y D L A M A A S E F K E T P E 76 4
2 4 2 2 CTC GAG AGC GCC GTC AGA GCC ATG GAA GCA GCA GCC AAC GTG GAC CCA CTG TTC CAA TCT 2 4 8 1
765 L E S A V R A M E A A A N V D P L F Q S 784
2 4 8 2 GCG CTC AGC GTG TTC ATG TGG CTG GAA GAG AAT GGG ATT GTG ACT GAT ATG GCC AAC TTC 2 5 4 1
73 5 A L 3 V F M W L E E N G I V T D M A N F 8 04
2 5 4 2 GCA CTC AGC GAC CCG AAC GCC CAT CGG ATG CGC AAT TTT CTC GCA AAC GCA CCA CAA GCA 2 6 0 1
80 5 A 1. S D P N A H R M R N F L A N A P 0 A 8 24
2 6 0 2 GGC AGC AAG TCG CAA AGA GCC AAG TAC GGG ACA GCA GGC TAC GGA GTG GAG GCC CGG GGC 2 6 6 1
82 5 G S K S Q R A K Y G T A G Y V E A R G 8 44
2 6 5 2 CCC ACT CCA GAG GGA GCA CAG AGG GAA AAA GAC ACA CGG ATC TCA AAG AAG ATG GAG ACT 2 7 2 1
84 5 P T P E G A Q R E K D T R I S K K M E T 864
27 2 2 ATG GGC ATC TAC TTT GCA ACA CCA GAA TGG GTA GCA CTC AAT GGG CAC CGG GGG CCA AGC 2 7 8 1
365 M G I Y F A T P E W V A L N G H K P S 884
2 7 3 2 CCC GGC CAG CTG AAG TAC TGG CAG AAC ACA CGA GAA ATA CCT GAT CCA AAC GAG GAC TAC 2 8 4 1
88 5 P G Q L K Y W Q N T R E I P D ? N E D Y 904
2 8 4 2 CTA GAC TAC GTG CAT GCA GAG AAG AGC CGG TTG GCG TCA GAA GGA CAA ATC CTA AGG GCA 2 9 0 1
905 u D Y V H A E K S R L A S E G 0 I L R A 924
2 9 0 2 GCT ACG TCG ATC TAC GGG GCT CCA GGA CAG GCA GAG CCA CCC CAA GCC TTC ATA GAC GAA 2 9 6 1
925 A T S I Y G A P G Q A E P p 0 A F I D E 944
2 9 6 2 GTC GCC AAA GTC TAT GAA GTC AAC CAT GGG CGT GGC CCC AAC CAA GAA CAG ATG AAA GAT 3 0 2 1
94 5 V A K V Y E V N H G R G P N 0 E 0 1! K D 964
302 2 CTG CTC TTG ACT GCG ATG GAG ATG AAG CAT CGC AAT CCC AGG CGG GCC CCA CCA AAG CCC 3 0 8 1
9 6 5 L L L T A M E M K H R N p R R A P P K P 984
3082 AAG CCA AAA CCC AAT GTT CCA ACA CAG AGA CCC CCT GGT CGG TTG GGC CGC TGG ATC AGG 3 1 4 1
9 85 K P K P N V P T 0 R P P G R L G R W I R 1 0 0 4
314 2 GCT GTC TCT GAT GAG GAC CTT GAG TGA GGCTCCTGGGAGTCT 3 1 8 3
100 5 A V S D E D L E * 1 0 1 3
Appendix 3 
N-terminal sequence data for IBDV proteins
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7 / 1 2 / 9 5  1 0 : 1 8  am 2 6 7 1  6 / 1 2 / 9 5
6/12/952671 4;Residue 1
1.00
0.00
5.0 30 .010.0 2 0 . 0 25.015.0
ABI 4 7 3A
7 / 1 2 / 9 5  1 0 : 1 9  am 2 6 7 1  6 / 1 2 / 9 5
6/12/952671 5 :Residue
1.00
0 . 0 0
5.0 10.0 15.0 25.0 30.020.0
ABI 4 7 3 A
7 / 1 2 / 9 5  1 0 : 1 9  am 2 6 7 1  6 / 1 2 / 9 5
6/12/952671 6 :Residue 3
1.00
0.00
5.0 10.0 30.020.015.0 25.0
ABI 4 7 3 A
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26/02/1997 8i5D 3144(A)
File Name: 3144(A)In Folder: Precise HD;Precise f:22 cycles acquired on an Applied Biosystems Precise Sequencer Sequencer Name: PROCISE-BasicRun started on Tuesday, February 25, 1997 at 10:05 
Sample Name: 3144(A)
Sample Amount: 0.0 picomoles Sampling Rate: 4.0 HertzStandard Amount: 20.0 picomoles Detector Scale: 1.000 AUFS
Called sequence: XXXXXXXXXXXXXXXXVHWH
User sequence : XXXXXXXXXXXXXXXXVHWH
Analyzed Using Smooth Degree 9, Interpolated Baseline
Analysis Limits: 1 - 128Integration Limits : 3.70 - 20.00 min.Baseline Limits: 0.10 - 1.00 min.Peak Half Width: 0.05 min.Peak Separation: 0.05 min.Search Length: 0.10 min.RT Factor: 1.00Sensitivity: 1.00
Applied Biosystems Precise - PROCISE-Basic
26/02/1997 8:50 3144(A)
SAMPLE: 3144(A)[ Tuesday, February 25, 1997, 10:05 ]
Sample Amount : 0.0 picomoles
:id# AAcidID R.Time(min) C . Time (min) Pmol(raw) Pmol(-back) Pmol(+lag) AAcidID
1 X 0.00 0.00 0.00 0.00 0 .00 Xaa2 X 0.00 0 .00 0.00 0.00 0.00 Xaa3 X 0.00 0.00 0.00 0.00 0.00 Xaa4 X 0.00 0.00 0.00 0.00 0.00 Xaa5 X 0.00 0.00 0.00 0.00 0.00 Xaa6 X 0.00 0.00 0.00 0.00 0.00 Xaa7 X 0 .00 0.00 0.00 0.00 0.00 Xaa8 X 0.00 0.00 0.00 0.00 0.00 Xaa9 X 0.00 0 .00 0.00 0.00 0.00 Xaa10 X 0.00 0.00 0.00 0.00 0.00 Xaa
11 X 0.00 0.00 0.00 0.00 0.00 Xaa12 X 0.00 0.00 0.00 0.00 0.00 Xaa13 X 0.00 0.00 0.00 0.00 0.00 Xaa14 X 0.00 0.00 0.00 0.00 0.00 Xaa15 X 0.00 0.00 0.00 0 .00 0.00 Xaa16 X 0.00 0.00 0.00 0 .00 0.00 Xaa17 V 15.32 15.26 5.29 0.08 0.08 Val18 H 9.17 9.10 0.82 0.57 0.57 His19 W 17.39 17.53 0.17 0.04 0.04 Trp20 H 9.15 9.10 0.79 0.50 0.50 His
REPETITIVE YIELD ANALYSIS:
X: 1, 2, 3, 4, 5, 6,X; 13, 14, 15, 16 H: 18, 20
7,
Average Repetitive Yield 
Combined Repetitive Yield 
Initial Yield 1,65%
9, 10, 11, 12,
Rep.Yield Variance
100  . 0 0 % 93.82%
96.91% 
92 .23%
1 . 0 0 0
1 . 0 0 0
0.298
:Xaa:His
Applied Biosystems Precise - PROCISE-Basic
26/02/1997 8:50 3144(A)
3144(A) 3:Residue 1Ai
0 . 0 0
-0.40
X
-0.80
- 1 . 2 0
-1.60
12.0 15.0 18.0
Applied Biosystems Precise - PROCISE-Basic
26/02/1997 8:50 3144(A)
3144(A) 4 :Residue 2
0 . 0 0
-0.40
-0.80
- 1.20
-1.60
12.0 15.0 18.0
Applied Biosystems Procise - PROCISE-Basic
26/02/1997 8:50 3144(A)
3144(A) 5:Residue 3
0 . 0 0
-0.40
-0.80
- 1 . 2 0
-1.60
12  . 0 15.0 18.0
Applied Biosystems Procise - PROCISE-Basic
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05/02/1997 8:38 3108(B)
File Name: 3108(B)In Folder: Procise HD;Procise f:17 cycles acquired on an Applied Biosystems Procise Sequencer Sequencer Name : PROCISE-BasicRun started on Tuesday, February 4, 1997 at 10:10 
Sample Name; 3108(B)
Sample Amount : 0.0 picomoles Sampling Rate : 4.0 HertzStandard Amount: 20.0 picomoles Detector Scale: 1.000 AUFS
Called sequence ; GLPTXXXGXHXHXXX
User sequence : GLPTXXXGXHXHXXX
Analyzed Using Smooth Degree 9, Interpolated Baseline
Analysis Limits: 1 - 1 2  8Integration Limits: 3.70 - 20.00 min.Baseline Limits : 0.10 - 1.00 min.Peak Half Width; 0.05 min.Peak Separation: 0.05 min.Search Length; 0.10 min.RT Factor: 1.00Sensitivity: 1.00
Applied Biosystems Procise - PROCISE-Basic
05/02/1997 8:38 3108(B)
SAMPLE: 3108(B)[ Tuesday, February 4, 1997, 10:10 ]
Sample Amount: 0.0 picomoles
AAcid AAcid R .Time C .Time Pmol Pmol Pmol AAcid# ID (min) (min) (raw) (-back) (+lag) ID
1 G 6.75 6.65 468.38 437.94 473.13 Gly2 L 19.31 19.26 7 .83 1.29 1.39 Leu3 P 14.29 14.21 6.79 0.44 0.44 Pro4 T 6.53 6.39 1.87 1.34 1.34 Thr5 X 0 .00 0,00 0.00 0.00 0.00 Xaa6 X 0.00 0.00 0.00 0.00 0.00 Xaa7 X 0.00 0.00 0.00 0.00 0.00 Xaa8 G 6.77 6.65 22.89 1.95 2.09 Gly9 X 0.00 0.00 0.00 0.00 0,00 Xaa10 H 9.13 9.03 0.94 0.81 0.81 His
11 X 0.00 0.00 0.00 0.00 0.00 Xaa12 H 9.15 9.03 0.47 0.37 0.39 His13 X 0.00 0.00 0.00 0.00 0.00 Xaa14 X 0.00 0.00 0.00 0.00 0.00 Xaa15 X 0.00 0.00 0.00 0.00 0.00 Xaa
REPETITIVE YIELD ANALYSIS: Rep.Yield Variance
G: 1, 8 46.13% 1.000 :GlyX: 5, 6, 7, 9, 11, 13, 14, 15 98 .28% 0.403 :XaaH: 10, 12 66.95% 1.000 :His
Average Repetitive Yield 70.45%
Combined Repetitive Yield 84 .96% 0.199
Initial Yield 5.24%
Applied Biosystems Procise - PROCISE-Basic
05/02/1997 8:38 3108(B)
3108(B) 3 :Residue 1
Jû
0 . 0 0
_0
- 1 . 0 0
1 0 . 0 12  . 0 14.0 16.0 18.0
Applied Biosystems Procise - PROCISE-Basic
05/02/1997 8:38 3108(B)
3108(B) 4:Residue 2 ^Jiptc
0 . 0 0
- 1 . 0 0
1 0 . 0 1 2 . 0 14.0 15.0 18.0
Applied Biosystems Procise - PROCISE-Basic
05/02/1997 8:38 3108(B)
3108(B) 5 : Residue 3
0 . 0 0
dR'
- 1.00
w
10.0 12.0 14.0 16.0 18.0
Applied Biosystems Procise - PROCISE-Basic
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27/02/1997 8:45 3145(A)
File Name: 3145(A)In Folder: Procise HD:Procise f:22 cycles acquired on an Applied Biosystems Procise Sequencer Sequencer Name : PROCISE-BasicRun started on Wednesday, February 25, 1997 at 9:47 
Sample Name: 3145(A)
Sample Amount : 0.0 picomoles Sampling Rate : 4.0 HertzStandard Amount: 20.0 picomoles Detector Scale: 1.000 AUFS
Called sequence : GXXXXXXXWXHXXXXXWHYX
User sequence: GXXXXXXXWXHXXXXXWHYX
Analyzed Using Smooth Degree 9, Interpolated Baseline
Analysis Limits: 1 - 128Integration Limits : 3.70 - 20.00 min.Baseline Limits : 0.10 - 1.00 min.Peak Half Width: 0.05 min.Peak Separation: 0.05 min.Search Length: 0.10 min.RT Factor: 1.00Sensitivity: 1.00
Applied Biosystems Procise - PROCISE-Basic
27/02/1997 8:45 3145(A)
SAMPLE ; 3145(A)[ Wednesday, February 26, 1997, 9:47 ]
Sample Amount : 0.0 picomoles
:id# AAcidID R . Time (min) C .Time (min) Pmol(raw) Pmol(-back) Pmol(+lag) AAcidID
1 G 6.68 6^a 914.21 897.67 1216.90 Gly2 X 0.00 0.00 0.00 0.00 0.00 Xaa3 X 0.00 0 .00 0.00 0.00 0.00 Xaa4 X 0.00 0.00 0.00 0.00 0.00 Xaa5 X 0.00 0 .00 0 .00 0.00 0.00 Xaa6 X 0.00 0.00 0.00 0.00 0.00 Xaa7 X 0.00 0.00 0.00 0.00 0.00 Xaa8 X 0.00 0.00 0.00 0.00 0.00 Xaa9 w 17.37 17 .48 0.25 0 .13 0.13 Trp10 X 0.00 0.00 0.00 0.00 0.00 Xaa
11 H 8. 86 9.07 0.25 0.10 0.13 His12 X 0.00 0.00 0.00 0.00 0.00 Xaa13 X 0.00 0.00 0.00 0.00 0.00 Xaa14 X 0.00 0.00 0.00 0.00 0.00 Xaa15 X 0 . 00 0 .00 0.00 0.00 0.00 Xaa16 X 0.00 0.00 0.00 0.00 0.00 Xaa17 w 17.54 17 .48 0.16 0.14 0 .14 Trp18 H 9.07 9.07 0.44 0.32 0 .32 His19 Y 11.82 11.70 2.17 0.23 0.28 Tyr20 X 0.00 0.00 0 .00 0.00 0.00 Xaa
REPETITIVE YIELD ANALYSIS:
Average Repetitive Yield 
Combined Repetitive Yield 
Initial Yield
Rep.Yield Variance
X: 2, 3, 4, 5, 6, 7, 8, 10, 12, 13, 14, 15,X: 16, 20 86.05% 0.206 :XaaW: 9, 17 100.94% 0.999 :TrpH: 11, 18 117.29% 1.000 :His
4 .14%
101.43%
86.45% 0 .224
Applied Biosystems Procise - PROCISE-Basic
27/02/1997 8:45 3145(A)
3145(A) 3:Residue 1
-0.30
-0.60
-0.90
_P
- 1 . 2 0
-1.50
1 2 . 0 15.0 18.0
Applied Biosystems Procise - PROCISE-Basic
27/02/1997 8:45 3145(A)
3145(A) 4 : Residue 2
-0.30
-0.60
-0.90
- 1 . 2 0
-1.50
12.0 15.0 18.0
Applied Biosystems Procise - PROCISE-Basic
27/02/1997 8:45 3145(A)
3145(A) 5 : R e s i d u e  3JU>t
- 0 . 3 0
- 0 . 6 0
- 0 . 9 0
- 1 . 2 0
- 1 . 5 0
1 2 . 0 1 5  . 0 1 8 . 0
Applied Biosystems Procise - PROCISE-Basic
i;5/07/1997 11:53 AM JK-2
File Name: JK-2In Folder: Macintosh HD:Procise/:14 cycles acquired on an Applied Biosystems Procise Sequencer Sequencer Name: PROCISE-HTRun started on Saturday, July 19, 1997 at 3:45 PM
Sample Name: 
Sample Amount: Standard Amount:
User Comments;
JK-2
0.0 picomoles12.0 picomoles Sampling Rate: Detector Scale: 4.0 Hertz1.000 AUFS
major structural protein VP2 - infectious bursal disease virus
Called sequence: 
User sequence:
TNLQDQTQQIVP
TNLQDQTQQIVP
Note; Modified Integration Parameters Were Used!
Applied Biosystems Procise - PROCISE-HT
25/07/1997 11:54 AM JK-2
SAMPLE: JK-2( Saturday, July 19, 1997, 3:45 PM ]
Sample Amount; 0.0 picomoles
AAcid AAcid R .Time C .Time Pmol Pmol Pmol AAcid# ID (min) (min) (raw) (-back) (+lag) ID
1 T 5.68 5.66 6.52 3.54 3.83 Thr2 N 4.67 4.51 9.25 7.09 8.16 Asn3 L 17.21 17.14 9.41 6.85 7.90 Leu4 Q 5.62 5.46 7.51 4.58 4.58 Gin5 D 4.28 4.16 7.90 3.05 3.05 Asp6 Q 5.63 5.46 5.39 1.89 1.89 Gin7 T 5.82 5.66 6.50 2.75 2.89 Thr8 Q 5.64 5.46 5.51 1.44 1.63 Gin9 Q 5.63 5.46 6.00 1.65 1.46 Gin10 I 16.73 16.64 7.13 3.80 4.29 lie
11 V 13.66 13.55 6.90 2.13 2.13 Val12 p 12.78 12.66 4.28 1.57 1.57 Pro
REPETITIVE YIELD ANALYSIS: Rep.Yield Variance
T; 1, 7 95.89% 1.000 :ThrQ: 4, 6, 8, 9 81.19% 0.785 :Gln
Average Repetitive Yield 
Combined Repetitive Yield 
Initial Yield 5.88%
88.54%
89.76% 0.502
Applied Biosystems Procise - PROCISE-HT
25/07/1997 11:54 AM JK-2
Uncorr A D E F 6 H I K L1 1.36 2.12 0.93 0.68 3.15 0.49 0.89 1.90 1.452 2.25 5.26 1.14 0.78 4.63 0.00 5.97 1.63 4.523 1.66 4.02 1.45 1.06 3.45 0.55 2.06 1.20 9.414 2.99 4.30 2.19 0.76 4.06 0.62 4.40 1.31 4.425 3.08 7.90 1.91 0.86 3.31 0.58 2.99 1.25 3.736 2.88 4.85 1.93 1.33 3.63 0.93 3.40 0.97 3.477 3.07 5.00 1.89 3.02 3.85 0.95 2.70 1.03 3,758 3.26 5.08 2.39 1.78 3.43 0.39 3.21 1.03 3.809 3.25 4.67 2.41 1.54 4.47 0.51 2.80 1.36 4.7010 3.11 5.26 1.89 2.17 3.88 0.61 7.13 1.32 4.0011 3.36 5.27 1.83 2.08 4.14 0.00 5.24 1.25 4.8312 2.71 4.69 2.06 1.79 3.93 0.85 3.75 1.12 4.55
M N P Q R S T V W1 0.00 1.79 1.90 1.53 2.34 5.69 6.52 1.05 0.002 1.73 9.25 1.87 2.59 0.28 4.04 3.41 3.68 0.083 1.75 5.20 3.05 2.71 0.00 3.66 2.99 3.71 0.144 1.63 3.53 2.39 7.51 0.00 3.88 3.49 2.77 0.055 1.69 3.81 2.00 3.03 0.00 3.98 3.83 3.80 0.006 1.69 3.29 2.53 5.39 0.00 1.93 3.51 2.89 0.007 1.56 3.78 2.18 3.67 0.00 3.86 6.50 3.66 0.008 1.41 3.35 2.84 5.51 0.00 1.86 4.02 4.45 0.009 1.57 3.20 2.53 6.00 0.00 2.47 3.24 3.38 0.0010 1.52 5.04 2.33 4.57 0.00 4.44 4.76 3.76 0.0011 1.63 4.98 2.52 3.58 0.00 4.81 4.97 6.90 0.0012 1.46 3.88 4.28 1.70 0.00 2.92 3.74 4.73 0.00
12345678 9101112
Y0.911.311.821.401.381.712.102.242.052.112.272.03
Applied Biosystems Procise - PROCISE-HT
25/07/1997 11:54 AM JK-2
Bkgnd A D E F G H I K L1 0.00 0.00 0.00 0.03 0 .00 0.01 0.00 0.46 0.002 0.00 0.62 0.00 0.00 0.87 0.00 4.28 0.23 2.243 0.00 0.00 0.00 0.14 0.00 0.05 0.17 0.00 6.864 0.43 0.00 0.60 0.00 0.25 0.11 2.30 0.00 1.595 0.39 3.05 0.24 0.00 0.00 0.06 0.69 0.00 0.646 0.06 0.00 0.18 0.00 0.00 0.40 0.89 0.00 0.117 0.13 0.01 0.05 1.56 0.00 0.40 0.00 0.00 0.128 0.19 0.02 0.46 0.19 0.00 0.00 0.29 0.00 0.009 0.04 0.00 0.40 0.00 0.52 0.00 0.00 0.18 0.5310 0.00 0.05 0.00 0.30 0.00 0.03 3.80 0.17 0.0011 0.00 0.00 0.00 0.08 0.12 0.00 1.70 0.13 0.1312 0.00 0.00 0.00 0.00 0.00 0.24 0.00 0.03 0.00
M N P Q R S T V W1 0.00 0.00 0.00 0.00 1.58 2.06 3.54 0.00 0.002 0.03 7.09 0.00 0.22 0.00 0.39 0.29 1.22 0.033 0.07 2.76 0.90 0.06 0.00 0.00 0.00 0.99 0.094 0.00 0.80 0.18 4.58 0.00 0.18 0.11 0.00 0.015 0.05 0.80 0.00 0.00 0.00 0.26 0.33 0.56 0.006 0.07 0.00 0.20 1.89 0.00 0.00 0.00 0.00 0.007 0.00 0.21 0.00 0.00 0.00 0.09 2.75 0.00 0.008 0.00 0.00 0.38 1.44 0.00 0.00 0.14 0.45 0.009 0.01 0.00 0.01 1.65 0.03 0.00 0.00 0.00 0.0010 0.00 0.63 0.00 0.00 0.13 0.58 0.62 0.00 0.0011 0.11 0.29 0.00 0.00 0.23 0.93 0.70 2.13 0.0112 0.00 0.00 1.57 0.00 0.32 0.00 0.00 0.00 0.02
12345678 9101112
Y0.000.050.450.000.000.000.280.310.000.000.00
0 . 0 0
Applied Biosystems Procise - PROCISE-HT
25/07/1997 11:54 AM JK-2
Lag A D E F G H I K L1 0.00 0.00 0.00 0.03 0.00 0.01 0.00 0.46 0.002 0.00 0.62 0.00 0.00 0.87 0.00 4.28 0.23 2.243 0.00 0.00 0.00 0.14 0.00 0.05 0.17 0.00 7.904 0.43 0.00 0.60 0.00 0.25 0.11 2.30 0.00 0.705 0.39 3.05 0.24 0.00 0.00 0.06 0.69 0.00 0.516 0.06 0.00 0.18 0.00 0.00 0.40 0.89 0.00 0.097 0.13 0.01 0.05 1.56 0.00 0.40 0.00 0.00 0.128 0.19 0.02 0.46 0.19 0.00 0.00 0.29 0.00 0.009 0.04 0.00 0.40 0.00 0.52 0.00 0.00 0.18 0.5310 0.00 0.05 0.00 0.30 0.00 0.03 4.29 0.17 0.0011 0.00 0.00 0.00 0.08 0.12 0.00 1.20 0.13 0.1312 0.00 0.00 0.00 0.00 0.00 0.24 0.00 0.03 0.00
M N P Q R S T V w1 0.00 0.00 0.00 0.00 1.58 2.06 3.83 0.00 0.002 0.03 8.16 0.00 0.22 0.00 0.39 0.00 1.22 0.033 0.07 1.83 0.90 0.06 0.00 0.00 0.00 0.99 0.094 0.00 0.67 0.18 4.58 0.00 0.18 0.11 0.00 0.015 0.05 0.78 0.00 0.00 0.00 0.26 0.33 0.56 0.006 0.07 0.00 0.20 1.89 0.00 0.00 0.00 0.00 0.007 0.00 0.21 0.00 0.00 0.00 0.09 2.89 0.00 0.008 0.00 0.00 0.38 1.63 0,00 0.00 0.00 0.45 0.009 0.01 0.00 0.01 1.46 0.03 0.00 0.00 0.00 0.0010 0.00 0.63 0.00 0.00 0.13 0.58 0.52 0.00 0.0011 0.11 0.29 0.00 0.00 0.23 0.93 0.70 2-13 0.0112 0.00 0.00 1.57 0.00 0.32 0.00 0.00 0.00 0.02
12345678 9101112
Y
0 . 0 00.050.450.00
0 . 0 0
0 . 0 00.280.31
0 . 0 0
0 . 0 0
0 . 0 0
0 . 0 0
Applied Biosystems Precise - PROCISE-HT
25/07/1997 11:54 AM JK-2
Call First Second Third1 T S R2 N I L3 L P H4 Q I E5 D T V6 Q H P7 T F S8 Q V E9 Q G L10 I N T11 V S L12 P H R
Applied Biosystems Procise - PROCISE-HT
25/07/1997 12:37 PM JK-3
File Name: JK-3In Folder: Macintosh HD:Procise/;17 cycles acquired on an Applied Biosystems Procise Sequencer Sequencer Name: PROCISE-HTRun started on Sunday, July 20, 1997 at 2:48 PM
Sample Name: 
Sample Amount; Standard Amount:
JK-3
0.0 picomoles12.0 picomoles Sampling Rate: Detector Scale: 4.0 Hertz1.000 AUFS
Called sequence: RPEYEVSNWNYRDNA
User sequence: XPEYEV
Note: Modified Integration Parameters Were Usedl
Applied Biosystems Procise - PROCISE-HT
25/07/1997 12:38 PM JK-3
SAMPLE: JK-3[ Sunday, July 20, 1997 , 2:48 PM 1
Sample Amount: 0. 0 picomoles
AAcid AAcid R.Time C .Time Pmol Pmol Pmol AAcid# ID (min) (min) (raw) (-back) (+lag) ID
1 X 0.00 0.00 0.00 0.00 0.00 Xaa2 P 12.72 12.39 2.61 1.02 1.05 Pro3 E 6.60 6.28 3.76 1.07 1.07 Glu4 Y 10.57 10.23 1.96 1.59 1.71 Tyr5 E 6.60 6.28 3.55 0.97 1.02 Glu6 V 13.56 13.29 1.78 0.87 0.87 Val
REPETITIVE YIELD ANALYSIS: Rep.Yield Variance
E: 3, 5 95.31% 1.000 :Glu
Average Repetitive Yield 
Combined Repetitive Yield 
Initial Yield 1.12%
95,31%
98.70% 0.014
Applied Biosystems Procise - PROCISE-HT
25/07/1997 12:38 PM JK-3
Uncorr A D E F G H I K L1 2.01 5.45 0.83 0.64 1.25 0.00 0.61 1.65 1.152 2.72 2.04 1.64 0.38 1.52 0.17 0.80 0.69 0.893 1.08 5.29 3.76 1.02 2.58 0.33 1.06 0.60 1.064 1.45 1.56 2.43 1.18 1.69 0.00 1.37 0.80 2.225 1.82 5.04 3.55 0.55 2.36 0.84 0.88 1.13 1.656 2.55 1.90 2.58 0.75 1.71 0.21 0.87 0.65 1.387 2.88 5.36 2.47 0.48 1.98 0.00 0.93 0.65 1.688 3.31 5.33 2.47 0.69 1.52 0.42 0.95 0.59 1.839 2.23 1.70 2.27 0.51 1.40 0.34 0.69 0.59 1.9010 2.73 5.18 2.39 0.53 1.87 0.00 1.20 0.66 2.0811 2.62 2.00 2.28 0.90 1.82 0.89 1.09 0.63 1.8712 2.38 1.84 2.19 0.92 1.91 0.23 1.32 0.57 2.0313 3.07 3.63 1.97 0.77 1.75 0.47 1.56 0.55 1.8614 3.28 4.51 1.79 0.89 1.70 0.73 1.83 0.96 2.0915 3.73 2.09 2.33 0.91 1.63 0.35 1.31 0.76 2.00
M N P Q R S T V W1 0.47 4.63 0.53 1.92 1.83 4.41 1.19 0.64 0.272 0.27 1.90 2.61 1.30 0.36 1.79 0.58 0.86 0.003 0 .00 4.39 1.62 2.19 0.37 3.85 1.51 0.61 0.004 0.20 1.13 1.64 1.34 1.34 1.17 0.64 0.52 0.365 0.24 4.40 1.98 1.91 0.44 3.02 0.89 1.10 0.196 0.24 0.85 1.38 1.09 0.57 1.41 0.71 1.78 0.087 0.42 4.65 1.54 2.61 0,00 4.12 1.94 0.86 0.388 0.66 4.99 1.88 2.38 0.00 3.54 1.17 1.57 0.009 0.48 1.21 1.41 1.21 0.31 0.89 0.57 1.15 0.3610 0.54 4.32 1.49 2.02 0.00 2.80 0.92 0.99 0.0511 1.28 1.00 1.50 0.83 0.00 0.85 0.63 1.11 0.0012 0.88 0.93 1.59 0.63 0.48 0.71 0.90 1.12 0.0013 0.56 1.49 1.65 0.87 0.23 0.79 0.91 1.34 0.5714 0.89 3.49 1.70 1.11 0.34 1.28 0.98 1.33 0.5315 0.79 1.08 1.73 1.07 0.38 0.85 0.75 1.50 0.60
1234567
8 9
10
11
12131415
Y0.780.340.371.960.820.57
0 . 0 00,300.19
0 . 1 21.070.180.43
0 . 2 10.13
Applied Biosystems Procise - PROCISE-HT
25/07/1997 12:38 PM JK-3
Bkgnd A D E F G H I K L1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.94 0.002 0.51 0.00 0.00 0.00 0.00 0.00 0.09 0-00 0.003 0.00 0.00 1.07 0.35 0.90 0.13 0.29 0.00 0.004 0.00 0.00 0.00 0.49 0.00 0.00 0.55 0.12 0.775 0.00 0.00 0.97 0.00 0.66 0.58 0.00 0.46 0.136 0.02 0.00 0.05 0.03 0.01 0.00 0.00 0.00 0.007 0.27 0.15 0.01 0.00 0.27 0.00 0.00 0.00 0.048 0.62 0.44 0.05 0.00 0.00 0.09 0.00 0.00 0.129 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.1210 0.00 0.93 0.09 0.00 0.13 0.00 0.04 0.04 0.2311 0.00 0.00 0.04 0.10 0.08 0.48 0.00 0.01 0.0012 0.00 0.00 0.01 0.10 0.16 0.00 0.04 0.00 0.0513 0.00 0.34 0.00 0.00 0.00 0.00 0.22 0.00 0.0014 0.11 1.54 0.00 0.04 0.00 0.23 0.43 0.38 0.0015 0.47 0.00 0.31 0.04 0.00 0.00 0.00 0.18 0.00
M N P Q R S T V W1 0.42 0.00 0.00 0.00 1.44 1.19 0.41 0.00 0.202 0.16 0.00 1.02 0.00 0.00 0.00 0.00 0.16 0.003 0.00 0.00 0.03 0.21 0.00 0.97 0.72 0.00 0.004 0.00 0. 00 0.05 0.00 0.98 0.00 0.00 0.00 0.225 0.00 0.05 0.38 0.09 0.08 0.49 0.09 0.24 0.036 0.00 0.00 0.00 0.00 0.22 0.00 0.00 0.87 0.007 0.04 0.86 0.00 0.94 0.00 1.94 1.13 0.00 0.178 0.23 1.47 0.26 0.79 0.00 1.53 0.36 0.54 0.009 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.1210 0.00 1.36 0.00 0.59 0.00 1.14 0.09 0.00 0.0011 0.68 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.0012 0.23 0.00 0.00 0.00 0.17 0.00 0.06 0.00 0.0013 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.04 0.2314 0.13 1.65 0.05 0.00 0.05 0.31 0.12 0.00 0.1715 0.00 0.00 0.07 0.02 0.10 0.06 0.00 0.10 0.22
12345678 9
10
1112131415
Y0.36
0 . 0 0
0 . 0 01.590.460.23
0 . 0 0
0 . 0 0
0 . 0 0
0 . 0 00.80
0 . 0 00.19
0 . 0 0
0 . 0 0
Applied Biosystems Procise - PROCISE-HT
;'5/07/1997 12:38 PM JK-3
Lag A D E F G H I K L1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.94 0.002 0.51 0.00 0.00 0.00 0.00 0.00 0.09 0.00 0.003 0.00 0.00 1.07 0.35 0.90 0.13 0.29 0.00 0.004 0.00 0.00 0.00 0.49 0.00 0.00 0.55 0.12 0.775 0.00 0.00 1.02 0.00 0.66 0.58 0.00 0.46 0.136 0.02 0.00 0.00 0.03 0.01 0.00 0.00 0.00 0.007 0.27 0.15 0.01 0.00 0.27 0.00 0.00 0.00 0.048 0.62 0.44 0.05 0.00 0.00 0.09 0.00 0.00 0.129 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.1210 0.00 0.93 0.09 0.00 0.13 0.00 0.04 0.04 0.2311 0.00 0.00 0.04 0.10 0.08 0.48 0.00 0.01 0.0012 0.00 0.00 0.01 0.10 0.16 0.00 0.04 0.00 0.0513 0.00 0.36 0.00 0.00 0.00 0.00 0.22 0.00 0.0014 0.11 1.52 0.00 0.04 0.00 0.23 0.43 0.38 0.0015 0.47 0.00 0.31 0.04 0.00 0.00 0.00 0.18 0.00
M N P Q R S T V w1 0.42 0.00 0.00 0.00 1.44 1.19 0.41 0.00 0.202 0.16 0.00 1.05 0.00 0.00 0. 00 0.00 0.16 0.003 0.00 0.00 0.00 0.21 0.00 0.97 0.72 0.00 0.004 0.00 0.00 0.05 0.00 0.98 0.00 0.00 0.00 0.225 0.00 0.05 0.38 0.09 0.08 0.49 0.09 0.24 0.036 0.00 0.00 0.00 0.00 0.22 0.00 0.00 0.87 0.007 0.04 0.86 0.00 0.94 0.00 2.07 1.13 0.00 0.178 0.23 1.47 0.26 0,79 0.00 1.40 0.36 0.54 0.009 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.1210 0.00 1.36 0.00 0.59 0.00 1.14 0.09 0.00 0.0011 0.68 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.0012 0.23 0.00 0.00 0.00 0.17 0.00 0.06 0.00 0.0013 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.04 0.2314 0.13 1.65 0.05 0.00 0.05 0.31 0.12 0.00 0.1715 0.00 0.00 0.07 0.02 0.10 0.06 0.00 0.10 0.22
12345678 9
10
11
12131415
Y0.36
0 . 0 0
0 . 0 01.710.36
0 . 2 2
0 . 0 0
0 . 0 0
0 . 0 0
0 . 0 00.80
0 . 0 00.19
0 . 0 0
0 . 0 0
Applied Biosystems Precise - PROCISE-HT
25/07/1997 12:38 PM JlC-3
Call First Second Third1 R D S2 P A E3 E D s4 Y R L5 E D H6 V A R7 S T N8 N V S9 W R L10 N D S11 Y M H12 R T M13 D W A14 N D S15 A E V
Applied Biosystems Precise - PROCISE-HT
Addendum
Addendum
H erpesvirus serine pro tease
Herpesviruses are dsDNA viruses that are divided into three subfamilies: the alpha 
subfamily includes herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) and 
varicella-zoster virus (VZV); the beta subfamily includes cytomegalovirus (CMV), 
hum an herpesvirus-6 (HHV-6) and HHV-7; and the gam m a subfam ily includes 
Epstein-Barr virus (EBV) and HHV-8. An essential step in herpesvirus capsid 
assembly is the processing of the assemblin protein designated ICP-35 in HSV-1 
(Gao et al., 1994). The processing is achieved by the virally encoded protease that 
encodes the assemblin protein in its C-terminus. The prom oter of the UL26.5 ORE is 
em bedded in the 5' terminal domain of the coding sequences of the UL26 ORE. The 
protease encoded by the UL26 gene can process itself and its substrate ICP35, 
encoded by the UL26.5 gene (Preston et a i, 1992). The protease then catalyses itself to 
produce a 247 residue N -terininal dom ain that has full catalytic activity (Liu & 
Roizman, 1993, Liu & Roizman, 1991). Results of studies w ith a variety of pro tease 
inhibtors showed that the UL26 protease was inhibited by serine pro tease inhibitors 
but not those that inhibited cysteine, aspartic or m etalloproteases (Liu & Roizman, 
1992). Of the conserved aspartic acid, histidine or serine residues in the amino- 
proxim al dom ain, only histid ine 16 and 148 could no t be replaced w ithout 
im pairm ent of the proteolytic activity (Liu & Roizman, 1992).
Expression of the pro tease in E. coli as a fusion protein containing a unique epitope 
and  the p ro te in  A b ind ing  dom ain at its carboxyl term inus, underw en t 
autoproteolytic cleavage at 2 distinct sites (Dilanni et aL, 1993). Protein sequencing 
revealed that the cleavage occurs between the alanine and serine residues at 610/611
and 247/248 of the HSV-1 pro tease. W ith the hum an CMV virus pro tease, other 
internal cleavage sites were identified between alanine 143
- alanine 144 and alanine 209 -  serine 210 (Jones et aL, 1994). The three dimensional 
structure of the hum an CMV protease by x-ray diffraction showed a catalytic triad of 
histidine 63, serine 132 and histidine 157, unlike other serine pro tease catalytic triads 
(Chen et aL, 1996, Qiu et aL, 1996, Shieh et aL, 1996, Tong et aL, 1996). The crystal 
structure of the hum an HSVl and 2 shows a similar catalytic triad of histidine 61, 
serine 129 and histidine 148 (see figure A l) (Hoog et aL, 1997). The overall structure 
of the herpesvirus proteases are unlike the classical chymo trypsin-like fold but are 
described as a seven stranded beta-barrel w ith seven alpha helices (see figure A l) 
(Chen et aL, 1996, Hoog et al., 1997, Qiu et al., 1996, Shieh et al., 1996, Tong et al., 
1996). Analysis of similar residues in the IBDV genome show ed that based on the 
CMV His(63) Ser(132) and His(157) there is a His at 670 in polyprotein making S652 
H670 which w asn't m utated because it is not conserved w ith the other birnaviruses. 
Also His at 697, which was m utated H697D, caused as m uch of an effect as K692N. 
H606 w asn't m utated and is not conserved and H546 w as m utated but it did not 
affect processing. Alignment of representative members of the IBDV sequences and 
the HSV-1, bovine herpesvirus (BHV) and pseudorabies virus (PRV) pro teases 
showed little homology between the proteases from each family (see figure A2).
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%Figure Al. Three-dimensional structure of the herpes simplex virus 1 serine 
protease. The structure is displayed using Rasmol v2.6 program. The molecule is 
display as a cartoon format with the alpha helices shown in red and the beta- 
sheets shown in yellow. The arrows on the beta sheets show the direction of the 
protein. The catalytic triad of His (61), Ser (129) and His (148) are displayed as a 
stick format and labelled with the residue name and the position.
Figure A2. A lignm ent of the VP4 region from  residue 454-755 from  IBDV strains UK661, KS-l, 52 /70  and 
PBG98 w ith  the serine pro  tease from  the herpesv iruses Bovine herpesv irus (BHV), H erpes Simplex Virus 
type 1 (FISV-1) and  Pseudorahiesv irus (PRV). The b lue shad ing  show s hom ologous residues w hilst the 
black outline show s the identical residues.
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